| First Author (yr) | Title | Citation | Data |
|---|
| Abad (2021) |
Prevalent subtypes and one-year outcomes of an HIV-cohort from an urban Philippine center. |
Medicine (Baltimore) |
|
| Abdellaziz (2016) |
Predominance of CRF06_cpx and Transmitted HIV Resistance in Algeria: Update 2013-2014. |
ARHR |
|
| Abdissa (2014) |
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. |
BMC Infect Dis |
|
| Abdoel Wahid (2016) |
HIV-1 genetic diversity and drug resistance mutations among treatment-naive adult patients in Suriname. |
ARHR |
|
| Abdool Karim (2010) |
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. |
Science |
|
| Abdullahi (2023) |
Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort. |
J Antimicrob Chemother |
|
| Abecasis (2007) |
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. |
J Virol |
|
| Abecasis (2011) |
Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients. |
AIDS Res Hum Retroviruses |
|
| Abidi (2021) |
Phylogenetic and Drug-Resistance Analysis of HIV-1 Sequences From an Extensive Paediatric HIV-1 Outbreak in Larkana, Pakistan. |
Front Microbiol |
|
| Abongwa (2019) |
Human immunodeficiency virus type 1 (HIV-1) subtypes in the northwest region, Cameroon. |
Virol J |
|
| Abram (2013) |
Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. |
AAC |
|
| Abram (2016) |
Pre-existing HIV-1 integrase polymorphisms do not impact treatment response to elvitegravir-containing fixed-dose combination regimens in treatment-naive patients. |
HIV Drug Therapy 2016 Glasgow |
|
| Acharya (2014) |
Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients. |
PLoS ONE |
|
| Acharya (2019) |
Near-Full-Length Genetic Characterization of a Novel HIV-1 Unique Recombinant with Similarities to A1, CRF01_AE, and CRFO2_AG Viruses in Yaounde, Cameroon. |
ARHR |
|
| Acharya (2020) |
Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy. |
Int J Mol Sci |
|
| Adhiambo (2021) |
Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross-sectional study conducted in Teso, Western Kenya. |
Pan Afr Med J |
|
| Adojaan (2005) |
Predominance of a rare type of HIV-1 in Estonia. |
JAIDS |
|
| Afonso (2012) |
HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola. |
PLoS ONE |
|
| Aghokeng (2009) |
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries. |
Antivir Ther |
|
| Aghokeng (2011) |
High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity |
J Clin Microbiol |
|
| Aghokeng (2011) |
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. |
AIDS |
|
| Aghokeng (2013) |
Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon. |
J Int AIDS Soc |
|
| Aghokeng (2014) |
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia. |
Clin Infect Dis |
|
| Agwale (2006) |
Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. |
ARHR |
|
| Agyingi (2014) |
The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations. |
J Med Virol |
|
| Ahmed (2019) |
Development of the R263K Mutation to Dolutegravir in an HIV-1 Subtype D Virus Harboring 3 Class-Drug Resistance |
Open Forum Infect Dis |
|
| Ait-Khaled (2002) |
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine, zidovudine in HIV-1 infected adults with no prior antiretroviral therapy. |
Antivir Ther |
|
| Ajoge (2012) |
Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in north-central Nigeria. |
ARHR |
|
| Akrim (2012) |
HIV-1 subtype distribution in Morocco based on national sentinel surveillance data 2004-2005. |
AIDS Res Ther |
|
| Alaoui (2018) |
Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco. |
BMC Res Notes |
|
| Alaoui (2019) |
HIV-1 Integrase Resistance among Highly Antiretroviral Experienced Patients from Morocco. |
Intervirology |
|
| Albert (1994) |
Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. |
J Virol |
|
| Albrecht (2000) |
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. |
ARHR |
|
| Albrecht (2001) |
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.AIDS Clinical Trials Group 364 Study Team. |
N Engl J Med |
|
| Alcantara (2013) |
Increasing heterosexual transmission of HIV-1 subtype C in inland central western Brazil. |
J Med Virol |
|
| Alencar (2013) |
HIV genotypes and primary drug resistance among HIV seropositive blood donors in Brazil: Role of infected blood donors as sentinel populations for molecular surveillance of HIV. |
JAIDS |
|
| Alessandri-Gradt (2017) |
HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors. |
J Antimicrob Chemother |
|
| Alexiev (2015) |
Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity. |
J Antimicrob Chemother |
|
| Alizon (1986) |
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. |
Cell |
|
| Alonso (2025) |
Prevalence of acquired resistance to antiretrovirals in children and adolescents living with HIV under clinical follow-up at the Roosevelt Hospital in Guatemala. |
J Infect Public Health |
|
| Alves (2019) |
Estimating HIV-1 Genetic Diversity in Brazil Through Next-Generation Sequencing. |
Front Microbiol |
|
| Amaral (2017) |
An overview of the molecular and epidemiological features of HIV-1 infection in two major cities of Bahia state, Brazil. |
Mem Ins Oswaldo Cruz |
|
| Ambike (2019) |
Partial pol sequences from drug naive HIV-2 infected individuals from Maharashtra, India. |
ARHR |
|
| Amogne (2016) |
Phylogenetic analysis of Ethiopian HIV-1 Subtype C near full-length genomes reveals high intrasubtype diversity and a strong geographical cluster. |
ARHR |
|
| An (2012) |
Reconstituting the epidemic history of HIV strain CRF01_AE among men who have sex with men (MSM) in Liaoning, northeastern China: Implications for the expanding epidemic among MSM in China |
J Virol |
|
| An (2021) |
The Viral Founder Effect and Economic-Driven Human Mobility Shaped the Distinct Epidemic Pattern of HIV-1 CRF01_AE in Northeast China. |
Front Med (Lausanne) |
|
| An (2021) |
Independent epidemic patterns of HIV-1 CRF01_AE lineages driven by mobile population in Shenzhen, an immigrant city of China. |
Virus Evol |
|
| Anderson (2000) |
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. |
J Virol |
|
| Andersson (1999) |
Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in west Africa. |
Virology |
|
| Andreatta (2013) |
HIV-2 antiviral potency and selection of drug resistance mutations by the integrase strand transfer inhibitor elvitegravir and NRTIs emtricitabine and tenofovir in vitro. |
JAIDS |
|
| Andreatta (2018) |
Integrase Inhibitor Resistance Selections Initiated with Drug Resistant HIV-1. |
CROI |
|
| Andresen (2007) |
Characterization of near full-length genomes of HIV type 1 strains in Denmark: Basis for a universal therapeutic vaccine. |
ARHR |
|
| Andries (2004) |
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. |
AAC |
|
| Anstett (2015) |
Dolutegravir resistance mutation R263K cannot coexist in combination with many classical integrase inhibitor resistance substitutions. |
J Virol |
|
| Anstett (2015) |
Dolutegravir-selected HIV-1 containing the N155H and R263K resistance substitutions does not acquire additional compensatory mutations under drug pressure that lead to higher-level resistance and increased replicative capacity. |
J Virol |
|
| Anstett (2016) |
Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity. |
J Antimicrob Chemother |
|
| Antoniadou (2013) |
Molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men. |
ARHR |
|
| Aoki (2018) |
Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance. |
mBio |
|
| Apetrei (1998) |
Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. |
J Virol |
|
| Apetrei (2003) |
HIV type 1 diversity in northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy. |
ARHR |
|
| Appah (2022) |
Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage. |
Viruses |
|
| Appiah (2024) |
Genetic landscape for majority and minority HIV-1 drug resistance mutations in antiretroviral therapy naive patients in Accra, Ghana. |
Heliyon |
|
| Araujo (2010) |
Lower prevalence of human immunodeficiency virus type 1 Brazilian subtype B found in northeastern Brazil with slower progression to AIDS. |
AIDS Res Hum Retroviruses |
|
| Araujo (2019) |
Characterization of a large cluster of HIV-1 A1 infections detected in Portugal and connected to several Western European countries. |
Sci Rep |
|
| Arcia (2019) |
Potential immune escape mutations under inferred selection pressure in HIV-1 strains circulating in Medellin, Colombia. |
Infect Genet Evol |
|
| Arien (2005) |
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. |
AIDS |
|
| Arien (2016) |
Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398. |
J Antimicrob Chemother |
|
| Ariffin (2014) |
Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia. |
J Infect Dev Ctries |
|
| Arimide (2018) |
HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013. |
PLoS ONE |
|
| Arimide (2022) |
Molecular Epidemiology and Transmission Dynamics of the HIV-1 Epidemic in Ethiopia: Epidemic Decline Coincided With Behavioral Interventions Before ART Scale-Up. |
Front Microbiol |
|
| Ariyoshi (2003) |
Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. |
JAIDS |
|
| Armenia (2012) |
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: A refined analysis by ultra-deep 454 pyrosequencing. |
J Infect Dis |
|
| Armenia (2020) |
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings. |
J Clin Virol |
|
| Armenia (2023) |
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. |
J Antimicrob Chemother |
|
| Armenia (2024) |
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry. |
J Antimicrob Chemother |
|
| Arora (2008) |
Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India. |
ARHR |
|
| Arroyo (2004) |
HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania. |
ARHR |
|
| Arroyo (2005) |
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. |
AIDS |
|
| Arruda (2010) |
Intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil. |
ARHR |
|
| Arruda (2010) |
Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in Sao Paulo City, Brazil. |
ARHR |
|
| Arruda (2018) |
Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals. |
J Int AIDS Soc |
|
| Asahchop (2011) |
Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes. |
Antimicrob Agents Chemother |
|
| Asahchop (2013) |
Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline. |
AIDS |
|
| Asio (2025) |
Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023. |
Open Forum Infect Dis |
|
| Atkinson (2000) |
Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine. |
J Infect Dis |
|
| Aulicino (2005) |
Sequence analysis of a south American HIV type 1 BC recombinant. |
ARHR |
|
| Aulicino (2005) |
Circulation of novel HIV type 1 A, B/C, and F subtypes in Argentina. |
ARHR |
|
| Aulicino (2011) |
Longitudinal analysis of HIV-1 BF1 recombinant strains in vertically infected children from Argentina reveals a decrease in CRF12_BF pol gene mosaic patterns and high diversity of BF unique recombinant forms. |
Infect Genet Evol |
|
| Aulicino (2012) |
Characterization of full-length HIV-1 CRF17_BF genomes and comparison to the prototype CRF12_BF strains |
Infect Genet Evol |
|
| Aulicino (2019) |
Pre-treatment drug resistance and HIV-1 subtypes in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission. |
J Antimicrob Chemother |
|
| Aulicino (2024) |
Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy. |
J Antimicrob Chemother |
|
| Auwanit (2009) |
Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand. |
ARHR |
|
| Avi (2009) |
Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia. |
J Med Virol |
|
| Avi (2010) |
Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia. |
ARHR |
|
| Avi (2011) |
Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. |
Scand J Infect Dis |
|
| Avi (2013) |
Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010. |
ARHR |
|
| Avi (2014) |
Full-length genome sequences of Estonian HIV-1 CRF06 and Eastern-European subtype A1 recombinant forms. |
BMC Infect Dis |
|
| Avi (2016) |
Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia. |
J Med Virol |
|
| Avidor (2013) |
Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy. |
PLoS ONE |
|
| Avila-Rios (2012) |
National prevalence and trends of HIV transmitted drug resistance in Mexico |
PLoS ONE |
|
| Ay (2020) |
Transmitted drug resistance in newly diagnosed and treatment-na?ve HIV type 1-infected patients in Hungary. |
J Glob Antimicrob Resist |
|
| Ayitewala (2020) |
Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda. |
AIDS Res Ther |
|
| Ayouba (2009) |
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 study. |
ARHR |
|
| Ayouba (2013) |
Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Cote d'Ivoire. |
AIDS |
|
| Azam (2013) |
Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India. |
Virus Genes |
|
| Azam (2014) |
Trends of drug-resistance-associated mutations in the reverse transcriptase gene of HIV type 1 isolates from North India. |
Arch Virol |
|
| Azijn (2010) |
TMC278, a next-generation NNRTI, active against wild-type and NNRTI-resistant HIV-1. |
AAC |
|
| Babic (2006) |
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004. |
Virus Res |
|
| Bacheler (2000) |
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. |
AAC |
|
| Bacheler (2001) |
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. |
J Virol |
|
| Badreddine (2007) |
Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: High level of genetic diversity found. |
ARHR |
|
| Baker (2007) |
HIV subtypes distribution and implication for antiretroviral treatment in a Ugandan population. |
J Int Assoc Physicians AIDS Care (Chic) |
|
| Balakrishnan (2005) |
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. |
ARHR |
|
| Balamane (2012) |
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine. |
AAC |
|
| Baldanti (2009) |
Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens. |
J Med Virol |
|
| Baldrich-Rubio (2001) |
A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa. |
J Gen Virol |
|
| Balinda (2022) |
Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011). |
Viruses |
|
| Balode (2010) |
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia. |
J Med Virol |
|
| Balotta (2000) |
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure. |
JAIDS |
|
| Balotta (2000) |
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region, outcome after treatment in recently infected individuals. |
Antivir Ther |
|
| Balotta (2001) |
Increasing prevalence of non-clade B HIV-1 strains heterosexuals, as monitored by the analysis of the RT and protease sequences. |
JAIDS |
|
| Bang (2008) |
Prevalence of primary antiretroviral resistance: Trends in Korea. |
ARHR |
|
| Banin (2019) |
Near full genome characterization of HIV-1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns. |
J Int AIDS Soc |
|
| Banin (2019) |
Development of a Versatile, Near Full Genome Amplification and Sequencing Approach for a Broad Variety of HIV-1 Group M Variants. |
Viruses |
|
| Banke (2009) |
Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations. |
J Virol |
|
| Bansode (2011) |
Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi. |
ARHR |
|
| Bao (2008) |
Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China. |
ARHR |
|
| Bao (2014) |
Characteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province, China. |
PLoS ONE |
|
| Barabona (2019) |
Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring. |
J Antimicrob Chemother |
|
| Barber (2012) |
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. |
J Antimicrob Chemother |
|
| Barditch-Crovo (2001) |
Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. |
AAC |
|
| Bareng (2022) |
HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads. |
Infect Drug Resist |
|
| Barik (2020) |
Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy. |
BMC Infect Dis |
|
| Barnett (1993) |
Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. |
J Virol |
|
| Barreto (2006) |
Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. |
JAIDS |
|
| Barrow (2013) |
HIV-1 drug resistance in treatment-naive chronically infected patients in Jamaica. |
Antivir Ther |
|
| Bartolini (2025) |
The Genetic Barrier to Resistance to LEN Is Not Affected by Non-B Subtypes or Treatment Exposure |
CROI |
|
| Bartolo (2009) |
HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. |
JAIDS |
|
| Bartolo (2009) |
Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance. |
AAC |
|
| Bartolo (2011) |
Origin and epidemiological history of HIV-1 CRF14_BG. |
PLoS One |
|
| Bartolo (2014) |
HIV-1 diversity, transmission dynamics and primary drug resistance in Angola. |
PLoS ONE |
|
| Bartolo (2016) |
Rare HIV-1 subtype J genomes and a new H/U/CRF02_AG recombinant genome suggests an ancient origin of HIV-1 in Angola. |
ARHR |
|
| Barugahare (2005) |
Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition. |
J Virol |
|
| Baryshev (2013) |
HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Siberia. |
ARHR |
|
| Basson (2015) |
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors. |
Antimicrob Agents Chemother |
|
| Basson (2020) |
HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance. |
PLoS One |
|
| Baudi (2017) |
Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe. |
J Med Virol |
|
| Baxter (2000) |
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 study team for the Terry Beirn community programs for clinical research on AIDS. |
AIDS |
|
| Baxter (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Baxter (2021) |
Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study. |
HIV Med |
|
| Bbosa (2019) |
Phylogeography of HIV-1 suggests that Ugandan fishing communities are a sink for, not a source of, virus from general populations. |
Sci Rep |
|
| Beck (2025) |
HIV resistance to dolutegravir varies with co-administered agents. |
Clin Infect Dis |
|
| Becker-Pergola (2000) |
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug naive Ugandan adults. |
ARHR |
|
| Belec (2000) |
High levels of drug resistance human immunodeficiency virus variants in patients exhibiting increasing CD4 + t cell counts despite virologic failure of protease inhibitors containing antiretroviral combination therapy. |
J Infect Dis |
|
| Bello (2019) |
Phylogeographic Analyses Reveal the Early Expansion and Frequent Bidirectional Cross-Border Transmissions of Non-pandemic HIV-1 Subtype B Strains in Hispaniola. |
Front Microbiol |
|
| Bellocchi (2005) |
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme. |
J Med Virol |
|
| Bellosillo (2003) |
G190A substitution is associated with delavirdine(DLV) hypersusceptibility in vitro and clinical response with DLV intensification. |
Antivir Ther |
|
| Beltran-Pavez (2020) |
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997-2017). |
Sci Rep |
|
| Bercoff (2010) |
Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir. |
Retrovirology |
|
| Berg (2016) |
A Pan-HIV Strategy for Complete Genome Sequencing. |
J Clin Microbiol |
|
| Bermudez-Aza (2011) |
Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil. |
J Acquir Immune Defic Syndr |
|
| Bernardin (2005) |
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes. |
J Virol |
|
| Bertine (2015) |
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients. |
AIDS |
|
| BERTINE (2024) |
Rapid Selection of HIV-2 Capsid Mutations After Failure of a Lenacapavir-Containing Regimen |
CROI |
|
| Bessong (2005) |
Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. |
ARHR |
|
| Bessong (2006) |
Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals. |
ARHR |
|
| Bessong (2013) |
Genetic analysis of HIV-1 integrase sequences from treatment naive individuals in northeastern South Africa. |
Int J Mol Sci |
|
| Betancor (2012) |
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy. |
Retrovirology |
|
| Bhattacharya (2007) |
Founder effects in the assessment of HIV polymorphisms and HLA allele associations. |
Science |
|
| Bhusal (2016) |
Prevalence of HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Nepal. |
Curr HIV Res |
|
| Bibollet-Ruche (2004) |
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). |
ARHR |
|
| Bikandou (2004) |
Genetic subtyping of gag and env regions of HIV type 1 isolates in Republic of Congo. |
AIDS Res Hum Retroviruses |
|
| Bila (2013) |
Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique. |
PLoS ONE |
|
| Billings (2016) |
The number and complexity of pure and recombinant HIV-1 strains observed within incident infections during the HIV and malaria cohort study conducted in Kericho, Kenya, from 2003 to 2006. |
PLoS ONE |
|
| Billings (2017) |
HIV-1 genetic diversity among incident infections in Mbeya, Tanzania. |
ARHR |
|
| Billings (2019) |
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men. |
J Acquir Immune Defic Syndr |
|
| Billong (2013) |
Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performance. |
PLoS ONE |
|
| Bivigou-Mboumba (2022) |
HIV Genetic Diversity, Virological Failure, and Drug Resistance in Libreville, Capital of Gabon, before a Total Dolutegravir-Based Regimen Transition |
Direct Genbank Submission |
|
| Blanco (2011) |
HIV-1 integrase inhibitor resistance and its clinical implications. |
J Infect Dis |
|
| Blanco (2018) |
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial. |
J Antimicrob Chemother |
|
| Bodelle (2004) |
Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon. |
ARHR |
|
| Boender (2015) |
Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. |
Clin Infect Dis |
|
| Boerma (2016) |
High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children. |
J Int AIDS Soc |
|
| Boillot (2016) |
Programmatic feasibility of dried blood spots for the virological follow-up of patients on antiretroviral treatment in Nord Kivu, Democratic Republic of the Congo. |
JAIDS |
|
| Bonhoeffer (2004) |
Evidence for positive epistasis in HIV-1. |
Science |
|
| Bontell (2011) |
Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in northern Vietnam. |
Infect Genet Evol |
|
| Bonura (2010) |
Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: A 5-year retrospective study in Sicily, Italy. |
ARHR |
|
| Botha (2022) |
Low-level viraemia despite emergence of dolutegravir-resistant variants. |
South Afr J HIV Med |
|
| Bouchard (2007) |
HIV type 1 drug resistance among naive patients from Venezuela. |
ARHR |
|
| Boucher (1993) |
High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. |
Antimicrob Agents Chemother |
|
| Bouzeghoub (2006) |
High diversity of HIV type 1 in Algeria. |
ARHR |
|
| Bouzeghoub (2008) |
First observation of HIV type 1 drug resistance mutations in Algeria. |
AIDS Res Hum Retroviruses |
|
| Bowman (2023) |
Real world use of dolutegravir two drug regimens. |
AIDS |
|
| Bracho (2014) |
Emerging trends in CRF02_AG variants transmission among men who have sex with men in Spain. |
JAIDS |
|
| Bradley-Stewart (2017) |
HIV-1 integrase inhibitor resistance among treatment na |
J Clin Virol |
|
| Brado (2018) |
Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa. |
Sci Rep |
|
| Bradshaw (2007) |
Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase. |
AAC |
|
| Brandin (2003) |
Pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. |
ARHR |
|
| Braun (2020) |
Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation. |
Viruses |
|
| Bredell (2007) |
HIV type 1 subtype C gag and nef diversity in Southern Africa. |
AIDS Res Hum Retroviruses |
|
| Brehm (2007) |
Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine. |
J Virol |
|
| Brehm (2011) |
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. |
JAIDS |
|
| Brehm (2012) |
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. |
Clin Infect Dis |
|
| Brennan (2000) |
Genetic variation in human immunodeficiency virus type 2: Identification of a unique variant from human plasma. |
ARHR |
|
| Brennan (2007) |
HIV-1 strains identified in Brazilian blood donors: Significant prevalence of B/F1 recombinants. |
ARHR |
|
| Brennan (2008) |
The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. |
JAIDS |
|
| Brennan (2009) |
Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. |
Transfusion |
|
| Brennan (2010) |
Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007. |
Transfusion |
|
| Brenner (2003) |
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. |
AIDS |
|
| Brenner (2011) |
Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors. |
J Med Virol |
|
| Brenner (2016) |
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors. |
J Antimicrob Chemother |
|
| Brenner (2017) |
HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters. |
J Antimicrob Chemother |
|
| Brenner (2021) |
Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir. |
J Antimicrob Chemother |
|
| Brenner (2023) |
Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure. |
J Antimicrob Chemother |
|
| Brigido (2007) |
HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil. |
ARHR |
|
| Brindeiro (2002) |
Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. |
J Clin Microbiol |
|
| Brindeiro (1999) |
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. |
AAC |
|
| Brindeiro (2003) |
Brazilian network for HIV drug resistance surveillance (HIV-BResNet): A survey of chronically infected individuals. |
AIDS |
|
| Brockman (2010) |
Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. |
J Virol |
|
| Brockman (2012) |
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. |
J Virol |
|
| Brooks (2013) |
Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions. |
BMC Infect Dis |
|
| Brooks (2016) |
Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya. |
J Int AIDS Soc |
|
| Brown (2009) |
Phylogenetic reconstruction of transmission events from individuals with acute HIV infection |
J Infect Dis |
|
| Brown (2000) |
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. |
J Virol |
|
| Brown (2005) |
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. |
J Virol |
|
| Brumme (2007) |
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. |
PLoS Pathog |
|
| Brumme (2008) |
Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. |
AIDS |
|
| Brumme (2009) |
HLA-associated immune escape pathways in HIV-1 subtype B gag, pol and nef proteins. |
PLoS Med |
|
| Brun (2001) |
Patterns of protease inhibitor cross resistance in viral isolates with reduced susceptibility to lopinavir. |
CROI 2001 |
|
| Bruzzone (2015) |
Prevalence of HIV-1 subtypes and drug resistance-associated mutations in HIV-1-positive treatment-naive pregnant women in Pointe Noire, Republic of the Congo (Kento-Mwana project). |
ARHR |
|
| Budambula (2015) |
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users. |
AIDS Res Ther |
|
| Budayanti (2018) |
Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia. |
Curr HIV Res |
|
| Buggert (2012) |
Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage. |
PLoS One |
|
| Bunupuradah (2011) |
Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens. |
Antivir Ther |
|
| Buranapraditkun (2011) |
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. |
PLoS One |
|
| Burda (2010) |
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon. |
J Med Virol |
|
| Burns (2002) |
Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes. |
ARHR |
|
| Bussmann (2005) |
HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. |
Antivir Chem Chemother |
|
| Bussmann (2011) |
Prevalence of transmitted HIV drug resistance in Botswana: Lessons learned from the HIVDR-threshold survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. |
ARHR |
|
| Buzon (2008) |
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. |
Antivir Ther |
|
| Buzon-Martin (2024) |
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature. |
J Antimicrob Chemother |
|
| Bwire (2023) |
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam. |
Sci Rep |
|
| Byrnes (1993) |
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. |
AAC |
|
| Byun (2024) |
Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir. |
Viruses |
|
| Cabana (1999) |
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. |
J Med Virol |
|
| Cahn (2013) |
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study. |
Lancet |
|
| Campbell (2011) |
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. |
PLoS One |
|
| Canducci (2009) |
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. |
AIDS |
|
| Canducci (2011) |
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir. |
J Infect Dis |
|
| Cao (2023) |
Using molecular network analysis to understand current HIV-1 transmission characteristics in an inland area of Yunnan, China. |
Epidemiol Infect |
|
| Capel (2012) |
Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness. |
J Gen Virol |
|
| Capel (2013) |
Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates. |
Virology |
|
| Caplinskas (2013) |
Distinct HIV type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania. |
ARHR |
|
| Capoferri (2020) |
Recombination Analysis of Near Full-Length HIV-1 Sequences and the Identification of a Potential New Circulating Recombinant Form from Rakai, Uganda. |
ARHR |
|
| Cardoso (2009) |
HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from central west Brazil. |
J Clin Virol |
|
| Cardoso (2009) |
High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil. |
ARHR |
|
| Cardoso (2011) |
Molecular characteristics of HIV type 1 infection among prisoners from Central Western Brazil. |
AIDS Res Hum Retroviruses |
|
| Cardoso (2018) |
Two cases of dolutegravir failure with R263K mutation |
AIDS |
|
| Carganico (2014) |
New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy. |
J Int AIDS Soc |
|
| Caride (2001) |
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. |
Virus Genes |
|
| Caron (2008) |
Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. |
ARHR |
|
| Caron (2012) |
Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa. |
BMC Infect Dis |
|
| Carr (1996) |
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. |
J Virol |
|
| Carr (1998) |
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. |
Virology |
|
| Carr (1999) |
Direct Genbank submission: HIV-1 isolates from the Democratic Republic of the Congo and from Gabon. |
Direct Genbank Submission |
|
| Carr (1999) |
Characterization of subtype A HIV-1 from Africa by full genome sequencing. |
AIDS |
|
| Carr (2001) |
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. |
Virology |
|
| Carr (2001) |
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. |
AIDS |
|
| Carr (2005) |
HIV subtype and drug resistance patterns among drug-naive infected persons in Jos, Nigeria. |
Direct Genbank Submission |
|
| Carr (2005) |
Outbreak of west African recombinant of HIV-1 in Tashkent, Uzbekistan. |
JAIDS |
|
| Carr (2006) |
High genetic complexity of HIV-1 in low-prevalence, rural regions of Cameroon. |
Direct Genbank Submission |
|
| Carr (2010) |
HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics?. |
Retrovirology |
|
| Carrillo (1998) |
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378. |
J Virol |
|
| Carrion (2003) |
Circulating recombinant form CRF02_AG in south America. |
ARHR |
|
| Carrion (2004) |
Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay. |
ARHR |
|
| Carvalho (2015) |
Analysis of a local HIV-1 epidemic in portugal highlights established transmission of non-B and non-G subtypes. |
J Clin Microbiol |
|
| Carvalho (2011) |
Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil. |
ARHR |
|
| Casado (2003) |
Near full-length genome characterization of an HIV type 1 CRF05_DF virus from Spain. |
ARHR |
|
| Casado (2005) |
Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba. |
JAIDS |
|
| Castagna (2018) |
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus. |
J Antimicrob Chemother |
|
| Castelbranco (2010) |
Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. |
ARHR |
|
| Castillo (2009) |
Surveillance of HIV type 1 drug resistance among naive patients from Venezuela. |
ARHR |
|
| Castley (2017) |
A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012. |
PLoS ONE |
|
| Castley (2016) |
Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000-2014. |
ARHR |
|
| Castro (2010) |
HIV-1 drug resistance transmission networks in southwest Switzerland. |
ARHR |
|
| Caumont (2001) |
Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh city, Vietnam. |
ARHR |
|
| Cavaco-Silva (2014) |
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen. |
PLoS ONE |
|
| Cazals (2018) |
HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man. |
Open Forum Infect Dis |
|
| Ceccherini-Silberstein (2004) |
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure. |
AIDS |
|
| Ceccherini-Silberstein (2007) |
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients. |
J Infect Dis |
|
| Chaillon (2017) |
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies. |
Retrovirology |
|
| Chaix (2003) |
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. |
AIDS |
|
| Chakravarty (2015) |
Outcome of patients on second line antiretroviral therapy under programmatic condition in India. |
BMC Infect Dis |
|
| Chamberland (2012) |
Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options. |
Sex Transm Infect |
|
| Chandler (2007) |
Effect of transporter modulation on the emergence of nelfinavir resistance in vitro. |
Antivir Ther |
|
| Chang (2015) |
HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression. |
Sci Rep |
|
| Chang (2018) |
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in Asia. |
J Int AIDS Soc |
|
| Chang (2008) |
Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. |
J Antimicrob Chemother |
|
| Chang (2020) |
HIV-1 genetic diversity and recombinant forms among men who have sex with men at a sentinel surveillance site in Xi'an City, China. |
Infect Genet Evol |
|
| Chantratita (2002) |
Prevalence of HIV-1 polymerase gene mutations in pre-treated patients in Thailand. |
Southeast Asian J Trop Med Public Health |
|
| Chantratita (2005) |
Prevalence of mutations related to HIV-1 antiretroviral drug resistance in Thailand, 2003. |
Direct Genbank Submission |
|
| Chaplin (2017) |
Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy. |
ARHR |
|
| Charpentier (2008) |
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. |
HIV Med |
|
| Charpentier (2010) |
Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen. |
AIDS |
|
| Charpentier (2011) |
High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. |
Antivir Ther |
|
| Charpentier (2011) |
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: A cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. |
ARHR |
|
| Charpentier (2011) |
Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon. |
ARHR |
|
| Charpentier (2011) |
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir. |
AAC |
|
| Charpentier (2014) |
Genotypic resistance profiles of HIV-2-treated patients in West Africa. |
AIDS |
|
| Charpentier (2018) |
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen. |
J Antimicrob Chemother |
|
| Charurat (2012) |
Characterization of acute HIV-1 infection in high-risk Nigerian populations. |
J Infect Dis |
|
| Chaturbhuj (2010) |
Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. |
ARHR |
|
| Chehadeh (2015) |
Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naive people in Kuwait. |
J Med Virol |
|
| Chehadeh (2017) |
Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Na |
Intervirology |
|
| Chehadeh (2018) |
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait. |
Med Princ Pract |
|
| Chehadeh (2020) |
Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting. |
Antivir Chem Chemother |
|
| Chen (2017) |
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States. |
AIDS Res Hum Retroviruses |
|
| Chen (2012) |
Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: A hot area of viral recombination in China |
BMC Infect Dis |
|
| Chen (2013) |
HIV-1 genotypes and drug resistance threshold survey in Honghe Prefecture of Yunnan Province in 2011 |
Direct Genbank Submission |
|
| Chen (2014) |
HIV-1 genetic characteristics and transmitted drug resistance among men who have sex with men in Kunming, China. |
PLoS ONE |
|
| Chen (2018) |
The changing HIV-1 genetic characteristics and transmitted drug resistance among recently infected population in Yunnan, China. |
Epidemiol Infect |
|
| Chen (2018) |
HIV-1 genetic transmission networks among men who have sex with men in Kunming, China. |
PLoS ONE |
|
| Chen (2019) |
Spatial clusters of HIV-1 genotypes in a recently infected population in Yunnan, China. |
BMC Infect Dis |
|
| Chen (2018) |
No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naive HIV Patients. |
Intervirology |
|
| Chen (2012) |
Molecular epidemiology of human immunodeficiency virus type 1 in Guangdong province of southern China. |
PLoS ONE |
|
| Chen (2017) |
First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar. |
Virulence |
|
| Chen (2020) |
Laos is Affected by HIV CRF01_AE and the Newly Identified CRF97_01B. |
Virol Sin |
|
| Chen (2014) |
Evolving molecular epidemiological profile of human immunodeficiency virus 1 in the southwest border of China. |
PLoS ONE |
|
| Chen (2016) |
Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan. |
PLoS ONE |
|
| Chen (2019) |
Increased predominance of HIV-1 CRF01_AE and its recombinants in the Philippines. |
J Gen Virol |
|
| Cheng (2020) |
Identification of a Novel HIV-1 Unique CRF01_AE/C Recombinant in Yan'an City, Shaanxi Province. |
AIDS Res Hum Retroviruses |
|
| Cheong (2014) |
Cross-border sexual transmission of the newly emerging HIV-1 clade CRF51_01B. |
PLoS ONE |
|
| Cheong (2015) |
Genetic characterization of a novel HIV-1 circulating recombinant form (CRF74_01B) identified among intravenous drug users in Malaysia: recombination history and phylogenetic linkage with previously defined recombinant lineages. |
PLoS ONE |
|
| Cheriro (2015) |
High prevalence of HIV low abundance drug-resistant variants in a treatment-naive population in north rift Kenya. |
ARHR |
|
| Cheung (2022) |
Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study. |
J Antimicrob Chemother |
|
| Chew (2015) |
Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study. |
BMC Infect Dis |
|
| Chibo (2011) |
HIV transmissions during seroconversion contribute significantly to new infections in men who have sex with men in Australia. |
ARHR |
|
| Chikata (2014) |
Host-specific adaptation of HIV-1 subtype B in the Japanese population. |
J Virol |
|
| Chimukangara (2016) |
HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing. |
J Virol Methods |
|
| Chimukangara (2020) |
Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals. |
J Antimicrob Chemother |
|
| Chimukangara (2021) |
Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa. |
AIDS Res Ther |
|
| Chin (2006) |
Inverse relationship between viral load and genotypic resistance mutations in Korean patients with primary HIV type 1 infections. |
ARHR |
|
| Chin (2010) |
Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. |
ARHR |
|
| Chin (2015) |
Increase of HIV-1 K103N transmitted drug resistance and its association with efavirenz use in South Korea. |
ARHR |
|
| Chinula (2023) |
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. |
Lancet HIV |
|
| Cho (2002) |
Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea. |
J Clin Microbiol |
|
| Cho (2013) |
Phylogenetic analysis of near full-length HIV type 1 genomic sequences from 21 Korean individuals. |
ARHR |
|
| Cho (2019) |
Genetic Analysis of the Full-Length gag Gene from the Earliest Korean Subclade B of HIV-1: An Outbreak among Korean Hemophiliacs. |
Viruses |
|
| Cho (2021) |
Sequence Length of HIV-1 Subtype B Increases over Time: Analysis of a Cohort of Patients with Hemophilia over 30 Years. |
Viruses |
|
| Chohan (2024) |
Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya. |
AIDS Res Hum Retroviruses |
|
| Choi (1997) |
HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant. |
ARHR |
|
| Choi (2008) |
National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005. |
JAIDS |
|
| Cholette (2020) |
HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade. |
PLoS One |
|
| Chopera (2013) |
No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. |
PLoS One |
|
| Chow (2012) |
Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia |
J Virol |
|
| Chow (2013) |
Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters. |
PLoS ONE |
|
| Chow (2014) |
A newly emerging HIV-1 recombinant lineage (CRF58_01B) disseminating among people who inject drugs in Malaysia. |
PLoS ONE |
|
| Chow (2016) |
Extensive genetic diversity of HIV-1 in incident and prevalent infections among Malaysian blood donors: multiple introductions of HIV-1 genotypes from highly prevalent countries. |
PLoS ONE |
|
| Chung (2014) |
Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. |
JAIDS |
|
| Chung (2020) |
Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial. |
Lancet |
|
| Church (2007) |
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. |
ARHR |
|
| Church (2008) |
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. |
J Infect Dis |
|
| Ciccozzi (2005) |
Molecular diversity of HIV in Albania. |
J Infect Dis |
|
| Ciccozzi (2011) |
Genetic diversity of HIV type 1 in Montenegro. |
ARHR |
|
| Cilento (2021) |
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains. |
Antimicrob Agents Chemother |
|
| Cilento (2023) |
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes. |
Viruses |
|
| Cilla (2001) |
Molecular evidence of homosexual transmission of HIV type 2 in Spain. |
ARHR |
|
| Cinque (2001) |
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. |
ARHR |
|
| Clavel (1986) |
Isolation of a new human retrovirus from west African patients with AIDS. |
Science |
|
| Clevenbergh (2002) |
Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1. |
Antivir Ther |
|
| Clipman (2022) |
Antiretroviral Drug Resistance in HIV Sequences From People Who Inject Drugs and Men Who Have Sex With Men Across 21 Cities in India. |
Open Forum Infect Dis |
|
| Clutter (2017) |
Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing. |
J Infect Dis |
|
| Coakley (2005) |
Atazanavir resistance in a protease inhibitor-naive patient treated with atazanavir/ritonavir associated with development of high-level atazanavir resistance and the N88S mutation in protease. |
CROI 2007 |
|
| Coakley (2000) |
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. |
AIDS |
|
| Cochrane (2018) |
First reported case of integrase (R263K, G163R) and reverse transcriptase (M184V)-transmitted drug resistance from a drug-naive patient failing Triumeq. |
AIDS |
|
| Coetzee (2017) |
HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study. |
PLoS ONE |
|
| Coetzer (2013) |
Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-Line antiretroviral therapy by WHO 2010 guidelines. |
ARHR |
|
| Colonno (2004) |
Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. |
J Infect Dis |
|
| Condra (1995) |
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. |
Nature |
|
| Condra (1996) |
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. |
J Virol |
|
| Corado (2017) |
HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil. |
PLoS ONE |
|
| Corbau (2010) |
Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1. |
Antimicrob Agents Chemother |
|
| Corbet (2000) |
Env sequences of SIV from chimpanzees in Cameroon are strongly related to HIV group N from the same geographic area. |
J Virol |
|
| Cornelissen (1997) |
Pol diversity of five HIV-1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. |
J Virol |
|
| Cornelissen (2000) |
Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. |
J Gen Virol |
|
| Cotton (2014) |
Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic. |
PLoS Genet |
|
| Courtney (2016) |
Monitoring HIV-1 group M subtypes in Yaounde, Cameroon reveals broad genetic diversity and a novel CRF02_AG/F2 infection. |
ARHR |
|
| Cousins (2017) |
Population sequencing analysis of samples from the MetroMates Study |
Direct Genbank Submission |
|
| Couto-Fernandez (2006) |
Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: Tracing the origin of this subtype in Brazil. |
ARHR |
|
| Cox (2017) |
Evolution of tenofovir-resistant HIV-1 isolates exposed to tenofovir alafenamide dose escalation. |
Antiviral Res |
|
| Cox (2018) |
Antiviral Activity of Tenofovir Alafenamide Against HIV-1 Subtypes and Emergence of K65R. |
AIDS Res Hum Retroviruses |
|
| Cox (2023) |
Antiviral activity of tenofovir alafenamide (TAF) against HIV-1 clinical isolates harboring K65R. |
J Med Virol |
|
| Craig (1998) |
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. |
AIDS |
|
| Crawford (2014) |
Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy. |
AIDS |
|
| Crispim (2019) |
Homogenous HIV-1 subtype B from the Brazilian Amazon with infrequent diverse BF1 recombinants, subtypes F1 and C among blood donors. |
PLoS ONE |
|
| Crowell (2021) |
Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries. |
Clin Infect Dis |
|
| Cuevas (2015) |
Extremely high mutation rate of HIV-1 in vivo. |
PLoS Biol |
|
| Cuevas (2009) |
Incidence of non-B subtypes of HIV-1 in Galicia, Spain: High frequency and diversity of HIV-1 among men who have sex with men. |
Euro Surveill |
|
| Cuevas (2002) |
High HIV-1 genetic diversity in Cuba. |
AIDS |
|
| Cuevas (2009) |
HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain. |
JAIDS |
|
| Cuevas (2010) |
Biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment. |
ARHR |
|
| Cunha (2012) |
Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C. |
PLoS One |
|
| Cunha (2015) |
Short Communication: In Vitro Accumulation of Drug Resistance Mutations in Chimeric Infectious Clones Containing Subtype B or C Reverse Transcriptase and Selected with Tenofovir or Didanosine. |
AIDS Res Hum Retroviruses |
|
| Cunyat (2010) |
Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir. |
Antivir Ther |
|
| Currier (2006) |
CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response. |
BMC Immunol |
|
| Cutillas (2015) |
The R262K substitution combined with H51Y in HIV-1 subtype B integrase confers low-level resistance against dolutegravir. |
AAC |
|
| D'Antoni (2025) |
Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir. |
J Antimicrob Chemother |
|
| D'Ettorre (2013) |
An HIV type 2 case series in Italy: a phylogenetic analysis. |
ARHR |
|
| da Costa (2016) |
High HIV-1 Genetic Diversity in Patients from Northern Brazil. |
ARHR |
|
| da Silva (2010) |
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. |
J Antimicrob Chemother |
|
| da Silveira (2012) |
HIV type 1 molecular epidemiology in pol and gp41 genes among naive patients from Mato Grosso do Sul State, central western Brazil. |
ARHR |
|
| Dagba Gbessin (2025) |
HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa. |
PLoS One |
|
| Dagnra (2011) |
High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lome, Togo. |
J Int AIDS Soc |
|
| Dalai (2009) |
Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. |
AIDS |
|
| Damond (2004) |
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. |
ARHR |
|
| Damond (2005) |
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. |
J Clin Microbiol |
|
| Darcissac (2016) |
HIV-1 pol gene polymorphism and antiretroviral resistance mutations in treatment-naive adult patients in French Guiana between 2006 and 2012. |
ARHR |
|
| Das (2004) |
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. |
J Med Chem |
|
| Das (2008) |
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations. |
PNAS |
|
| Datir (2020) |
In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix. |
mBio |
|
| Dau (2010) |
Connection domain mutations in treatment-experienced patients in the OPTIMA trial. |
JAIDS |
|
| Dauber (2002) |
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease. |
J Virol |
|
| Dauwe (2015) |
Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate. |
BMC Infect Dis |
|
| Davydenko (2024) |
HIV protein profile characteristics in patients with first-time detected infection |
Unpublished |
|
| de Azevedo (2022) |
HIV-1 Diversity and Drug Resistance in Treatment-Naive Children and Adolescents from Rio de Janeiro, Brazil. |
Viruses |
|
| de Baar (2000) |
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. |
ARHR |
|
| de Carvalho Lima (2020) |
Evidence of genomic information and structural restrictions of HIV-1 PR and RT gene regions from individuals experiencing antiretroviral virologic failure. |
Infect Genet Evol |
|
| de Felipe (2011) |
Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010. |
Virol J |
|
| De Gascun (2012) |
Human Immunodeficiency Virus Type 1 in Ireland: Phylogenetic Evidence for Risk Group-Specific Subepidemics. |
ARHR |
|
| de Jesus Herrera-Castillo (2022) |
Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection. |
World J Pediatr |
|
| de Lourdes Teixeira (2015) |
High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil. |
Int J STD AIDS |
|
| de Medeiros (2011) |
Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naive population from Southernmost Brazil: Analysis of primary resistance mutations. |
J Med Virol |
|
| De Meyer (2005) |
TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. |
Antimicrob Agents Chemother |
|
| De Meyer (2009) |
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients. |
AIDS |
|
| De Miguel (2020) |
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO). |
EBioMedicine |
|
| de Moraes (2023) |
High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil. |
Front Microbiol |
|
| De Mulder (2011) |
Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain. |
J Antimicrob Chemother |
|
| de Mulder (2012) |
High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. |
PLoS ONE |
|
| De Mulder (2014) |
HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA. |
HIV Med |
|
| de Oliveira (2008) |
High frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil. |
Arch Virol |
|
| De Oliveira (2017) |
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. |
Retrovirology |
|
| de Pina-Araujo (2014) |
Profile of the HIV epidemic in Cape Verde: molecular epidemiology and drug resistance mutations among HIV-1 and HIV-2 infected patients from distinct islands of the archipelago. |
PLoS ONE |
|
| de Sa Filho (2002) |
Mutations associated with drug resistance in a population of drug naive HIV-1 infected individuals. |
Direct Genbank Submission |
|
| de Sa Filho (2003) |
Analysis of the protease sequences of HIV-1 infected individuals after indinavir monotherapy. |
J Clin Virol |
|
| de Sa Filho (2005) |
Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil. |
ARHR |
|
| de Sa Filho (2006) |
Identification of two HIV type 1 circulating recombinant forms in Brazil. |
ARHR |
|
| de Sa Filho (2008) |
HIV type 1 poltype 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil. |
ARHR |
|
| de Sa-Filho (2009) |
HIV type 1 diversity from newly diagnosed patients in Santos metropolitan area/Brazil. |
ARHR |
|
| de Silva (2011) |
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form. |
ARHR |
|
| de Silva (2018) |
HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation. |
AIDS |
|
| de Souza Cavalcanti (2014) |
High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen. |
J Antimicrob Chemother |
|
| Dean (2011) |
Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: A multicenter study. |
ARHR |
|
| Deeks (1999) |
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. |
J Infect Dis |
|
| Deho (2008) |
Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland. |
ARHR |
|
| DeJesus (2012) |
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. |
Lancet |
|
| DeKoven (2023) |
Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series. |
HIV Med |
|
| Delatorre (2016) |
Tracing the origin of a singular HIV-1 CRF45_cpx clade identified in Brazil. |
Infect Genet Evol |
|
| Delatorre (2017) |
High HIV-1 diversity and prevalence of transmitted drug resistance among antiretroviral-naive HIV-infected pregnant women from Rio de Janeiro, Brazil. |
ARHR |
|
| Delatorre (2017) |
HIV-1 Genetic Diversity in Northeastern Brazil: High Prevalence of Non-B Subtypes. |
ARHR |
|
| Delaugerre (2005) |
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF. |
J Clin Virol |
|
| Delaugerre (2011) |
HIV-1 group N: travelling beyond Cameroon. |
Lancet |
|
| Delaunay (2005) |
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021). |
J Virol |
|
| Delelis (2009) |
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo. |
AAC |
|
| Delgado (2001) |
Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study. |
ARHR |
|
| Delgado (2002) |
Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. |
JAIDS |
|
| Delgado (2008) |
High prevalence of unique recombinant forms of HIV-1 in Ghana: Molecular epidemiology from an antiretroviral resistance study. |
JAIDS |
|
| Delgado (2010) |
Identification of a new HIV type 1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile. |
ARHR |
|
| Delgado (2015) |
Phylogeny and phylogeography of a recent HIV-1 subtype F outbreak among men who have sex with men in Spain deriving from a cluster with a wide geographic circulation in western Europe. |
PLoS ONE |
|
| Delgado (2004) |
Genotypic (and phenotypic) predictors of a response to DDI monotherapy in ZDV-experienced patients. |
Antivir Ther |
|
| Delwart (2012) |
Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. |
J Infect Dis |
|
| Demeter (2000) |
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). |
AAC |
|
| Demirdjian (2025) |
Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV Clinical Isolates. |
J Med Virol |
|
| Deng (2009) |
Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China. |
AIDS |
|
| Dennis (2012) |
Phylogenetic insights into HIV transmission in North Carolina. |
AIDS |
|
| Dennis (2017) |
Rising prevalence of non-B HIV-1 subtypes in North Carolina and evidence for local onward transmission. |
Virus Evol |
|
| Dennis (2018) |
HIV-1 Transmission Clustering and Phylodynamics Highlight the Important Role of Young Men Who Have Sex with Men. |
ARHR |
|
| Depatureaux (2015) |
HIV-1 Group O Resistance Against Integrase Inhibitors. |
J Acquir Immune Defic Syndr |
|
| Derache (2007) |
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali. |
Antivir Ther |
|
| Derache (2008) |
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006. |
J Antimicrob Chemother |
|
| Derache (2015) |
HIV drug resistance mutations in proviral DNA from a community treatment program. |
PLoS One |
|
| Derache (2018) |
Impact of next generation sequencing defined HIV pre-treatment drug resistance on virological outcomes in the ANRS 12249 treatment as prevention trial. |
Clin Infect Dis |
|
| Desbois (2008) |
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors. |
Antimicrob Agents Chemother |
|
| Descamps (1997) |
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. |
J Virol |
|
| Descamps (2004) |
High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen. |
J Med Virol |
|
| Descamps (2010) |
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France |
J Antimicrob Chemother |
|
| Descamps (2015) |
Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program. |
Clin Infect Dis |
|
| Deshpande (2004) |
Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. |
ARHR |
|
| Deshpande (2009) |
Phylogenetic analysis of HIV-1 reverse transcriptase sequences from 382 patients recruited in JJ Hospital of Mumbai, India, between 2002 and 2008. |
ARHR |
|
| Deshpande (2010) |
Analysis of RT sequences of subtype C HIV-type 1 isolates from Indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines. |
ARHR |
|
| Deshpande (2011) |
Drug Resistance Mutations in HIV Type 1 isolates from naive patients eligible for first line antiretroviral therapy in JJ Hospital, Mumbai, India. |
ARHR |
|
| Deuba (2023) |
Prevalence of viral load suppression and acquired drug resistance among people living with HIV in Nepal: a nationally representative surveillance study. |
J Glob Antimicrob Resist |
|
| Deuzing (2015) |
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses. |
J Virol |
|
| Di Giallonardo (2020) |
Increased HIV Subtype Diversity Reflecting Demographic Changes in the HIV Epidemic in New South Wales, Australia. |
Viruses |
|
| Di Giallonardo (2021) |
Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia. |
J Int AIDS Soc |
|
| Diallo (2012) |
Comparison of HIV-1 resistance profiles in plasma RNA versus PBMC DNA in heavily treated patients in Honduras, a resource-limited country. |
Int J Mol Epidemiol Genet |
|
| Diallo (2015) |
Viral genetic diversity and polymorphisms in a cohort of HIV-1-infected patients eligible for initiation of antiretroviral therapy in Abuja, Nigeria. |
AIDS Res Hum Retroviruses |
|
| Diamond (2022) |
Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs). |
Antimicrob Agents Chemother |
|
| Diamond (2024) |
No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir. |
Antimicrob Agents Chemother |
|
| Diaz (2015) |
The virological and immunological characteristics of the HIV-1-infected population in Brazil: from initial diagnosis to impact of antiretroviral use. |
PLoS ONE |
|
| Diaz (2023) |
Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil. |
BMC Infect Dis |
|
| Dietrich (1989) |
A highly divergent HIV-2-related isolate. |
Nature |
|
| Dilernia (2007) |
HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina. |
ARHR |
|
| Dilernia (2008) |
HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations. |
PLoS One |
|
| Dinesha (2016) |
Genotypic HIV-1 drug resistance among patients failing tenofovir-based first-line HAART in South India. |
ARHR |
|
| Diniz (2016) |
Analysis of the in vitro susceptibility of primary isolates of HIV-2 from Portugal to dolutegravir. |
Ciencia |
|
| Diop-Ndiaye (2010) |
Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal. |
ARHR |
|
| Diouara (2014) |
Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry. |
J Int AIDS Soc |
|
| Diphoko (2018) |
Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. |
ARHR |
|
| Djoko (2010) |
HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea. |
ARHR |
|
| Djoko (2010) |
High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, DRC. |
ARHR |
|
| Dlamini (2011) |
Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa. |
JAIDS |
|
| Do (2017) |
An Alarmingly High Proportion of HIV-1 Isolates Carrying Mutations Corresponding to Resistance to Antiretroviral Drugs among HIV-Positive High-Risk Groups in Central Vietnam: a Substudy of the National Sentinel Survey. |
Jpn J Infect Dis |
|
| Dominguez-Rodriguez (2018) |
Effect of HIV/HCV Co-Infection on the Protease Evolution of HIV-1B: A Pilot Study in a Pediatric Population. |
Sci Rep |
|
| Dos Anjos Silva (2016) |
HIV-1 genetic diversity and transmitted drug resistance in antiretroviral treatment-naive individuals from Amapa state, northern Brazil. |
ARHR |
|
| Doualla-Bell (2006) |
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. |
AAC |
|
| Doualla-Bell (2006) |
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. |
AAC |
|
| Dow (2017) |
HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania. |
ARHR |
|
| Dowling (2002) |
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. |
AIDS |
|
| Doyle (2015) |
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades. |
J Antimicrob Chemother |
|
| Doyon (2005) |
Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. |
Antiviral Res |
|
| Duc (2012) |
Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008 |
Clin Infect Dis |
|
| Dueweke (1993) |
A mutation in reverse transcriptase of bis(heteroaryl)piperazine- resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. |
PNAS |
|
| Dumans (2002) |
Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. |
AAC |
|
| Dumans (2004) |
Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. |
J Infect Dis |
|
| Dumans (2009) |
Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure. |
Infect Genet Evol |
|
| Dunne (2001) |
Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs. |
AIDS |
|
| Duque (2002) |
Prevalence of drug resistance and HIV-1 subtypes in antiretroviral inexperienced patients, during the year 2000 in Portugal. |
Direct Genbank Submission |
|
| Duque (2003) |
Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. |
Clin Microbiol Infect |
|
| Durant (1999) |
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. |
Lancet |
|
| Dvali (2012) |
Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia. |
J Med Virol |
|
| Edoul (2020) |
High HIV burden and recent transmission chains in rural forest areas in southern Cameroon, where ancestors of HIV-1 have been identified in ape populations. |
Infect Genet Evol |
|
| Egger (2024) |
HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST). |
BMJ Open |
|
| Ekollo Mbange (2021) |
High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat. |
Infect Dis (Auckl) |
|
| Ekushov (2025) |
Characterization of a New HIV-1 Second-Generation Circulating Recombinant Form CRF173_63A6 in the Jewish Autonomous Region of Russia. |
Pathogens |
|
| El Annaz (2011) |
Presence of drug resistance mutations among drug-naive patients in Morocco. |
ARHR |
|
| El Annaz (2012) |
Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco. |
ARHR |
|
| El Moussi (2017) |
Genetic Diversity of HIV-1 in Tunisia. |
AIDS Res Hum Retroviruses |
|
| El-Badry (2020) |
Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol. |
J Virol |
|
| El-Khatib (2010) |
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. |
AIDS |
|
| Ellenberger (1999) |
Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. |
ARHR |
|
| Engone-Ondo (2021) |
High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy. |
J Antimicrob Chemother |
|
| Engone-Ondo (2022) |
HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa. |
J Antimicrob Chemother |
|
| Epalza (2024) |
Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain. |
Pediatr Infect Dis J |
|
| Eron (2013) |
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study. |
J Infect Dis |
|
| Escoto-Delgadillo (2005) |
Drug-resistance mutations in antiretroviral-naive patients with established HIV-1 infection in Mexico. |
HIV Med |
|
| Escoto-Delgadillo (2016) |
HIV drug resistance in antiretroviral-naive patients in Mexico after 10 years: is there a difference? |
ARHR |
|
| Eshleman (2001) |
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (HIV network for prevention trials 012 study). |
J Infect Dis |
|
| Eshleman (2001) |
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). |
J Infect Dis |
|
| Eshleman (2002) |
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. |
ARHR |
|
| Eshleman (2002) |
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012). |
JAIDS |
|
| Eshleman (2004) |
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. |
ARHR |
|
| Eshleman (2004) |
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine. |
JAIDS |
|
| Eshleman (2004) |
Performance of the Celera Diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. |
J Clin Microbiol |
|
| Eshleman (2005) |
Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. |
ARHR |
|
| Eshleman (2005) |
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. |
J Infect Dis |
|
| Eshleman (2006) |
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations. |
ARHR |
|
| Eshleman (2007) |
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. |
AIDS |
|
| Eshleman (2009) |
Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. |
ARHR |
|
| Eshleman (2009) |
Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. |
AIDS |
|
| Eshleman (2022) |
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention. |
J Infect Dis |
|
| Espinosa (2004) |
Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. |
JAIDS |
|
| Etiebet (2013) |
Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. |
AIDS |
|
| Etienne (2011) |
Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms. |
Retrovirology |
|
| Eyer-Silva (2007) |
Autochthonous horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil. |
Mem Ins Oswaldo Cruz |
|
| Eyzaguirre (2007) |
Genetic characterization of HIV-1 strains circulating in Kazakhstan. |
JAIDS |
|
| Fabeni (2020) |
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy. |
Viruses |
|
| Fabeni (2021) |
Molecular Transmission Dynamics of Primary HIV Infections in Lazio Region, Years 2013-2020. |
Viruses |
|
| Fabeni (2024) |
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21. |
J Antimicrob Chemother |
|
| Fall-Malick (2014) |
Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania. |
J Med Virol |
|
| Falloon (2000) |
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity. |
Clin Infect Dis |
|
| Fan (2022) |
Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China. |
Front Genet |
|
| Fang (2004) |
Long-term survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations. |
J Infect Dis |
|
| Faraci (2023) |
Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing
|
J Clin Virol |
|
| Faria (2012) |
Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A. |
J Gen Virol |
|
| Farinre (2021) |
Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa. |
Retrovirology |
|
| Farrokhi (2017) |
Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran. |
Iran J Public Health |
|
| Fayssel (2016) |
HIV-1 genotyping and antiretroviral drug-resistance mutations determination among drug-naive individuals infected in Morocco. |
Direct Genbank Submission |
|
| Feng (2015) |
In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. |
Antimicrob Agents Chemother |
|
| Feng (2016) |
Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations. |
Antimicrob Agents Chemother |
|
| Feng (2013) |
The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. |
AIDS |
|
| Feng (2014) |
Identification of a novel HIV Type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_AE and subtypes B and C in Western Yunnan, China. |
ARHR |
|
| Feng (2016) |
Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC. |
Sci Rep |
|
| Feng (2016) |
Diverse intersubtype recombinants and high frequency of drug-resistance mutations of HIV-1 among newly diagnosed and antiretroviral treatment naive HIV-infected individuals in Baoshan, a western prefecture of Yunnan, China. |
Direct Genbank Submission |
|
| Feng (2018) |
First report of a novel HIV-1 recombinant form (CRF100_01C) comprising CRF01_AE and C among heterosexuals in Yunnan, China. |
J Infect |
|
| Fernandez-Garcia A (2009) |
Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia. |
ARHR |
|
| Fernandez-Garcia (2010) |
Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain. |
ARHR |
|
| Fernandez-Garcia (2012) |
The analysis of near full-length genome sequences of HIV-1 subtype A viruses from Russia supports the monophyly of major intrasubtype clusters. |
ARHR |
|
| Fernandez-Garcia (2016) |
Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain. |
PLoS ONE |
|
| Ferradini (2011) |
High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia. |
J Int AIDS Soc |
|
| Ferreira (2011) |
Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. |
J Med Virol |
|
| Ferreira (2010) |
Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically infected children in Belo Horizonte, Brazil. |
ARHR |
|
| Ferreira (2008) |
Molecular characterisation of newly identified HIV-1 infections in Curitiba, Brazil: Preponderance of clade C among males with recent infections. |
Mem Ins Oswaldo Cruz |
|
| Ferreira (2013) |
Transmitted drug resistance among people living with HIV/AIDS at major cities of Sao Paulo State, Brazil. |
Adv Virol |
|
| Fikkert (2003) |
Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations. |
J Virol |
|
| Fikkert (2004) |
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360. |
AIDS |
|
| Fily (2018) |
HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line. |
Trop Med Int Health |
|
| Fish (2010) |
Natural polymorphisms of integrase among HIV type 1-infected south African patients. |
ARHR |
|
| Fitzgibbon (1992) |
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. |
AAC |
|
| Fitzgibbon (2001) |
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens. |
ARHR |
|
| Florea (2011) |
HIV transmitted drug resistance in Romania 2007-2010 |
Direct Genbank Submission |
|
| Flores (1999) |
HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in north America. |
Emerg Infect Dis |
|
| Fofana (2023) |
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children. |
Viruses |
|
| Fogel (2020) |
HIV drug resistance in a cohort of HIV-infected MSM in the United States. |
AIDS |
|
| Fokam (2011) |
Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon. |
Pediatr Infect Dis J |
|
| Fokam (2016) |
Population-based surveillance of HIV-1 drug resistance in Cameroonian adults initiating antiretroviral therapy according to the World Health Organization guidelines. |
ARHR |
|
| Fokam (2020) |
Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon. |
PLoS One |
|
| Fokam (2023) |
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens. |
Viruses |
|
| Foli (1996) |
In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-{2-(phosphonomethoxy)ethyl}adenine (PMEA). |
Antiviral Res |
|
| Fonjungo (2002) |
Human immunodeficiency virus type 1 group m protease in Cameroon: Genetic diversity and protease inhibitor mutational features. |
J Clin Microbiol |
|
| Foster (2014) |
Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of circulating recombinant form (CRF) 50_A1D. |
PLoS ONE |
|
| Fourati (2012) |
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure. |
AIDS |
|
| Frange (2012) |
Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency. |
PLoS ONE |
|
| Frange (2021) |
Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance. |
HIV Med |
|
| Fransen (2009) |
Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. |
J Virol |
|
| Fransen (2012) |
HIV-1 mutations at positions 143, 148, and 155 of integrase define different genetic barriers to raltegravir resistance in vivo. |
Journal of Virology |
|
| Frentz (2013) |
Limited cross-border infections in patients newly diagnosed with HIV in Europe. |
Retrovirology |
|
| Friend (2004) |
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen. |
AIDS |
|
| Fujisaki (2009) |
An 11-year surveillance of HIV type 1 subtypes in Nagoya, Japan. |
ARHR |
|
| Fujiwara (1998) |
S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. |
AAC |
|
| Fulcher (2018) |
Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir. |
Clin Infect Dis |
|
| Fun (2018) |
Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance. |
Retrovirology |
|
| Gafarova (2010) |
Investigation of genetic polymorphism of the integrase gene in the HIV-1 subtype A populations circulating in the Russian Federation. |
Vopr Virusol |
|
| Galkin (2006) |
Sequencing and analysis of full-length HIV-1 CRF06_cpx isolate from Russia. |
Direct Genbank Submission |
|
| Galkin (2006) |
Full-length genomic sequencing and analysis of four HIV type 1 subtype B isolates circulating in the territory of Russia. |
ARHR |
|
| Gallant (2005) |
Early virologic non-response to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral naive subjects. |
J Infect Dis |
|
| Galluzzo (2007) |
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda. |
ARHR |
|
| Gandhi (2020) |
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS). |
J Infect Dis |
|
| Gantner (2018) |
Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs. |
J Antimicrob Chemother |
|
| Gao (1992) |
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. |
Nature |
|
| Gao (1994) |
Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology. |
J Virol |
|
| Gao (1996) |
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. |
J Virol |
|
| Gao (1996) |
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID networks for HIV isolation and characterization. |
J Virol |
|
| Gao (1998) |
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. |
J Virol |
|
| Gao (1998) |
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes. |
J Virol |
|
| Gao (1999) |
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. |
Nature |
|
| Gao (2001) |
Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. |
ARHR |
|
| Gao (2001) |
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. |
ARHR |
|
| Gao (2022) |
Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China. |
Curr HIV Res |
|
| Gao (1992) |
In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine. |
J Virol |
|
| Gao (1993) |
The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine. |
Antimicrob Agents Chemother |
|
| Garcia-Bujalance (2005) |
Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs. |
J Clin Microbiol |
|
| Garcia-Knight (2016) |
Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection. |
Sci Rep |
|
| Garcia-Lerma (2001) |
Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. |
Proc Natl Acad Sci U S A |
|
| Garcia-Lerma (2003) |
A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation. |
J Virol |
|
| Garcia-Lerma (2004) |
Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine. |
J Virol |
|
| Gare (2022) |
High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study. |
BMC Infect Dis |
|
| Garrido (2009) |
Dynamics in the selection of resistance mutations in HIV patients failing raltegravir and following its discontinuation. |
EUHIV DRW 2009 |
|
| Garrido (2009) |
Integrase variability and susceptibility to HIV integrase inhibitors: Impact of subtypes, antiretroviral experience and duration of HIV infection. |
J Antimicrob Chemother |
|
| Garrido (2012) |
Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens. |
AAC |
|
| Garrido (2012) |
Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations. |
ARHR |
|
| Garriga (2009) |
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations. |
J Antimicrob Chemother |
|
| Garvey (2008) |
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral. |
Antimicrob Agents Chemother |
|
| Gashnikova (2015) |
A rapid expansion of HIV-1 CRF63_02A1 among newly diagnosed HIV-infected individuals in the Tomsk Region, Russia. |
ARHR |
|
| Gashnikova (2016) |
Predominance of CRF63_02A1 and multiple patterns of unique recombinant forms of CRF63_A1 among individuals with newly diagnosed HIV-1 infection in Kemerovo Oblast, Russia. |
Arch Virol |
|
| Gashnikova (2016) |
HIV-1 epidemiology, genetic diversity, and primary drug resistance in the Tyumen Oblast, Russia. |
Biomed Res Int |
|
| Gaspareto (2012) |
Genetic diversity and primary resistance among HIV-1-positive patients from Maringa, Parana, Brazil. |
Rev Inst Med Trop Sao Paulo |
|
| Gatanaga (1999) |
Anti-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors. |
ARHR |
|
| Gatanaga (2007) |
Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan |
Antiviral Res |
|
| Gatanaga (2010) |
Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine. |
AAC |
|
| Gatell (2019) |
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial. |
Antivir Ther |
|
| Geldmacher (2009) |
Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response. |
Blood |
|
| Gemechu (2025) |
Pretreatment HIV-1 Drug Resistance Among Newly Diagnosed People in Eastern Ethiopia. |
Health Sci Rep |
|
| George (2018) |
Rapid development of high level resistance to dolutegravir with emergence of T97A mutation in two treatment experienced individuals with baseline partial sensitivity to dolutegravir. |
Open Forum Infect Dis |
|
| Germanaud (2010) |
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali |
AAC |
|
| Gerstenberg (2024) |
Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance. |
Open Forum Infect Dis |
|
| Getaneh (2022) |
Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia. |
J Glob Antimicrob Resist |
|
| Ghafari (2017) |
Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naive persons in the Southwest of Iran |
Arch Virol |
|
| Giacobbi (2017) |
In Vitro Cross-Resistance Profiles of Rilpivirine, Dapivirine, and MIV-150, Nonnucleoside Reverse Transcriptase Inhibitor Microbicides in Clinical Development for the Prevention of HIV-1 Infection. |
Antimicrob Agents Chemother |
|
| Giammarino (2024) |
Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes. |
J Infect Dis |
|
| Giammarino (2025) |
Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. |
Antiviral Res |
|
| Giandhari (2015) |
Genetic changes in HIV-1 gag-protease associated with protease inhibitor-based therapy failure in pediatric patients. |
ARHR |
|
| Giannini (2019) |
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro. |
J Antimicrob Chemother |
|
| Gibb (2002) |
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). |
Antivir Ther |
|
| Gil (2022) |
Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens. |
Front Microbiol |
|
| Giovanetti (2022) |
Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naive patients in South Sudan. |
J Med Virol |
|
| Gittens (2003) |
The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados. |
ARHR |
|
| Godwe (2023) |
Structural Features and Genetic Diversity in Gag Gene of Rare HIV-1 Subtypes from the Democratic Republic of Congo. |
AIDS Res Hum Retroviruses |
|
| Gody (2008) |
High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations. |
JAIDS |
|
| Goethals (2008) |
Resistance mutations in HIV-1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors. |
J Virol |
|
| Goethals (2010) |
Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles. |
Virology |
|
| Goldsamt (2011) |
Prevalence of sexually acquired antiretroviral drug resistance in a community sample of HIV-positive men who have sex with men in New York City. |
AIDS Patient Care STDS |
|
| Gomez-Carrillo (2004) |
Drug resistance testing provides evidence of the globalization of HIV type 1: A new circulating recombinant form. |
ARHR |
|
| Gong (2000) |
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. |
AAC |
|
| Gonsalez (2007) |
Drug resistance among chronic HIV-1-infected patients naive for use of anti-retroviral therapy in Sao Paulo city. |
Virus Res |
|
| Gonzales (2001) |
HIV-1 reverse transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. |
J Infect Dis |
|
| Gonzales (2003) |
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. |
AIDS |
|
| Gonzales (2003) |
Protease and reverse transcriptase mutation patterns in HIV-1 isolates from heavily treated persons: Comparison of isolates from northern California with isolates from other regions. |
ARHR |
|
| Gonzales (2003) |
Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing. |
JAIDS |
|
| Gonzalez Perez (2003) |
Epidemiological and molecular characteristics of HIV and HTLV infection in Equatorial Guinea, 1996-1998. |
Direct Genbank Submission |
|
| Gonzalez (2010) |
Short communication: Antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia. |
ARHR |
|
| Gonzalez-Domenech (2018) |
Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-na |
PLoS ONE |
|
| Gonzalez-Domenech (2020) |
High Prevalence of Sequences Included in Transmission Clusters Within Newly Diagnosed HIV-1 Patients in Southern Spain (2004-2015). |
Microb Drug Resist |
|
| Gopalan (2019) |
Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug resistance and virological failure in children. |
J Med Virol |
|
| Gordon (2003) |
Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. |
J Virol |
|
| Got (2021) |
Absence of Resistance Mutations in the Integrase Coding Region among ART-Experienced Patients in the Republic of the Congo. |
Microorganisms |
|
| Gottlieb (2008) |
HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal. |
ARHR |
|
| Gottlieb (2009) |
Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. |
Clin Infect Dis |
|
| Gottlieb (2011) |
HIV-2 integrase variation in integrase inhibitor-naive adults in Senegal, West Africa. |
PLoS ONE |
|
| Graf (1998) |
Cloning and characterization of a virtually full-length HIV-1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in china. |
ARHR |
|
| Graf (2011) |
HIV-1 genetic diversity and drug resistance among treatment naive patients from southern Brazil: An association of HIV-1 subtypes with exposure categories. |
J Clin Virol |
|
| Granier (2013) |
Pressure from TRIM5a contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles. |
J Virol |
|
| Grant (2020) |
Pervasive and non-random recombination in near full-length HIV genomes from Uganda. |
Virus Evol |
|
| Grant (2022) |
A large population sample of African HIV genomes from the 1980s reveals a reduction in subtype D over time associated with propensity for CXCR4 tropism. |
Retrovirology |
|
| Grant-McAuley (2020) |
Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic. |
PLoS One |
|
| Green (2011) |
Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in south Africa. |
ARHR |
|
| Grgic (2013) |
The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation. |
ARHR |
|
| Grobler (2018) |
Efficacy of MK-8591 against diverse HIV-1 subtypes and NRTI-resistant clinical isolates. |
HIV Glasgow Conference |
|
| Grossman (2004) |
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. |
AAC |
|
| Grossman (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Grossman (2005) |
Drug-resistant HIV infection among drug-naive patients in Israel. |
Clin Infect Dis |
|
| Grossman (2014) |
Comparable long-term efficacy of lopinavir/ritonavir and similar drug-resistance profiles in different HIV-1 subtypes. |
PLoS ONE |
|
| Grossmann (2015) |
Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management. |
J Int AIDS Soc |
|
| Gu (1992) |
Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine. |
J Virol |
|
| Gu (1994) |
Identification of novel mutations that confer drug resistance in the human immunodeficiency virus polymerase gene. |
Leukemia |
|
| Guan (2020) |
HIV-1 genetic diversity and transmitted drug resistance among newly diagnosed HIV-1 individuals in Jiangmen, China. |
J Med Virol |
|
| Gui (2015) |
Genetic Characterization of a Unique Recombinant Originating from CRF55_01B, CRF01_AE, and CRF07_BC in Shenzhen, China. |
ARHR |
|
| Guichet (2016) |
Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa. |
ARHR |
|
| Guimaraes (2008) |
Identification of two new CRF_BF in Rio de Janeiro State, Brazil. |
AIDS |
|
| Guimaraes (2009) |
Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates. |
Retrovirology |
|
| Guimaraes (2010) |
Analysis of HIV-1 BF pr/rt recombinant strains from Rio de Janeiro/Brazil reveals multiple unrelated mosaic structures. |
Infect Genet Evol |
|
| Guimaraes (2015) |
Assessing the HIV-1 epidemic in Brazilian drug users: a molecular epidemiology approach. |
PLoS ONE |
|
| Guimaraes (2015) |
Transmitted Drug Resistance Among Recently Diagnosed Adults and Children in Sao Paulo, Brazil. |
ARHR |
|
| Gulick (2004) |
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. |
N Engl J Med |
|
| Guo (2009) |
First detection of a novel HIV Type 1 CRF01_AE/07_BC recombinant among an epidemiologically linked cohort of IDUs in Jiangsu, China. |
ARHR |
|
| Guo (2015) |
Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011. |
BMC Public Health |
|
| Gupta (2005) |
Analysis of HIV type 1 subtype C full-length gag gene sequences from India: novel observations and plausible implications. |
AIDS Res Hum Retroviruses |
|
| Gupta (2011) |
Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens |
AAC |
|
| Gupta (2023) |
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial. |
Lancet HIV |
|
| Gupta-Wright (2020) |
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. |
Lancet HIV |
|
| Gurjar (2009) |
Molecular characterization of a full-length genome of a HIV-2 isolate from India. |
JAIDS |
|
| Gurtler (1994) |
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. |
J Virol |
|
| Hachiya (2011) |
K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism. |
PLoS One |
|
| Hachiya (2015) |
Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance. |
Antiviral Res |
|
| Hachiya (2017) |
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: Nationwide surveillance from 2013 to 2015 in Japan. |
Direct Genbank Submission |
|
| Hachiya (2017) |
Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors. |
Antimicrob Agents Chemother |
|
| Hachiya (2022) |
Anti-HBV monotherapy caused M184V/I mutation prior to initiation of antiretroviral therapy in recent years in Japan |
Direct Genbank Submission |
|
| Haddad (2011) |
Mutation Y188L of HIV-1 reverse transcriptase is strongly associated with reduced susceptibility to rilpivirine |
CROI 2012 |
|
| Haddad (2013) |
Combinations of HIV-1 reverse transcriptase mutations L100I+K103N/S and L100I+K103R+V179D reduce susceptibility to rilpivirine. |
Interscience Conference on Antimicrobial Agents an |
|
| Hai-Long (2007) |
Genetic characterization of CRF01_AE full-length human immunodeficiency virus type 1 sequences from Fujian, China. |
ARHR |
|
| Hall (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Hamers (2010) |
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia. |
JAIDS |
|
| Hamers (2011) |
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: A multicentre observational study. |
Lancet |
|
| Hamers (2012) |
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. |
Clin Infect Dis |
|
| Hamilton (2012) |
Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults. |
ARHR |
|
| Hamkar (2010) |
Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients. |
AIDS |
|
| Hammer (1997) |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. |
N Engl J Med |
|
| Han (2015) |
Development of an HIV-1 subtype panel in China: isolation and characterization of 30 HIV-1 primary strains circulating in China. |
PLoS ONE |
|
| Han (2007) |
Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: Baseline prevalence and subtype-specific difference. |
ARHR |
|
| Han (2010) |
Genetic and epidemiologic characterization of HIV-1 infection In Liaoning Province, China. |
JAIDS |
|
| Han (2013) |
High prevalence of HIV-1 intersubtype BC recombinants among injecting drug users in Dehong, China. |
PLoS ONE |
|
| Han (2013) |
Genome sequences of a novel HIV-1 circulating recombinant form (CRF59_01B) identified among men who have sex with men in northeastern China. |
Genome Announc |
|
| Han (2013) |
Genome sequences of a novel HIV-1 circulating recombinant form, CRF55_01B, identified in China. |
Genome Announc |
|
| Han (2013) |
Identification of 3 distinct HIV-1 founding strains responsible for expanding epidemic among men who have sex with men in 9 Chinese cities. |
JAIDS |
|
| Handema (2002) |
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. |
ARHR |
|
| Hanke (2019) |
Reconstruction of the Genetic History and the Current Spread of HIV-1 Subtype A in Germany. |
J Virol |
|
| Hanke (2020) |
A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones. |
Open Forum Infect Dis |
|
| Hanna (2003) |
Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection. |
J Infect Dis |
|
| Hansen (2025) |
Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavir. |
mBio |
|
| Hao (2017) |
Low Rates of Transmitted Drug Resistances Among Treatment-Naive HIV-1-infected Students in Beijing, China. |
AIDS Res Hum Retroviruses |
|
| Hardy (2015) |
Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance. |
J Antimicrob Chemother |
|
| Harrigan (1996) |
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility. |
J Virol |
|
| Harrigan (2002) |
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance. |
J Virol |
|
| Harrigan (2005) |
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. |
AIDS |
|
| Harris (2005) |
Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany. |
ARHR |
|
| Harris (2002) |
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate. |
AIDS Res Hum Retroviruses |
|
| Harris (2003) |
A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions. |
ARHR |
|
| Hasegawa (1989) |
Genomic divergence of HIV-2 from Ghana. |
ARHR |
|
| Hassan (2013) |
Low prevalence of transmitted HIV-1 drug resistance amongst ARV naive adults in a rural HIV clinic in Kenya. |
ARHR |
|
| Hassan (2014) |
HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study. |
AIDS Res Ther |
|
| Hassan (2018) |
HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya. |
PLoS ONE |
|
| Hassan (2019) |
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya. |
PLoS One |
|
| Hassounah (2017) |
Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1. |
Antimicrob Agents Chemother |
|
| Hatano (2010) |
Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy. |
JAIDS |
|
| Hattori (2010) |
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan. |
Antiviral Res |
|
| Hattori (2016) |
Characteristics of transmitted drug-resistant HIV-1 in recently infected treatment-naive patients in Japan. |
JAIDS |
|
| Hawke (2013) |
HIV non-B subtype distribution: Emerging trends and risk factors for imported and local infections newly diagnosed in South Australia |
ARHR |
|
| Hawkins (2016) |
HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults. |
J Antimicrob Chemother |
|
| Hawkins (2009) |
Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. |
JAIDS |
|
| Hazuda (2004) |
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. |
PNAS |
|
| Hazuda (2018) |
Understanding the Resistance Profile of the HIV-1 NNRTI Doravirine in Combination With the Novel NRTTI MK-8591. |
IAC |
|
| Hebberecht (2019) |
Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach. |
J Virol Methods |
|
| Hebberecht (2020) |
High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing. |
Infect Genet Evol |
|
| Heipertz (2013) |
Molecular epidemiology of early and acute HIV type 1 infections in the United States Navy and Marine Corps, 2005-2010. |
ARHR |
|
| Heipertz (2016) |
Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG. |
Medicine (Baltimore) |
|
| Henerico (2022) |
Primary Resistance Against Integrase Strand Transfer Inhibitors in Dolutegravir Naive Patients Failing First- and Second-Line ART in Tanzania |
J Antimicrob Chemother |
|
| Henn (2012) |
Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. |
PLoS Pathog |
|
| Heredia (1997) |
Evidence of HIV-2 infection in Equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus. |
ARHR |
|
| Heredia (1997) |
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS. |
ARHR |
|
| Hermans (2020) |
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART. |
J Int AIDS Soc |
|
| Hernandez-Sanchez (2018) |
Prevalence of Drug Resistance Mutations in Protease, Reverse Transcriptase, and Integrase Genes of North Central Mexico HIV Isolates. |
ARHR |
|
| Herring (2001) |
Natural variation in HIV-1 integrase. |
Direct Genbank Submission |
|
| Hertogs (2000) |
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. |
AAC |
|
| Hierholzer (2002) |
Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. |
ARHR |
|
| Hierholzer (2002) |
HIV type 1 strains from east and west Africa are intermixed in Sudan. |
ARHR |
|
| Hightower (2013) |
HIV-1 clade B pol evolution following primary infection. |
PLoS ONE |
|
| Hikichi (2024) |
Epistatic pathways can drive HIV-1 escape from integrase strand transfer inhibitors. |
Sci Adv |
|
| Hikichi (2025) |
Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors. |
Sci Adv |
|
| Hingankar (2012) |
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India. |
Clin Infect Dis |
|
| Ho (1994) |
Characterization of human immunodeficiency virus type1 variants with increased resistance to a C2-symmetric protease inhibitor. |
J Virol |
|
| Hocqueloux (2019) |
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial. |
Clin Infect Dis |
|
| Hoelscher (2001) |
High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. |
AIDS |
|
| Hoenigl (2016) |
Characterization of HIV transmission in south-east Austria. |
PLoS ONE |
|
| Hoffmann (2009) |
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in south Africa. |
Clin Infect Dis |
|
| Hoffmann (2013) |
Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa. |
Antivir Ther |
|
| Hohan (2024) |
Estimating the Current Routes of Transmission in HIV-1 F1 Subtype Infected Persons in Romania: Differences Between Self-Reporting and Phylogenetic Data. |
Pathogens |
|
| Holguin (2000) |
Recombinant human immunodeficiency viruses type 1 circulating in Spain. |
ARHR |
|
| Holguin (2000) |
Protease gene analysis of HIV Type 1 non-B subtypes in Spain. |
ARHR |
|
| Holguin (2001) |
Prevalence of human immunodeficiency virus type 1 (HIV-1) Non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. |
J Clin Microbiol |
|
| Holguin (2002) |
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. |
AIDS |
|
| Holguin (2002) |
HIV-1 subtype J recombinant viruses in Spain. |
ARHR |
|
| Holguin (2003) |
HIV-positive immigrants in the Canary Islands, Spain: Implications for public health in Europe. |
HIV Clin Trials |
|
| Holguin (2004) |
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes. |
J Clin Virol |
|
| Holguin (2005) |
Heterogeneous nature of HIV-1 recombinants spreading in Spain. |
J Med Virol |
|
| Holguin (2005) |
Differences in the length of gag proteins among different HIV type 1 subtypes. |
ARHR |
|
| Holguin (2007) |
Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands. |
ARHR |
|
| Holguin (2008) |
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools. |
J Med Virol |
|
| Holguin (2008) |
Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. |
Curr HIV Res |
|
| Holguin (2011) |
Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009. |
Pediatr Infect Dis J |
|
| Holguin (2013) |
Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America. |
Clin Microbiol Infect. |
|
| Holzmayer (2005) |
Near-full-length genomic sequence of a human immunodeficiency type 1 subtype g strain from Cameroon. |
ARHR |
|
| Holzmayer (2009) |
Characterization of genetically diverse HIV type 1 from a London cohort: Near full-length genomic analysis of a subtype H strain. |
ARHR |
|
| Hombrouck (2008) |
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. |
AAC |
|
| Hong (2023) |
HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021. |
Virol J |
|
| Hora (2015) |
Genetic characterization of a panel of diverse HIV-1 isolates at seven international sites. |
PLoS ONE |
|
| Hosaka (2016) |
HIV-1 CRF01_AE and subtype B transmission networks crossover: a new AE/B recombinant identified in Japan. |
ARHR |
|
| Hosseinipour (2009) |
The public health approach to identify antiretroviral therapy failure: High-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. |
AIDS |
|
| Howard (1996) |
Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. |
ARHR |
|
| Hsi (2012) |
Genome sequence of a Novel HIV-1 circulating recombinant form (CRF64_BC) identified from Yunnan, China. |
ARHR |
|
| Hsu (2005) |
Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment naive and experienced patients in Singapore. |
JAIDS |
|
| Hu (2007) |
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. |
JAIDS |
|
| Huang (2003) |
Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. |
ARHR |
|
| Huang (2009) |
Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC). |
ARHR |
|
| Huang (2006) |
Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian province, China. |
Chin Med J (Engl) |
|
| Huang (2009) |
Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa. |
Antivir Ther |
|
| Huang (1999) |
Complex interactions involving multiple amino acid substitutions alter NNRTI susceptibility. |
Antivir Ther |
|
| Huang (2000) |
A novel HIV-1 RT mutation (M230L) confers NNRTI resistance and dose-dependent stimulation of replication. |
Antivir Ther |
|
| Huang (2003) |
Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. |
J Virol |
|
| Huang (2013) |
Multiple genetic pathways involving amino acid position 143 of HIV-1 integrase are preferentially associated with specific secondary amino acid substitutions and confer resistance to raltegravir and cross-resistance to elvitegravir. |
AAC |
|
| Hue (2011) |
HIV Type 1 in a Rural Coastal Town in Kenya Shows Multiple Introductions with Many Subtypes and Much Recombination. |
ARHR |
|
| Huet (1990) |
Genetic organization of a chimpanzee lentivirus related to HIV-1. |
Nature |
|
| Huik (2019) |
The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx. |
PLoS ONE |
|
| Hunt (2019) |
Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods. |
Antivir Ther |
|
| Hunt (2003) |
Characterization of near-full length genome sequences of three south African human immunodeficiency virus type 1 subtype C isolates. |
Virus Genes |
|
| Hunt (2012) |
Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009. |
Clin Infect Dis |
|
| Hunt (2017) |
Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa. |
J Antimicrob Chemother |
|
| Hurt (2014) |
Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012. |
Clin Infect Dis |
|
| Huruy (2015) |
Limited increase in primary HIV-1C drug resistance mutations in treatment naive individuals in Ethiopia |
J Med Virol |
|
| Huruy (2018) |
HIV-1C proviral DNA for detection of drug resistance mutations. |
PLoS ONE |
|
| Iamarino (2012) |
BF integrase genes of HIV-1 circulating in Sao Paulo, Brazil, with a recurrent recombination region. |
PLoS ONE |
|
| Ibe (2008) |
Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: Amino acid mutations associated with viral replication activity. |
ARHR |
|
| Ibe (2008) |
Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: An 8-year surveillance from 1999 to 2006. |
ARHR |
|
| Ibe (2010) |
HIV-2 CRF01_AB: first circulating recombinant form of HIV-2. |
JAIDS |
|
| Imade (2013) |
Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. |
ARHR |
|
| Imamichi (2000) |
High-level resistance to 3'-azido-3'-deoxythymidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1. |
J Virol |
|
| Indriati (2018) |
Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia. |
Curr HIV Res |
|
| Indriati (2020) |
The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia. |
Acta Med Indones |
|
| Invernizzi (2013) |
The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites. |
J Antimicrob Chemother |
|
| Inzaule (2013) |
Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country. |
J Clin Microbiol |
|
| Inzaule (2016) |
Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk. |
J Antimicrob Chemother |
|
| Inzaule (2018) |
Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa. |
J Antimicrob Chemother |
|
| Iqbal (2009) |
Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, southern India. |
J Int Assoc Physicians AIDS Care (Chic) |
|
| Irias (2019) |
HIV-1 Transmitted Drug Resistance Mutations in Recently Diagnosed Antiretroviral-Naive Patients in Bel |
ARHR |
|
| Isarangkura-Na-Ayuthaya (2010) |
Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 CRF01_AE integrase derived from drug-naive Thai patients. |
ARHR |
|
| Ishikawa (1988) |
Isolation and characterization of HIV-2 from an AIDS patient in Ghana. |
AIDS |
|
| Ishizaki (2009) |
Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam. |
ARHR |
|
| Ismael (2025) |
HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique. |
Pathogens |
|
| Iweriebor (2012) |
Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa. |
Arch Virol |
|
| Jackson (2000) |
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. |
AIDS |
|
| Jacobs (2008) |
Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa. |
ARHR |
|
| Jacobs (2014) |
HIV-1 subtypes B and C unique recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa. |
PLoS ONE |
|
| Jacobsen (1995) |
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. |
Virology |
|
| Jagdagsuren (2017) |
The second molecular epidemiological study of HIV infection in Mongolia between 2010 and 2016. |
PLoS ONE |
|
| Jahanbakhsh (2012) |
Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011. |
PLoS ONE |
|
| Jahanbakhsh (2013) |
Molecular epidemiology of HIV type 1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use. |
ARHR |
|
| Jallow (2006) |
Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia. |
AIDS |
|
| Jallow (2007) |
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene. |
J Clin Microbiol |
|
| Jallow (2009) |
Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau. |
Clin Infect Dis |
|
| Jallow (2009) |
Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants. |
J Clin Microbiol |
|
| Janssens (1999) |
HIV-1 subtype H near-full genome reference strains and analysis of subtype-H-containing inter-subtype recombinants. |
AIDS |
|
| Janssens (2000) |
Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants. |
ARHR |
|
| Jayaraman (2006) |
A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program. |
JAIDS |
|
| Jeffrey (2022) |
Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine. |
Antimicrob Agents Chemother |
|
| Jenabian (2015) |
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays. |
Niger Med J |
|
| Jeong (2018) |
Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea. |
ARHR |
|
| Jespersen (2018) |
Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial. |
JAIDS |
|
| Jia (2019) |
Two-year cross-sectional studies reveal that single, young MSMs in Shenzhen, China are at high risk for HIV infection. |
Virol J |
|
| Jiamsakul (2013) |
HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia. |
J Int AIDS Soc |
|
| Jiamsakul (2015) |
Transmitted drug resistance in recently infected HIV-positive Individuals from four urban locations across Asia (2007-2010) - TASER-S. |
AIDS Res Ther |
|
| Joao (2020) |
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. |
Lancet HIV |
|
| Johnston (2003) |
High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. |
J Virol |
|
| Johnston (2004) |
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance. |
AAC |
|
| Johnston (2005) |
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations. |
AIDS |
|
| Johnston (2014) |
Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch. |
J Infect Dis |
|
| Jonassen (1997) |
Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. |
Virology |
|
| Jonassen (2000) |
Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. |
ARHR |
|
| Jones (2007) |
In Vitro Resistance Profile of HIV-1 Mutants Selected by the HIV-1 Integrase Inhibitor, GS-9137 (JTK-303) |
CROI 2007 |
|
| Jones (2007) |
In Vitro Resistance Profile of HIV-1 Mutants Selected by the HIV-1 Integrase Inhibitor, GS-9137 (JTK-303) |
CROI |
|
| Jones (2009) |
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. |
AAC |
|
| Jones (2009) |
In-depth analysis of the origins of HIV type 1 subtype C in South America. |
ARHR |
|
| Jones (2012) |
Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues. |
ARHR |
|
| Jorgensen (2000) |
Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine. |
Antivir Ther |
|
| Jorgensen (2003) |
Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark. |
Scand J Infect Dis |
|
| Juarez-Gonzalez (2024) |
Resistance to second-Generation InSTIs in Mexican PLWH: Emergence of the R263K Mutant |
CROI |
|
| Junqueira (2020) |
New Genomes from the Congo Basin Expand History of CRF01_AE Origin and Dissemination. |
AIDS Res Hum Retroviruses |
|
| K'Aluoch (2005) |
Characterization of HIV-1 subtypes and recombinants in a Uganda cohort by use of the gag, nef and pol genes. |
Direct Genbank Submission |
|
| Kagan (2005) |
Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir. |
Protein Sci |
|
| Kagan (2007) |
Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase. |
Antiviral Res |
|
| Kagan (2009) |
Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples. |
AIDS |
|
| Kahle (2014) |
HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples. |
AIDS |
|
| Kaleebu (2015) |
Virological response and antiretroviral drug resistance emerging during antiretroviral therapy at three treatment centers in Uganda. |
PLoS ONE |
|
| Kamori (2023) |
Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey. |
J Antimicrob Chemother |
|
| Kamoto (2008) |
Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. |
Antivir Ther |
|
| Kandathil (2009) |
A comparison of interpretation by three different HIV type 1 genotypic drug resistance algorithms using sequences from non-clade B HIV type 1 strains. |
ARHR |
|
| Kandathil (2009) |
The frequency of HIV-I drug resistance mutations among treatment-naive individuals at a tertiary care centre in South India. |
Int J STD AIDS |
|
| Kane (2001) |
Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal. |
ARHR |
|
| Kannangai (2015) |
Frequency of transmitted drug resistance mutations among treatment-naive HIV-1-infected individuals at a tertiary care centre in South India. |
Mol Diagn Ther |
|
| Kantor (2002) |
Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy. |
AAC |
|
| Kantor (2002) |
HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. |
ARHR |
|
| Kantor (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Kantor (2015) |
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial |
Clin Infect Dis |
|
| Kao (2011) |
Surveillance of HIV type 1 recent infection and molecular epidemiology among different risk behaviors between 2007 and 2009 after the HIV type 1 CRF07_BC outbreak in Taiwan. |
ARHR |
|
| Kapaata (2021) |
HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity. |
Viruses |
|
| Karade (2016) |
Limited HIV pretreatment drug resistance among adults attending free antiretroviral therapy clinic of Pune, India. |
ARHR |
|
| Karade (2019) |
Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naive and Experienced Individuals from Western India. |
ARHR |
|
| Karade (2016) |
Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India. |
Medicine (Baltimore) |
|
| Karade (2017) |
Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study. |
PLoS ONE |
|
| Karamov (2018) |
HIV-1 Genetic Diversity in Recently Diagnosed Infections in Moscow: Predominance of A(FSU), Frequent Branching in Clusters, and Circulation of the Iberian Subtype G Variant. |
ARHR |
|
| Karkashadze (2019) |
Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia. |
J Med Virol |
|
| Karlsson (2012) |
Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010. |
PLoS ONE |
|
| Karunaianantham (2022) |
Molecular Characterization of the pol Gene of Vertically Transmitted HIV-1 Strains in Children with Virological Failure. |
AIDS Res Hum Retroviruses |
|
| Kasang (2011) |
HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. |
PLoS ONE |
|
| Kassaye (2009) |
Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy. |
JAIDS |
|
| Kassu (2007) |
Molecular epidemiology of HIV-1 in treatment-naive patients in North Ethiopia. |
ARHR |
|
| Katlama (2016) |
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia. |
J Antimicrob Chemother |
|
| Katzenstein (2000) |
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group. |
ARHR |
|
| Katzenstein (2001) |
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. |
ARHR |
|
| Kawashima (2009) |
Adaptation of HIV-1 to human leukocyte antigen class I. |
Nature |
|
| Kaye (2002) |
Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial). |
Antivir Ther |
|
| Kazennova (2017) |
Genetic Variants of HIV Type 1 in Men Who Have Sex with Men in Russia. |
ARHR |
|
| Kebe (2013) |
High rate of antiretroviral drug resistance mutations in HIV type 1 infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines. |
ARHR |
|
| Keele (2006) |
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. |
Science |
|
| Keele (2009) |
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. |
Nature |
|
| Keita (2019) |
Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali. |
J Antimicrob Chemother |
|
| Keita (2020) |
Primary resistance to antiretroviral drugs of HIV strains in Chad: a retrospective investigation by analysis of frozen dried blood spot samples. |
Eur J Clin Microbiol Infect Dis |
|
| Kekitiinwa (2017) |
Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children. |
Pediatr Infect Dis J |
|
| Kelentse (2020) |
Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana. |
Medicine (Baltimore) |
|
| Kelentse (2022) |
High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana. |
J Antimicrob Chemother |
|
| Kellam (1992) |
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. |
PNAS |
|
| Kellam (1994) |
Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance. |
J Gen Virol |
|
| Kelley (2024) |
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. |
N Engl J Med |
|
| Kemal (2013) |
Molecular epidemiology of HIV type 1 subtypes in Rwanda. |
ARHR |
|
| Kempf (2001) |
Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. |
J Virol |
|
| Keulen (1997) |
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. |
J Virol |
|
| Keulen (1999) |
Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential. |
AIDS |
|
| Khairunisa (2014) |
Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients. |
ARHR |
|
| Khairunisa (2016) |
Genotypic characterization of human immunodeficiency virus type 1 isolated in Bali, Indonesia in 2016. |
HIV & AIDS Review |
|
| Khairunisa (2018) |
Genotypic Characterization of Human Immunodeficiency Virus Type 1 Prevalent in Kepulauan Riau, Indonesia. |
ARHR |
|
| Khairunisa (2020) |
2018-2019 Update on the Molecular Epidemiology of HIV-1 in Indonesia. |
AIDS Res Hum Retroviruses |
|
| Khairunisa (2020) |
Identification of HIV-1 subtypes and drug resistance mutations among HIV-1-infected individuals residing in Pontianak, Indonesia. |
Germs |
|
| Khamadi (2023) |
Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania. |
J Pediatric Infect Dis Soc |
|
| Kiepiela (2004) |
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. |
Nature |
|
| Kiertiburanakul (2013) |
Comparisons of primary HIV-1 drug resistance between recent and chronic HIV-1 infection within a sub-regional cohort of Asian patients. |
PLoS ONE |
|
| Kiguoya (2017) |
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression. |
J Virol |
|
| Kijak (2001) |
Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina. |
Antivir Ther |
|
| Kijak (2004) |
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa. |
ARHR |
|
| Kijak (2013) |
HIV-1 prevalence and subtype distribution in HIV-1 positive volunteers deferred from enrollment in a phase III prime-boost HIV-1 vaccine trial in Thailand |
J Virol |
|
| Kim (2011) |
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naive patients with HIV/AIDS in Korea. |
Clin Microbiol Infect |
|
| Kim (2013) |
HIV antiretroviral resistance mutations among antiretroviral treatment-naive and -experienced patients in South Korea. |
ARHR |
|
| King (2006) |
Phenotypic susceptibility to TMC-114 and tipranavir before and after lopinavir/ritonavir-based treatment in subjects demonstrating evolution of lopinavir resistance. |
IHDRW 2006 |
|
| Kingwara (2024) |
Dolutegravir (DTG) resistance among ART-experienced viremic patients in Kenya receiving DTG-based ART |
CROI |
|
| Kinloch (2016) |
Population-level immune-mediated adaptation in HIV-1 polymerase during the North American epidemic. |
J Virol |
|
| Kinloch (2019) |
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity. |
J Virol |
|
| Kinomoto (2005) |
HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. |
Clin Infect Dis |
|
| Kinyua (2018) |
Antiretroviral resistance among HIV-1 patients on first-line therapy attending a comprehensive care clinic in Kenyatta National Hospital, Kenya: a retrospective analysis. |
Pan Afr Med J |
|
| Kiptoo (2013) |
HIV-1 drug resistance-associated mutations among hiv-1 infected drug-naive antenatal clinic attendees in rural Kenya. |
BMC Infect Dis |
|
| Kirchhoff (1990) |
A novel proviral clone of HIV-2: biological and phylogenetic relationship to other primate immunodeficiency viruses. |
Virology |
|
| Kirichenko (2020) |
Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs. |
Viruses |
|
| Kirichenko (2022) |
Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries. |
PLoS One |
|
| Kirichenko (2022) |
Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017-2018 and 2020-2021 following a WHO Survey. |
Viruses |
|
| Kiros (2020) |
Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia. |
Retrovirology |
|
| Kiros (2022) |
Low level of HIV-1C integrase strand transfer inhibitor resistance#mutations among recently diagnosed ART-naive Ethiopians |
Direct Genbank Submission |
|
| Kityo (2016) |
HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda. |
ARHR |
|
| Kityo (2017) |
Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children. |
J Antimicrob Chemother |
|
| Kityo (2017) |
HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa. |
JAIDS |
|
| Knops (2010) |
The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V. |
AIDS |
|
| Knops (2010) |
Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates. |
J Antimicrob Chemother |
|
| Kobayashi (2008) |
Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants. |
Antiviral Res |
|
| Kobayashi (2011) |
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor |
AAC |
|
| Koch (2001) |
Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant. |
ARHR |
|
| Koigi (2014) |
HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya. |
BMC Res Notes |
|
| Koizumi (2006) |
Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon. |
JAIDS |
|
| Kojima (2008) |
Recent diversity of human immunodeficiency virus type 1 in individuals who visited sexually transmitted infection-related clinics in Osaka, Japan. |
J Infect Chemother |
|
| Kolomeets (2014) |
A uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in Russian subtype A HIV-1 viruses. |
AIDS |
|
| Konings (2004) |
Protease mutations in HIV-1 non-B strains infecting drug-naive villagers of Cameroon. |
ARHR |
|
| Konings (2004) |
V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon. |
ARHR |
|
| Konou (2015) |
Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo. |
AIDS |
|
| Konou (2015) |
Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo. |
AIDS Res Ther |
|
| Konou (2016) |
Genetic diversity and transmission networks of HIV-1 strains among men having sex with men (MSM) in Lom |
Infect Genet Evol |
|
| Kostaki (2018) |
Molecular Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals in a Network-Based Intervention (Transmission Reduction Intervention Project): Phylogenetics Identify HIV-1-Infected Individuals With Social Links. |
J Infect Dis |
|
| Kostaki (2019) |
Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions. |
Front Microbiol |
|
| Kostrikis (2018) |
HIV-1 transmission networks across Cyprus (2010-2012). |
PLoS ONE |
|
| Kotaki (2013) |
Detection of drug resistance-associated mutations in human immunodeficiency virus type 1 integrase derived from drug-naive individuals in Surabaya, Indonesia. |
ARHR |
|
| Kotaki (2015) |
HIV-1 transmitted drug resistance mutations among antiretroviral therapy-naive individuals in Surabaya, Indonesia |
AIDS Res Ther |
|
| Kouamou (2019) |
Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy. |
AIDS |
|
| Kouamou (2020) |
Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment. |
ARHR |
|
| Koulinska (2001) |
A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. |
ARHR |
|
| Koulinska (2002) |
Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania. |
ARHR |
|
| Kouri (2012) |
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba. |
J Clin Virol |
|
| Kouri (2015) |
CRF19_cpx is an evolutionary fit HIV-1 variant strongly associated with rapid progression to AIDS in Cuba. |
EBioMedicine |
|
| Kousiappa (2009) |
Genetic analysis of HIV type 1 strains from newly infected untreated patients in Cyprus: high genetic diversity and low prevalence of drug resistance. |
ARHR |
|
| Kousiappa (2009) |
Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection. |
ARHR |
|
| Kousiappa (2011) |
Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance. |
ARHR |
|
| Koyalta (2009) |
High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad. |
Clin Infect Dis |
|
| Kroidl (2020) |
High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania. |
Trop Med Int Health |
|
| Kroon (2018) |
Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand. |
AIDS |
|
| Kuhnel (1989) |
Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate. |
PNAS |
|
| Kuhnel (1990) |
Nucleotide sequence of HIV-2D194, an isolate from a Gambian case of 'neuro-AIDS', which showed excellent growth in macrophages. |
Nucleic Acids Res |
|
| Kulkarni (2012) |
The HIV-1 reverse transcriptase M184I mutation enhances the E138K-associated resistance to rilpivirine and decreases viral fitness. |
JAIDS |
|
| Kumar (2014) |
Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India. |
AIDS Res Hum Retroviruses |
|
| Kumarasamy (2015) |
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230. |
Clin Infect Dis |
|
| Kuritzkes (2004) |
Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens. |
JAIDS |
|
| Kurle (2007) |
Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in hiv type 1 subtype C infected infants in India. |
ARHR |
|
| Kusagawa (2003) |
Identification of HIV type 2 subtype B transmission in East Asia. |
ARHR |
|
| Kusagawa (2015) |
Novel HIV-1 recombinant identified in a foreign heterosexual resident in Japan: relatedness to recently reported CRF69_01B, detected primarily among Japanese men who have sex with men. |
Genome Announc |
|
| Kusagawa (2021) |
Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV In Vitro Diagnostics in Japan. |
AIDS Res Hum Retroviruses |
|
| Kwon (2020) |
HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo. |
PLoS One |
|
| Lacey (1994) |
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'- dideoxythymidine in cell culture. |
AAC |
|
| Laeyendecker (2005) |
Molecular epidemiology of HIV-1 subtypes in southern China. |
JAIDS |
|
| Laeyendecker (2013) |
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
PLoS One |
|
| Laga (2015) |
HIV type 1 subtype A1 dominates in Armenia. |
Curr HIV Res |
|
| Lahuerta (2008) |
Rapid spread and genetic diversification of hiv type 1 subtype C in a rural area of southern Mozambique. |
ARHR |
|
| Lai (2009) |
Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. |
Antimicrob Agents Chemother |
|
| Lai (2014) |
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor. |
Antimicrob Agents Chemother |
|
| Lai (2018) |
Characterization of Doravirine-Selected Resistance Patterns From Participants in Treatment-Naive Phase 3 Clinical Trials. |
IAC |
|
| Lai (2022) |
Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance. |
Antimicrob Agents Chemother |
|
| Lakhashe (2008) |
Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. |
ARHR |
|
| Lall (2008) |
Profile of primary resistance in HIV-1-infected treatment-naive individuals from western India. |
ARHR |
|
| Lam (2003) |
Amprenavir resistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation. |
Clin Infect Dis |
|
| Lam (2016) |
Antiretroviral resistance after first-line antiretroviral therapy failure in diverse HIV-1 subtypes in the SECOND-LINE study. |
ARHR |
|
| Lama (2006) |
Linking HIV and antiretroviral drug resistance surveillance in Peru: A model for a third-generation HIV sentinel surveillance. |
JAIDS |
|
| Lan (2003) |
HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh city(Vietnam): ANRS 1257 study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. |
ARHR |
|
| Lan (2020) |
Genetic characteristics of CRF12_BF first identified in Guangdong Province, China. |
AIDS Res Hum Retroviruses |
|
| Lan (2021) |
Complicated genotypes circulating among treatment naive HIV-1 patients in Guangzhou, China. |
Infect Genet Evol |
|
| Lan (2022) |
Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China. |
Pathogens |
|
| Land (2008) |
Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants. |
ARHR |
|
| Lanier (2004) |
Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens. |
HIV Med |
|
| Lapovok (2019) |
Genetic characterization of HIV-1 variants circulating in the Republic of Guinea in 2015-2017 |
Unpublished |
|
| Lapovok (2014) |
Molecular epidemiology of HIV-infection in Volga federal district, Russia. |
Direct Genbank Submission |
|
| Lapovok (2014) |
Molecular epidemiology of HIV type 1 infection in Kazakhstan: CRF02_AG prevalence is increasing in the southeastern provinces. |
ARHR |
|
| Lapovok (2017) |
HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries. |
Curr HIV Res |
|
| Larder (1992) |
3'-Azido-3'-Deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. |
AAC |
|
| Larder (1993) |
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. |
Nature |
|
| Larder (1999) |
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. |
AAC |
|
| Larrouy (2013) |
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients. |
AIDS |
|
| Lataillade (2007) |
Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance. |
Antivir Ther |
|
| Lau (2007) |
Near full-length sequence analysis of a unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. |
ARHR |
|
| Laukkanen (1999) |
Virtually full-length sequences of HIV type 1 subtype J reference strains. |
ARHR |
|
| Laukkanen (2000) |
Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America. |
Virology |
|
| Laurent (2006) |
Antiretroviral drug resistance and routine therapy, Cameroon. |
Emerg Infect Dis |
|
| Lavu (2017) |
High levels of transmitted HIV drug resistance in a study in Papua New Guinea. |
PLoS ONE |
|
| Lawrence (1999) |
Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons. |
J Infect Dis |
|
| Lawrence (2006) |
Analysis of polymorphism in the protease and reverse transcriptase genes of HIV type 1 CRF02-AG subtypes from drug-naive patients from Saint-Etienne, France. |
JAIDS |
|
| Lazaro (2011) |
Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159). |
PLoS ONE |
|
| Le Hingrat (2018) |
A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain. |
Clin Infect Dis |
|
| Leal (2020) |
Characterization of HIV-1 genetic diversity and antiretroviral resistance in the state of Maranhao, Northeast Brazil. |
PLoS One |
|
| Lebedev (2019) |
Human Immunodeficiency Virus-1 Diversity in the Moscow Region, Russia: Phylodynamics of the Most Common Subtypes. |
Front Microbiol |
|
| Lebedev (2020) |
Prevalence and spatiotemporal dynamics of HIV-1 Circulating Recombinant Form 03_AB (CRF03_AB) in the Former Soviet Union countries. |
PLoS One |
|
| Lebedev (2017) |
Analysis of the env gene variability of the IDU-A HIV-1 variant in the outbreak of the HIV infection epidemic in Perm region of Russia (1996-2011). |
Vopr Virusol. |
|
| Ledwaba (2019) |
Low frequency of protease inhibitor resistance mutations and insertions in HIV-1 subtype C protease inhibitor naive Sequences |
ARHR |
|
| Lee (2009) |
Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore. |
HIV Med |
|
| Lee (2005) |
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. |
J Infect Dis |
|
| Lee (2012) |
Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus pbmc samples revealed by 454 |
PLoS ONE |
|
| Lee (2014) |
Prevalence and Virologic Consequences of Transmitted HIV-1 Drug Resistance in Uganda. |
ARHR |
|
| Lee (2016) |
Characterization of the near full-length genome of a novel HIV-1 CRF01_AE/CRF07_BC recombinant in an injection drug user from southern Taiwan. |
ARHR |
|
| Leigh Brown (2004) |
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. |
J Virol |
|
| Leigh Brown (2011) |
Transmission network parameters estimated from HIV sequences for a nationwide epidemic. |
J Infect Dis |
|
| Leitman (2017) |
HLA-B*14:02-Restricted Env-Specific CD8(+) T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection. |
J Virol |
|
| Lennerstrand (2001) |
Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine. |
AAC |
|
| Lennox (2014) |
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. |
Ann Intern Med |
|
| Leoz (2008) |
Integrase polymorphism and HIV-1 group O diversity. |
AIDS |
|
| Leoz (2011) |
Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02. |
AIDS |
|
| Leoz (2013) |
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France. |
AIDS |
|
| Lepik (2017) |
Emergent drug resistance with integrase strand transfer inhibitor-based regimens. |
AIDS |
|
| Leung (2019) |
Molecular Characterization of HIV-1 Minority Subtypes in Hong Kong: A Recent Epidemic of CRF07_BC among the Men who have Sex with Men Population. |
Curr HIV Res |
|
| Leye (2013) |
High frequency of HIV-1 infections with multiple HIV-1 strains in men having sex with men (MSM) in Senegal. |
Infect Genet Evol |
|
| Li (2007) |
Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. |
J Virol |
|
| Li (2022) |
HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China. |
BMC Infect Dis |
|
| Li (2012) |
Screening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in China |
PLoS ONE |
|
| Li (2016) |
The prevalence of drug resistance among treatment-naive HIV-1-infected individuals in China during pre- and post- 2004. |
BMC Infect Dis |
|
| Li (2009) |
Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations. |
Chin Med J (Engl) |
|
| Li (2018) |
HIV-1 Transmissions Among Recently Infected Individuals in Southwest China are Predominantly Derived from Circulating Local Strains. |
Sci Rep |
|
| Li (2024) |
Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4(+) T-cell loss. |
mBio |
|
| Li (2010) |
Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi, China. |
ARHR |
|
| Li (2010) |
Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China. |
ARHR |
|
| Li (2011) |
High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang, China. |
Infect Genet Evol |
|
| Li (2012) |
Recombination form and epidemiology of HIV-1 unique recombinant strains identified in Yunnan, China. |
PLoS ONE |
|
| Li (2012) |
Multiple introductions of HIV into men who have sex with men were found in Zhengzhou City, China. |
AIDS Res Hum Retroviruses |
|
| Li (2013) |
Relatively high prevalence of drug resistance among antiretroviral-naive patients from Henan, central China. |
ARHR |
|
| Li (2013) |
Subtype CRF01_AE dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China. |
J Med Virol |
|
| Li (2013) |
Genetic characterization and transmitted drug resistance of the HIV type 1 epidemic in men who have sex with men in Beijing, China |
ARHR |
|
| Li (2015) |
CRF07_BC strain dominates the HIV-1 epidemic in injection drug users in Liangshan prefecture of Sichuan, China. |
ARHR |
|
| Li (2016) |
HIV-1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, China. |
J Med Virol |
|
| Li (2017) |
Drug resistance mutation profiles of the drug-naive and first-line regimen-treated HIV-1-infected population of Suzhou, China |
Virol Sin |
|
| Li (2013) |
Genome sequences of a novel HIV-1 circulating recombinant form (CRF61_BC) identified among heterosexuals in China. |
Genome Announc |
|
| Li (2014) |
Molecular epidemiology of HIV-1 in Jilin province, northeastern China: emergence of a new CRF07_BC transmission cluster and intersubtype recombinants. |
PLoS ONE |
|
| Li (2015) |
HIV-1 genetic diversity and its impact on baseline CD4+T cells and viral loads among recently infected men who have sex with men in Shanghai, China. |
PLoS ONE |
|
| Li (2005) |
Molecular epidemiology of the heterosexual HIV-1 transmission in Kunming, Yunnan province of China suggests origin from the local IDU epidemic. |
ARHR |
|
| Li (2010) |
Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: A descendant of the previously identified CRF33_01B. |
JAIDS |
|
| Li (2011) |
High prevalence of HIV type 1 subtype B' among heterosexuals in western Hubei, Central China: Bridging the epidemic into the general population. |
ARHR |
|
| Li (2017) |
Identification of a novel HIV type 1 circulating recombinant form (CRF86_BC) among heterosexuals in Yunnan, China. |
ARHR |
|
| Li (2017) |
Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF79_0107) Identified from Shanxi, China. |
ARHR |
|
| Li (2022) |
Effect of Switching Antiretroviral Treatment Regimen in Patients With Drug-Resistant HIV-1 Infection: Retrospective Observational Cohort Study. |
JMIR Public Health Surveill |
|
| Li (2025) |
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa. |
J Int AIDS Soc |
|
| Li (2012) |
Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses. |
AIDS |
|
| Li (2013) |
The in vitro cross-resistance profile of the NRTI BMS-986001 against known NRTI resistance mutations |
Antimicrob Agents Chemother |
|
| Li (2015) |
Trends of HIV subtypes and phylogenetic dynamics among young men who have sex with men in China, 2009-2014. |
Sci Rep |
|
| Liang (2015) |
The combination of the R263K and T66I resistance substitutions in HIV-1 integrase is incompatible with high-level viral replication and the development of high-level drug resistance. |
J Virol |
|
| Liang (2020) |
The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017. |
PLoS One |
|
| Liao (2009) |
Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. |
Virology |
|
| Liao (2007) |
Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China. |
ARHR |
|
| Liegeois (2013) |
HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains. |
ARHR |
|
| Liegler (2014) |
HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial. |
J Infect Dis |
|
| Lihana (2009) |
HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy. |
ARHR |
|
| Lihana (2010) |
Genetic characterization of HIV type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya. |
ARHR |
|
| Liitsola (2000) |
An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: Low requirements for sequence identity in recombination. UNAIDS virus isolation network. |
ARHR |
|
| Lillemark (2011) |
Characterization of HIV-1 from patients with virological failure to a boosted protease inhibitor regimen. |
J Med Virol |
|
| Lima (2016) |
Epidemiological, clinical and antiretroviral susceptibility characterization of human immunodeficiency virus subtypes B and non-B in Pernambuco, northeast Brazil. |
PLoS ONE |
|
| Lima (2016) |
HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study. |
BMJ Open |
|
| Lin (1994) |
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. |
J Infect Dis |
|
| Lin (2013) |
Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users. |
Emerg Microbes Infect |
|
| Lin (2007) |
Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan. |
J Infect Dis |
|
| Lindstrom (2006) |
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men. |
Antivir Ther |
|
| Link (2020) |
Clinical targeting of HIV capsid protein with a long-acting small molecule. |
Nature |
|
| Little (2002) |
Antiretroviral-drug resistance among patients recently infected with HIV. |
N Engl J Med |
|
| Little (2014) |
Using HIV networks to inform real time prevention interventions. |
PLoS ONE |
|
| Liu (2007) |
Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian province, China. |
Arch Virol |
|
| Liu (2011) |
Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. |
ARHR |
|
| Liu (2022) |
Prevalence of transmitted drug resistance mutations among patients infected with human immunodeficiency virus type 1 (HIV-1) in Henan Province, China. |
Chin Med J (Engl) |
|
| Liu (2025) |
Transmitted drug resistance profiles among people living with HIV-1 in Henan province, China, 2024. |
J Antimicrob Chemother |
|
| Liu (2005) |
Genetic characterization of full-length HIV type 1 genomes from 3 infected paid blood donors in Henan, China. |
JAIDS |
|
| Liu (2007) |
Polymorphism and antiretroviral drug resistance patterns in the protease gene of HIV-1 subtypes infecting PI naive Chinese patients. |
Direct Genbank Submission |
|
| Liu (2008) |
Molecular epidemiology of human immunodeficiency virus type 1 and hepatitis C virus in former blood donors in central China. |
AIDS Res Hum Retroviruses |
|
| Liu (2012) |
Identification of a novel HIV type 1 circulating recombinant form (CRF52_01B) in Southeast Asia. |
ARHR |
|
| Liu (2015) |
Phylogenetic analysis of HIV-1 CRF65_CPX reveals Yunnan province is still a source contributing to the spread of HIV-1 in China. |
JAIDS |
|
| Liu (2025) |
Rapid circulation of HIV-1 CRF85_BC in Southwest China: its geographic origins and molecular transmission networks analysis. |
Front Cell Infect Microbiol |
|
| Lloyd (2008) |
Prevalence of resistance mutations in HIV-1 infected Hondurans at the beginning of the national antiretroviral therapy program. |
ARHR |
|
| Lockman (2012) |
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. |
PLoS Med |
|
| Lockman (2012) |
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. |
PLoS Med |
|
| Lole (1999) |
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. |
J Virol |
|
| Loosli (2023) |
HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis. |
Lancet HIV |
|
| Loosli (2025) |
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study. |
Clin Infect Dis |
|
| Lopez (2016) |
The genetic diversity and evolution of HIV-1 subtype B epidemic in Puerto Rico. |
Direct Genbank Submission |
|
| Lopez (2018) |
Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG. |
ARHR |
|
| Loubet (2014) |
Prevalence of HIV-1 transmitted drug resistance in Liberia. |
ARHR |
|
| Louwagie (1993) |
Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. |
AIDS |
|
| Low (2009) |
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors. |
AAC |
|
| Lu (2015) |
HIV-1 genetic diversity and transmitted drug resistance among recently infected individuals at men who have sex with men sentinel surveillance points in Hebei province, China. |
ARHR |
|
| Lu (2016) |
Recombinant patterns of nine novel HIV-1 recombinant strains identified in Hebei province, China. |
ARHR |
|
| Lu (2017) |
Surveillance of transmitted drug resistance in HIV-1-infected youths aged 16 to 25 years, a decade after scale-up of antiretroviral therapy in Hebei, China. |
ARHR |
|
| Lu (2018) |
Regional Transmission Pattern of HIV-1 Non-CRF01_AE Strains Circulating in Hebei Province, China. |
ARHR |
|
| Lu (2019) |
Large transmission clusters of HIV-1 main genotypes among HIV-1 individuals before antiretroviral therapy in the Hebei province, China. |
ARHR |
|
| Lu (2025) |
Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China. |
Sci Rep |
|
| Lubke (2019) |
Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R
|
N Engl J Med |
|
| Luebbert (2012) |
Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi. |
Clin Infect Dis |
|
| Luk (2001) |
Naturally occurring sequence polymorphisms within HIV type 1 group O protease. |
ARHR |
|
| Luk (2007) |
Near full-length genome characterization of three additional HIV type 1 CRF13_cpx strains from Cameroon. |
ARHR |
|
| Luk (2008) |
Near full-length genome characterization of an HIV type 1 CRF25_cpx strain from Cameroon. |
ARHR |
|
| Luk (2015) |
Utility of Metagenomic Next-Generation Sequencing for Characterization of HIV and Human Pegivirus Diversity. |
PLoS ONE |
|
| Lunar (2013) |
Prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010. |
ARHR |
|
| Lunar (2015) |
Longitudinal trends of recent HIV-1 infections in Slovenia (1986-2012) determined using an incidence algorithm. |
J Med Virol |
|
| Lunar (2018) |
HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update. |
PLoS ONE |
|
| Lunar (2019) |
Sequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trends. |
Infect Genet Evol |
|
| Lunar (2020) |
HIV-1 Unique Recombinant Forms Identified in Slovenia and Their Characterization by Near Full-Length Genome Sequencing. |
Viruses |
|
| Lunkuse (2025) |
Diagnostic Accuracy of Next-Generation Sequencing: Prevalence of HIV-1 Drug Resistance and Associated Factors Among Adults on Integrase Inhibitors with Virologic Failure. |
Viruses |
|
| Luo (2009) |
Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China. |
JAIDS |
|
| Luthuli (2023) |
Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses. |
Virology |
|
| Luu (2012) |
HIV type 1 coreceptor tropism, CCR5 genotype, and integrase inhibitor resistance profiles in Vietnam: Implications for the introduction of new antiretroviral regimens. |
ARHR |
|
| Lwembe (2007) |
Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure. |
J Med Virol |
|
| Ly (2005) |
Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs. |
ARHR |
|
| Ly (2007) |
Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission. |
ARHR |
|
| Ma (2023) |
Consistency of drug-resistant mutations in plasma and peripheral blood mononuclear cells of patients with treatment-naive and treatment-experienced HIV-1 infection. |
Front Cell Infect Microbiol |
|
| Machado (2002) |
Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. |
AIDS |
|
| Machado (2004) |
Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil. |
An Acad Bras Cienc |
|
| Machado (2004) |
Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. |
J Clin Virol |
|
| Machado (2004) |
Alternative, age- and viral load-related routes of nelfinavir resistance in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. |
Pediatr Infect Dis J |
|
| Machado (2009) |
Molecular epidemiology of HIV type 1 in northern Brazil: Identification of subtypes C and D and the introduction of CRF02_AG in the amazon region of Brazil. |
ARHR |
|
| Machado (2012) |
HIV type 1 genetic diversity in newly diagnosed Cuban patients. |
ARHR |
|
| Machado (2012) |
Transmitted HIV yype 1 drug resistance in newly diagnosed Cuban patients. |
ARHR |
|
| Machado (2019) |
National survey of pre-treatment HIV drug resistance in Cuban patients. |
PLoS ONE |
|
| Macharia (2016) |
Transmitted HIV-1 Drug resistance and the Role of Herpes Simplex Virus-2 Co-infection among Fishermen along the Shores of Lake Victoria, Kisumu, Kenya. |
J HIV Retrovirus |
|
| Machnowska (2019) |
Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort. |
PLoS ONE |
|
| Madsen (2007) |
Introduction of HIV type 1 into an isolated population: Molecular epidemiologic study from Greenland. |
ARHR |
|
| Maeda (2014) |
Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001. |
Antivir Ther |
|
| Maggiorella (2020) |
High HIV-1 diversity in immigrants resident in Italy (2008-2017). |
Sci Rep |
|
| Maguire (2002) |
Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: Selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. |
AAC |
|
| Mahomed (2020) |
Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy. |
South Afr J HIV Med |
|
| Maia Teixeira (2006) |
Trends in drug resistance mutations in antiretroviral-naive intravenous drug users of Rio de Janeiro. |
J Med Virol |
|
| Maiga (2010) |
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naive patients infected with non-B HIV-1 subtypes. |
AAC |
|
| Maksimenko (2022) |
Novel HIV-1 A6/B recombinant forms (CRF133_A6B and URF_A6/B) circulating in Krasnoyarsk region, Russia. |
J Infect |
|
| Makwaga (2020) |
Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya. |
Pan Afr Med J |
|
| Malan (2010) |
96-week efficacy and safety of atazanavir, with and without ritonavir, in a HAART regimen in treatment-naive patients. |
J Int Assoc Physicians AIDS Care |
|
| Malet (2008) |
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro. |
AAC |
|
| Malet (2011) |
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype. |
J Antimicrob Chemother |
|
| Malet (2014) |
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors. |
J Antimicrob Chemother |
|
| Malet (2015) |
Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance. |
J Antimicrob Chemother |
|
| Malet (2018) |
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance. |
J Antimicrob Chemother |
|
| Malinga (2023) |
Breaking the unbreakable: A paediatric case of dolutegravir resistance from KwaZulu-Natal. |
South Afr J HIV Med |
|
| Maljkovic (2003) |
Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U, and CRF01_AE. |
ARHR |
|
| Mamadou (2002) |
Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa. |
AIDS Res Hum Retroviruses |
|
| Mamadou (2003) |
Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa. |
ARHR |
|
| Mamatkulov (2017) |
Monitoring of HIV drug resistance in Uzbekistan. |
Direct Genbank Submission |
|
| Manak (2012) |
Pilot studies for development of an HIV subtype panel for surveillance of global diversity. |
AIDS Res Hum Retroviruses |
|
| Manasa (2011) |
Primary drug resistance in South Africa - data from 20 years of surveys. |
ARHR |
|
| Manasa (2013) |
High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. |
PLoS ONE |
|
| Manasa (2017) |
Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors. |
Sci Rep |
|
| Mandikiyana Chirimuta (2022) |
Emergent dolutegravir resistance in integrase-naive, treatment experienced patients from Zimbabwe. |
South Afr J HIV Med |
|
| Manolescu (2011) |
Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patients. |
Rom Biotechnol Lett |
|
| Manosuthi (2010) |
Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine. |
ARHR |
|
| Marcelin (2019) |
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients. |
J Antimicrob Chemother |
|
| Marconi (2008) |
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. |
Clin Infect Dis |
|
| Marechal (2006) |
Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: a 2005 study. |
ARHR |
|
| Margot (2020) |
Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V. |
Antimicrob Agents Chemother |
|
| Margot (2022) |
Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study. |
J Antimicrob Chemother |
|
| Margot (2023) |
Resistance Analysis of Long-Acting Lenacapavir in Heavily Treatment-Experienced People with HIV after 104 Weeks of Treatment |
EUAIDS19 |
|
| Margot (2025) |
Bictegravir + Lenacapavir: Baseline and Week 48 Resistance Analyses in ARTISTRY-1 Phase 2 |
CROI |
|
| Margot (2002) |
Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. |
AIDS |
|
| Margot (2006) |
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903 |
HIV Med |
|
| Margot (2006) |
In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine. |
Antimicrob Agents Chemother |
|
| Margot (2010) |
Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat. |
AAC |
|
| Margot (2012) |
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4 |
Antiviral Res |
|
| Margot (2015) |
Characterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro. |
Antimicrob Agents Chemother |
|
| Margot (2019) |
Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naive individuals. |
J Med Virol |
|
| Margot (2025) |
Resistance Analyses in Heavily Treatment-Experienced People with HIV Treated with the Novel HIV Capsid Inhibitor Lenacapavir After 2 years. |
J Infect Dis |
|
| Marie (2019) |
Gag-protease coevolution shapes the outcome of lopinavir-inclusive treatment regimens in chronically infected HIV-1 subtype C patients. |
Bioinformatics |
|
| Marjani (2020) |
HIV-1 integrase drug-resistance mutations in Iranian treatment-experienced HIV-1-infected patients. |
Arch Virol |
|
| Markowitz (1995) |
Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. |
J Virol |
|
| Markowitz (1998) |
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection. |
J Infect Dis |
|
| Marques (2018) |
Potential overestimation of HIV-1 sub-subtype F1 circulation in Rio de Janeiro, Brazil. |
Mem Inst Oswaldo Cruz |
|
| Martin (2014) |
Early immune adaptation in HIV-1 revealed by population-level approaches. |
Retrovirology |
|
| Martinez-Cajas (2012) |
The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors. |
J Antimicrob Chemother |
|
| Martins (2018) |
Resistance mutations to protease inhibitors in proviral DNA of HIV-2 infected patients predict response to treatment. |
HIV Glasgow Conference |
|
| Martinson (2007) |
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. |
JAIDS |
|
| Maruapula (2020) |
Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naive HIV-1 Subtype C-infected patients in Botswana. |
Direct Genbank Submission |
|
| Maruapula (2022) |
Low-frequency HIV-1 drug resistance mutations in antiretroviral naive individuals in Botswana. |
Medicine (Baltimore) |
|
| Marzinke (2021) |
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. |
J Infect Dis |
|
| Marzinke (2023) |
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. |
Antimicrob Agents Chemother |
|
| Masciotra (2000) |
Evidence of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina. |
ARHR |
|
| Masharsky (2003) |
Molecular cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union. |
ARHR |
|
| Masimba (2013) |
Prevalence of drug-resistance mutations and HIV-1 subtypes in a HIV-1 infected cohort in rural Tanzania. |
ARHR |
|
| Masoud (2020) |
Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring. |
Direct Genbank Submission |
|
| Masoud (2020) |
Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen. |
AIDS Res Hum Retroviruses |
|
| Masquelier (1999) |
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study. |
Antivir Ther |
|
| Masquelier (2001) |
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors. |
AAC |
|
| Masquelier (2002) |
Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: The APROVIR study. |
J Infect Dis |
|
| Masse (2007) |
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir. |
Antimicrob Agents Chemother |
|
| Mata-Munguia (2014) |
Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis. |
BMC Bioinformatics |
|
| Matsuda (2017) |
High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in Sao Paulo State, Brazil |
ARHR |
|
| Matsuda (2024) |
Transmitted Antiretroviral Drug Resistance to Integrase Strand Transfer Inhibitors Class in Sao Paulo Metropolitan Area, Brazil. |
AIDS Res Hum Retroviruses |
|
| Matthews (2008) |
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. |
J Virol |
|
| Maxeiner (2002) |
Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients. |
J Infect Dis |
|
| Mazzuti (2020) |
Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naive patients: A single-centre experience. |
J Glob Antimicrob Resist |
|
| Mbange (2018) |
Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea. |
BMC Res Notes |
|
| Mbisa (2020) |
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK. |
J Antimicrob Chemother |
|
| McCluskey (2021) |
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda. |
AIDS |
|
| McClutchan (2002) |
Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. |
ARHR |
|
| McColl (2010) |
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy. |
Antiviral Res |
|
| McConnell (2008) |
Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain. |
ARHR |
|
| McCormick (2020) |
Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa. |
Antimicrob Agents Chemother |
|
| McCutchan (2004) |
HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. |
ARHR |
|
| McIntosh (1991) |
Complete genome sequence of a Cambridge isolate of human immunodeficiency virus type 1. |
Direct Genbank Submission |
|
| McLaughlin (2004) |
Sequence diversity of HIV-1 genomes from the HIV vaccine trials network. |
Direct Genbank Submission |
|
| McNulty (2007) |
Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. |
J Clin Microbiol |
|
| Meeme (2015) |
Drug resistance mutations among antiretroviral-treated female sex workers in Nairobi, Kenya |
African Journal of Health Sciences |
|
| Megasari (2019) |
Genotypic Characterization of Human Immunodeficiency Virus Type 1 Isolated from Antiretroviral Treatment-Experienced Individuals in Buleleng Regency, Bali, Indonesia. |
ARHR |
|
| Megasari (2019) |
The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia. |
Acta Med Indones |
|
| Megede (2002) |
Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa. |
ARHR |
|
| Meini (2015) |
Frequent detection of antiretroviral drug resistance in HIV-1-infected orphaned children followed at a donor-funded rural pediatric clinic in Dodoma, Tanzania. |
ARHR |
|
| Meixenberger (2014) |
Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies. |
J Clin Microbiol |
|
| Meixenberger (2017) |
Molecular evolution of HIV-1 integrase during the 20 |
Virol J |
|
| Melikian (2012) |
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility. |
AAC |
|
| Melikian (2013) |
Nonnucleoside RT inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing. |
J Antimicrob Chemother |
|
| Mellors (1992) |
In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase. |
Mol Pharmacol |
|
| Mellors (1995) |
Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates. |
AAC |
|
| Melo (2012) |
Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in S |
AIDS Res Hum Retroviruses |
|
| Meloni (2004) |
Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: Sub-subtype A3. |
J Virol |
|
| Meloni (2017) |
Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options. |
Open Forum Infect Dis |
|
| Memarnejadian (2015) |
Transmitted drug resistance mutations in antiretroviral-naïve injection drug users with chronic HIV-1 infection in Iran. |
PLoS ONE |
|
| Memarnejadian (2018) |
Prevalence of HIV-1 pre-treatment drug resistance in a southern province of Iran, 2016-2017. |
Arch Virol |
|
| Memarnejadian (2019) |
HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran. |
Intervirology |
|
| Mendes Da Silva (2021) |
Genetic Characterization of a New HIV-1 Sub-Subtype A in Cabo Verde, Denominated A8. |
Viruses |
|
| Mendoza (2014) |
Human immunodeficiency virus type 1 (HIV-1) subtype B epidemic in Panama is mainly driven by dissemination of country-specific clades. |
PLoS ONE |
|
| Meng (2013) |
Five new CRF07_BC near full-length sequences isolated from Sichuan, China. |
ARHR |
|
| Mens (2022) |
Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART. |
Infect Dis Rep |
|
| Merati (2021) |
Prevalence of HIV Infection and Resistance Mutations in Patients Hospitalized for Febrile Illness in Indonesia. |
Am J Trop Med Hyg |
|
| Mesplede (2013) |
Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure. |
Retrovirology |
|
| Mesplede (2014) |
Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity. |
J Antimicrob Chemother |
|
| Mesplede (2015) |
The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B. |
AIDS |
|
| Mezei (2011) |
Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV Type 1-infected, untreated patients in Hungary. |
ARHR |
|
| Miao (2018) |
Characterization of a Novel HIV-1 Circulating Recombinant Form, CRF01_AE/B'/C (CRF96_cpx), in Yunnan, China. |
ARHR |
|
| Mikasi (2020) |
HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon. |
AIDS Res Hum Retroviruses |
|
| MIkasi (2020) |
Investigation of the HIV-1 diversity in the Cape Wine-lands district of the Western Cape Province of South Africa. |
Direct Genbank Submission |
|
| Milazzo (1999) |
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine. |
JAIDS |
|
| Miller (2003) |
Characterization of resistance mutation patterns emerging over 2 years during first-line antiretroviral treatment with tenofovir DF or stavudine and efavirenz. |
Antivir Ther |
|
| Miller (2000) |
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. |
AIDS |
|
| Milne (2019) |
Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women. |
AIDS |
|
| Mintsa-Ndong (2009) |
High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa. |
ARHR |
|
| Miri (2011) |
Characterization of protease resistance associated mutations in HIV-1 drug naive patients following the increasing prevalence of CRF02_AG strain in Morocco. |
ARHR |
|
| Misbah (2013) |
Evaluation of mutation profile of protease gene in confirmed HIV-1 infected patients Presenting with antiretroviral drug resistance. |
Direct Genbank Submission |
|
| Misbah (2016) |
Comparative analysis of drug resistance mutations in the human immunodeficiency virus reverse transcriptase gene in patients who are non-responsive, responsive and naive to antiretroviral therapy. |
Arch Virol |
|
| Mitsuya (2006) |
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure. |
ARHR |
|
| Miura (2008) |
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: Lack of gross genetic defects or common amino acid changes. |
J Virol |
|
| Mo (2003) |
Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir. |
Antiviral Res |
|
| Mo (2005) |
Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlates. |
J Virol |
|
| Mo (2006) |
Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to HIV protease inhibitors and impair viral replication. |
AAC |
|
| Mohamad (2012) |
Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia. |
Braz J Infect Dis |
|
| Mokgethi (2024) |
High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana. |
Front Microbiol |
|
| Mokili (2002) |
Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo. |
ARHR |
|
| Molina (2012) |
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study. |
Lancet Infect Dis |
|
| Molla (1996) |
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. |
Nat Med |
|
| Mollan (2012) |
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status. |
J Infect Dis |
|
| Monaco (2016) |
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression. |
J Exp Med |
|
| Monleau (2011) |
Antiretroviral drug resistance in HIV-1 infected patients receiving antiretroviral treatment in routine clinics in Cotonou, Benin |
J. AIDS HIV Res |
|
| Monleau (2012) |
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations. |
ARHR |
|
| Monno (2003) |
HIV-1 phenotypic susceptibility to lopinavir(LPV) and genotypic analysis in LPV/r-naive subjects with prior protease inhibitor experience. |
JAIDS |
|
| Monno (2003) |
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART. |
J Med Virol |
|
| Monno (2005) |
HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy. |
J Med Virol |
|
| Montavon (1999) |
The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries. |
ARHR |
|
| Montavon (2000) |
Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. |
JAIDS |
|
| Montavon (2002) |
CRF06-cpx: A new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. |
JAIDS |
|
| Montavon (2002) |
Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. |
ARHR |
|
| Monteiro (2009) |
Genetic variability of human immunodeficiency virus-1 in Bahia state, Northeast, Brazil: high diversity of HIV genotypes. |
J Med Virol |
|
| Monteiro-Cunha (2011) |
Lack of high-level resistance mutations in HIV type 1 BF recombinant strains circulating in northeast Brazil. |
ARHR |
|
| Montes (2004) |
Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B. |
JAIDS |
|
| Moranguinho (2020) |
Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy
|
AIDS |
|
| Mortier (2022) |
Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019. |
Open Forum Infect Dis |
|
| Mosha (2010) |
Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania. |
ARHR |
|
| Moskaleychik (2015) |
Rapid spread of the HIV1 circular recombinant CRF02AG in Russia and neighboring countries. |
Vopr Virusol |
|
| Mossoro-Kpinde (2017) |
High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study. |
Medicine (Baltimore) |
|
| Mothe (2012) |
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. |
PLoS One |
|
| Moura (2015) |
Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhao State, northeast Brazil. |
ARHR |
|
| Moura (2015) |
HIV-1 transmitted drug resistance and genetic diversity among patients from Piaui State, Northeast Brazil. |
J Med Virol |
|
| Moussa (2010) |
First data on HIV-1 resistance mutations to antiretroviral drugs in Central African Republic. |
ARHR |
|
| Moyo (2020) |
HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey. |
PLoS One |
|
| Msimanga (2015) |
HIV-1 diversity in an antiretroviral treatment naive cohort from Bushbuckridge, Mpumalanga province, South Africa. |
Virol J |
|
| Mueller (2004) |
Susceptibility to saquinavir and atazanavir in highly protease inhibitor(PI) resistant HIV-1 is caused by lopinavir-induced drug resistance mutation L76V. |
Antivir Ther |
|
| Mueller (2007) |
Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease. |
J Virol |
|
| Muenchhoff (2014) |
Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma. |
PLoS One |
|
| Mulato (2016) |
Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug Levels. |
AIDS Res Hum Retroviruses |
|
| Mulato (1998) |
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy. |
AAC |
|
| Mulu (2015) |
Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia. |
BMC Infect Dis |
|
| Mulu (2015) |
Lack of integrase inhibitors associated resistance mutations among HIV-1C isolates. |
J Transl Med |
|
| Munir (2015) |
G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance. |
J Antimicrob Chemother |
|
| Murillo (2010) |
Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment. |
HIV Med |
|
| Murillo (2012) |
Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America. |
J Med Virol |
|
| Murphy (2004) |
HIV protease mutations associated with amprenavir resistance during salvage therapy: Importance of I54M. |
J Clin Virol |
|
| Murphy (1999) |
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. |
J Infect Dis |
|
| Murzakova (2019) |
Molecular Epidemiology of HIV-1 Subtype G in the Russian Federation. |
Viruses |
|
| Musyoki (2012) |
Genetic characterization of HIV before widespread testing of HIV vaccine candidates at a clinical trial site in Pretoria, South Africa. |
ARHR |
|
| Mwaengo (1998) |
Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic HIV-1 infections. |
J Virol |
|
| Myers (2012) |
Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature. |
ARHR |
|
| Mziray (2020) |
Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania. |
PLoS One |
|
| Nadai (2009) |
HIV-1 epidemic in the Caribbean is dominated by subtype B. |
PLoS ONE |
|
| Naeger (2016) |
Effect of dolutegravir functional monotherapy on HIV-1 virological response in integrase strand transfer inhibitor resistant patients. |
Antivir Ther |
|
| Nagarajan (2024) |
Spectrum of Nonnucleoside Reverse Transcriptase Inhibi-tor-Associated Drug Resistance Mutations in Persons Living With HIV-1 Receiving Rilpivirine |
Viruses |
|
| Naik (2025) |
Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes. |
AIDS |
|
| Nakahara (2009) |
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics. |
Antiviral Res |
|
| Nanfack (2016) |
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design. |
Curr HIV Res |
|
| Nanfack (2017) |
Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients. |
J Clin Microbiol |
|
| Nasioulas (1999) |
Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. |
ARHR |
|
| Nasiri Tajabadi (2020) |
A surveillance on protease inhibitor resistance-associated mutations among Iranian HIV-1 patients. |
Archives of Clinical Infectious Diseases |
|
| Naugler (2002) |
T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. |
J Infect Dis |
|
| Naziri (2016) |
Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014. |
Arch Virol |
|
| Nazziwa (2012) |
HIV-1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral naive individuals from Ugandan fishing communities of Lake Victoria |
ARHR |
|
| Ndahimana Jd Riedel (2016) |
HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda. |
Antivir Ther |
|
| Ndahimana (2016) |
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virologic failure in Rwanda. |
Trop Med Int Health |
|
| Ndase (2012) |
Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships. |
JAIDS |
|
| Ndashimye (2018) |
Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda. |
ARHR |
|
| Ndashimye (2020) |
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. |
J Antimicrob Chemother |
|
| Ndashimye (2021) |
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations. |
J Antimicrob Chemother |
|
| Ndembi (2008) |
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. |
J Clin Microbiol |
|
| Ndembi (2008) |
Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. |
ARHR |
|
| Ndembi (2010) |
Viral rebound and emergence of drug resistance in the absence of viral load testing: A randomized comparison between zidovudine-lamivudine plus nevirapine and zidovudine-lamivudine plus abacavir. |
J Infect Dis |
|
| Ndembi (2011) |
Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala. |
AIDS |
|
| Ndiaye (2013) |
HIV type 1 subtype C remains the predominant subtype in men having sex with men in Senegal. |
ARHR |
|
| Ndongmo (2006) |
HIV genetic diversity in Cameroon: possible public health importance. |
ARHR |
|
| Nduva (2020) |
HIV-1 Transmission Patterns Within and Between Risk Groups in Coastal Kenya. |
Sci Rep |
|
| Negi (2017) |
Genotypic Characterization of Human Immunodeficiency Virus Type 1 Derived from Antiretroviral Drug-Treated Individuals Residing in Earthquake-Affected Areas in Nepal. |
ARHR |
|
| Neilson (1999) |
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. |
J Virol |
|
| Neogi (2010) |
Naturally occurring polymorphisms and primary drug resistance profile among antiretroviral-naive individuals in Bangalore, India. |
ARHR |
|
| Neogi (2011) |
Characterization of HIV type 1 subtype C protease gene: selection of L63P mutation in protease inhibitor-naive Indian patients. |
ARHR |
|
| Neogi (2013) |
Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals. |
J Int AIDS Soc |
|
| Neogi (2014) |
Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades. |
PLoS ONE |
|
| Neogi (2014) |
Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India. |
Antivir Ther |
|
| Neogi (2016) |
Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa. |
ARHR |
|
| Neogi (2017) |
Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden. |
Sci Rep |
|
| Nerrienet (2005) |
Simian immunodeficiency virus infection in wild-caught chimpanzees from Cameroon. |
J Virol |
|
| Nerrienet (2014) |
HIV-1 protease inhibitors resistance profiles patients virological failure LPV/r based 2nd line regimen Cambodia. |
J AIDS Clin Res |
|
| Nesakumar (2019) |
Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India. |
ARHR |
|
| Ng (2012) |
Genome sequence of a novel HIV-1 circulating recombinant form 54_01B from Malaysia |
J Virol |
|
| Ng (2011) |
Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms. |
ARHR |
|
| Ng (2011) |
Identification of New CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. |
ARHR |
|
| Ngo-Giang-Huong (2011) |
Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A bayesian analysis. |
PLoS ONE |
|
| Ngo-Giang-Huong (2019) |
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries. |
J Antimicrob Chemother |
|
| Ngo-Malabo (2017) |
HIV Drug Resistance Testing in a Resource Limited Setting with High Viral Diversity: The First Twenty Eight Months Experience. |
Curr HIV Res |
|
| Nguyen (2008) |
HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam. |
Antivir Ther |
|
| Nguyen (2018) |
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing. |
J Antimicrob Chemother |
|
| Niama (2006) |
HIV-1 subtypes and recombinants in the Republic of Congo. |
Infect Genet Evol |
|
| Niama (2009) |
CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL. |
ARHR |
|
| Niculescu (2014) |
Recent HIV-1 outbreak among intravenous drug users in Romania: evidence for cocirculation of CRF14_BG and subtype F1 strains. |
ARHR |
|
| Nii-Trebi (2013) |
HIV-1 drug-resistance surveillance among treatment-experienced and -naive patients after the implementation of antiretroviral therapy in Ghana. |
PLoS ONE |
|
| Nii-Trebi (2017) |
Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana. |
J Med Microbiol |
|
| Nijhuis (1997) |
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo. |
J Infect Dis |
|
| Nijhuis (2009) |
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V. |
J Infect Dis |
|
| Njai (2006) |
The predominance of human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. |
Retrovirology |
|
| Njenda (2018) |
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. |
J Antimicrob Chemother |
|
| Njouom (2003) |
Assessment of HIV-1 subtyping for Cameroom strains using phylogenetic analysis of pol gene sequences. |
J Virol Methods |
|
| Nkengasong (2000) |
Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Cote d'Ivoire. |
JAIDS |
|
| Nkone (2022) |
Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages. |
Virol J |
|
| Nomura (2013) |
Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan. |
J Virol |
|
| Nouhin (2009) |
Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in Cambodia. |
ARHR |
|
| Nouhin (2011) |
Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naive individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study. |
Infect Genet Evol |
|
| Nouhin (2013) |
Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia. |
PLoS ONE |
|
| Novitsky (2002) |
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? |
J Virol |
|
| Novitsky (2007) |
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. |
ARHR |
|
| Novitsky (2015) |
Long-range HIV genotyping using viral RNA and proviral DNA for analysis of HIV drug resistance and HIV clustering. |
J Clin Microbiol |
|
| Novitsky (1999) |
Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from Botswana. |
J Virol |
|
| Novitsky (1999) |
HIV-1 A/J recombinant with a pronounced pol gene mosaicism. |
ARHR |
|
| Ntale (2012) |
Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression. |
J Virol |
|
| Ntamatungiro (2017) |
Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression. |
J Antimicrob Chemother |
|
| Ntemgwa (2007) |
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors. |
Antimicrob Agents Chemother |
|
| Ntemgwa (2008) |
Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada. |
ARHR |
|
| Nukoolkarn (2004) |
Sequence variability of the HIV type 1 protease gene in Thai patients experienced with antiretroviral therapy. |
ARHR |
|
| Nunes (2022) |
HIV-1 genetic diversity and transmitted drug resistance to integrase strand transfer inhibitors among recently diagnosed adults in Porto Alegre, South Brazil. |
J Antimicrob Chemother |
|
| Nwobegahay (2011) |
Prevalence of drug-resistant mutations in newly diagnosed drug-naive HIV-1-infected individuals in a treatment site in the Waterberg district, Limpopo province. |
S Afr Med J |
|
| Nwobegahay (2011) |
Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa. |
J Health Popul Nutr |
|
| Nwobegahay (2012) |
Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naive patients entering antiretroviral treatment programs at two sites in northern South Africa. |
J Med Virol |
|
| Nyombi (2008) |
Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania. |
ARHR |
|
| Nzeyimana (2010) |
Monitoring of HIV-1 drug resistance and associated programmatic factors in patients initiating antiretroviral therapy at two ART sites in Bujumbura, Burundi. |
IWHHVDR |
|
| Ochoa de Echaguen (2005) |
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir. |
AIDS |
|
| Oelrichs (1998) |
A novel subtype A/G/J recombinant full-length HIV Type 1 genome from Burkina Faso. |
ARHR |
|
| Oelrichs (1999) |
Full-length genomic sequence of a subtype G HIV-1 from Kinshasa. |
ARHR |
|
| Oette (2006) |
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. |
JAIDS |
|
| Ojesina (2006) |
Subtype-specific patterns in HIV type 1 reverse transcriptase and protease in Oyo State, Nigeria: Implications for drug resistance and host response. |
ARHR |
|
| Ojesina (2007) |
Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria. |
ARHR |
|
| Ojwach (2018) |
Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection. |
J Virol |
|
| Oldenbuettel (2017) |
Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results. |
Antivir Ther |
|
| Oliveira (2014) |
Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors. |
AIDS |
|
| Oliveira (2015) |
The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir. |
AIDS |
|
| Oliveira (2016) |
The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir. |
AIDS |
|
| Oliveira (2017) |
M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA. |
J Antimicrob Chemother |
|
| Oliveira (2018) |
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir. |
Retrovirology |
|
| Oliveira (2012) |
Genetic diversity and naturally polymorphisms in HIV type 1 integrase isolates from Maputo, Mozambique: Implications for integrase inhibitors. |
ARHR |
|
| Oliveira (2012) |
Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands. |
ARHR |
|
| Omooja (2019) |
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda. |
J Antimicrob Chemother |
|
| Ong (2013) |
Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment naive patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. |
J Med Virol |
|
| Onoriode Digban (2019) |
Analyses of HIV-1 integrase gene sequences among treatment-naive patients in the Eastern Cape, South Africa. |
J Med Virol |
|
| Onsongo (2016) |
Prevalence of transmitted drug resistance mutations in HIV-1-infected drug-naive patients from urban and suburban regions of Kenya. |
ARHR |
|
| Onwuamah (2020) |
Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study. |
BMC Microbiol |
|
| Onywera (2017) |
Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya. |
PLoS ONE |
|
| Op de Coul (2000) |
Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors and to children. |
ARHR |
|
| Op de Coul (2000) |
Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and the Netherlands. |
Virology |
|
| Orkin (2020) |
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. |
AIDS |
|
| Orkin (2024) |
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials. |
Lancet HIV |
|
| Orkin (2025) |
Doravirine resistance patterns identified through week 192 in the DRIVE-FORWARD and DRIVE-AHEAD phase 3 clinical trials |
J Acquir Immune Defic Syndr |
|
| Orlandi (1998) |
Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine. |
JAIDS |
|
| Orlova-Morozova (2025) |
Real-world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV-1 sub-subtype A6 harbouring the L74I mutation. |
HIV Med |
|
| Oroz (2019) |
Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia. |
Sci Rep |
|
| Orrell (2009) |
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. |
Antivir Ther |
|
| Orta-Resendiz (2020) |
HIV-1 acquired drug resistance to integrase inhibitors in a cohort of antiretroviral therapy multi-experienced Mexican patients failing to raltegravir: a cross-sectional study. |
AIDS Res Ther |
|
| Otecko (2016) |
Viral and host characteristics of recent and established HIV-1 infections in Kisumu based on a multiassay approach. |
Sci Rep |
|
| Overton (2021) |
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. |
Lancet |
|
| Pace (2006) |
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation. |
J Virol |
|
| Palacios (2008) |
Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Malaga (Spain). |
Enferm Infecc Microbiol Clin |
|
| Palm (2015) |
Cocirculation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing. |
ARHR |
|
| Palma (2007) |
Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. |
Infect Genet Evol |
|
| Palmer (1999) |
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. |
AIDS |
|
| Palmier (2023) |
Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study. |
HIV Med |
|
| Palumbo (2018) |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052. |
JAIDS |
|
| Palumbo (2019) |
HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074. |
PLoS One |
|
| Palumbo (2022) |
Multiple Infection and Human Immunodeficiency Virus Superinfection Among Persons who Inject Drugs in Indonesia and Ukraine. |
J Infect Dis |
|
| Pandey (2013) |
Molecular characterization of unique intersubtype HIV type 1 A1/C recombinant strain circulating in Pune, India. |
ARHR |
|
| Pandey (2016) |
Phylogenetic and molecular characterization of six full-length HIV-1 genomes from India reveals a monophyletic lineage of Indian sub-subtype A1. |
ARHR |
|
| Pando (2006) |
First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. |
Retrovirology |
|
| Pandrea (2001) |
HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova. |
ARHR |
|
| Pandrea (2002) |
Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon. |
ARHR |
|
| Pang (2021) |
HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China. |
BMC Infect Dis |
|
| Panichsillapakit (2016) |
Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013. |
JAIDS |
|
| Paolucci (2014) |
Phylogenetic analysis of HIV type 1 CRF02_AG in multiple genes in Italian and African patients living in Italy. |
ARHR |
|
| Papa (2002) |
Genetic variation of the protease and reverse transcriptase genes in HIV-1 CRF04_cpx strains. |
ARHR |
|
| Papa (2002) |
HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece. |
Virus Res |
|
| Papathanasopoulos (2002) |
Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. |
ARHR |
|
| Papathanasopoulos (2003) |
Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa. |
ARHR |
|
| Papathanasopoulos (2010) |
Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS vaccine integrated project (AVIP) study. |
ARHR |
|
| Paraschiv (2007) |
Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains. |
Int J Infect Dis |
|
| Paraschiv (2009) |
Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania. |
Int J Infect Dis |
|
| Paraschiv (2017) |
Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users. |
PLoS ONE |
|
| Paraskevis (2000) |
Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences. |
ARHR |
|
| Paraskevis (2001) |
Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. |
J Gen Virol |
|
| Paraskevis (2005) |
Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. |
Virus Res |
|
| Paraskevis (2009) |
Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. |
J Infect Dis |
|
| Parboosing (2011) |
Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa. |
J Med Virol |
|
| Parczewski (2012) |
HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from northwestern Poland. |
BMC Infect Dis |
|
| Parczewski (2014) |
Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype. |
J Antimicrob Chemother |
|
| Paredes (2011) |
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy |
J Infect Dis |
|
| Parham (2011) |
Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004. |
ARHR |
|
| Pariente (2004) |
Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes. |
J Med Virol |
|
| Park (2021) |
Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada. |
Viruses |
|
| Park (2003) |
Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy. |
ARHR |
|
| Park (2024) |
Portable Nanopore sequencing solution for next-generation HIV drug resistance testing. |
J Clin Virol |
|
| Parkin (2000) |
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients. |
AIDS |
|
| Parkin (2001) |
Discordance between genotype-based predictions of protease inhibitor susceptibility and actual phenotype in HIV-1 isolates containing mutations at positions 82 and 90: Modulatory effects of mutations at secondary positions. |
ICAAC 2000 |
|
| Parkin (2001) |
Genotypic and phenotypic analysis of a large database of patient samples reveals distinct patterns of protease inhibitor cross-resistance. |
Antivir Ther |
|
| Parkin (2003) |
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. |
AAC |
|
| Parkin (2003) |
HIV-1 reverse transcriptase mutations that suppress zidovudine resistance also increase in vitro susceptibility to tenofovir, but not stavudine. |
IHDRW 2003 |
|
| Parkin (2006) |
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors. |
AAC |
|
| Parreira (2004) |
Natural polymorphism of HIV-1 subtype G protease and cleavage sites. |
AIDS |
|
| Parreira (2006) |
Genetic characterization of human immunodeficiency virus type 1 from Beira, Mozambique |
Microbes Infect |
|
| Parreira (2006) |
Natural polymorphisms of HIV type 2 pol sequences from drug-naive individuals. |
ARHR |
|
| Partaledis (1995) |
In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease. |
J Virol |
|
| Pasquier (2001) |
HIV-1 subtyping using phylogenetic analysis of pol gene sequences. |
J Virol Methods |
|
| Passaes (2009) |
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil. |
JAIDS |
|
| Passaes (2009) |
Near full-length genome characterization of HIV type 1 unique BC recombinant forms from southern Brazil. |
ARHR |
|
| Patick (1996) |
Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. |
AAC |
|
| Patick (1998) |
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. |
AAC |
|
| Patil (2020) |
HIV-1 pol gene diversity and molecular dating of subtype C from Sri Lanka. |
PLoS One |
|
| Patino-Galindo (2017) |
The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): analysis of transmission clusters. |
Sci Rep |
|
| Patino-Galindo (2017) |
Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain. |
PLoS ONE |
|
| Paton (2021) |
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial. |
Lancet HIV |
|
| Payne (2014) |
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence. |
Proc Natl Acad Sci U S A |
|
| Peeters (1999) |
Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. |
J Virol |
|
| Peeters (2000) |
Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution. |
AIDS Res Hum Retroviruses |
|
| Pei (2019) |
Multiple HIV-1 Subtypes Were Found Circulating in Suqian District of Jiangsu Province, China. |
ARHR |
|
| Pellegrin (1999) |
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. |
AIDS |
|
| Pena Lopez (2018) |
Virological failure through the R263K pathway to a first line dolutegravir containing regimen. |
IAS |
|
| Pennetzdorfer (2026) |
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defects. |
Sci Transl Med |
|
| Penrose (2017) |
Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa. |
Antimicrob Agents Chemother |
|
| Pere (2012) |
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic. |
ARHR |
|
| Perez (2001) |
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients. |
J Infect Dis |
|
| Perez (2006) |
HIV Type 1 molecular epidemiology in Cuba: High genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombinant forms. |
ARHR |
|
| Perez-Alvarez (2001) |
HIV-1 subtype G and BG recombinant viruses in Spanish natives: Evidence of characteristic mutations in reverse transcriptase and protease. |
AIDS |
|
| Perez-Losada (2017) |
Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC. |
PLoS ONE |
|
| Perez-Parra (2016) |
Phylodynamic and phylogeographic profiles of subtype B HIV-1 epidemics in south Spain. |
PLoS ONE |
|
| Perez-Parra (2017) |
High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach. |
PLoS One |
|
| Perno (2001) |
Impact of mutations conferring reduced susceptibility to lamivudine(3TC) on the response to antiretroviral therapy. |
Antivir Ther |
|
| Pessoa (2014) |
Identification of a novel HIV-1 circulating recombinant form (CRF72_BF1) in deep sequencing data from blood donors in southeastern Brazil. |
Genome Announc |
|
| Pessoa (2014) |
Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, Brazil. |
PLoS ONE |
|
| Pessoa (2015) |
Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil. |
Transfusion |
|
| Pessoa (2016) |
Ultra-deep sequencing of HIV-1 near full-length and partial proviral genomes reveals high genetic diversity among Brazilian blood donors. |
PLoS One |
|
| Petch (2005) |
Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. |
ARHR |
|
| Peters (2008) |
An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort. |
J Virol |
|
| Petroni (2006) |
Update on primary HIV-1 resistance in Argentina: Emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. |
JAIDS |
|
| Petropoulos (2000) |
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. |
AAC |
|
| Pham (2018) |
The S230R Integrase Substitution Associated with Viral Rebound during DTG Monotherapy Confers Low Levels INSTI Drug Resistance. |
J Infect Dis |
|
| Pham (2021) |
Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir. |
J Antimicrob Chemother |
|
| Pham (2015) |
Change in the prevalence of HIV-1 and the rate of transmitted drug-resistant HIV-1 in Haiphong, Northern Vietnam. |
ARHR |
|
| Phan (2010) |
Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in northern Vietnam. |
ARHR |
|
| Phung (2016) |
Prevalence of drug resistance and associated mutation among HIV-1 naive infected children at the National Hospital of Pediatrics, Hanoi Vietnam. |
Direct Genbank Submission |
|
| Pieniazek (1998) |
Evidence for the introduction of multiple HIV-1 subtypes in Lebanon. |
Emerg Infect Dis |
|
| Pieniazek (1999) |
Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. |
ARHR |
|
| Pieniazek (2004) |
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1. |
AIDS |
|
| Pieniazek (2004) |
HIV-1 complex recombinant was the predominant strain in Burkina Faso by the mid-1980s. |
CROI 2004 |
|
| Pillay (2002) |
HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa. |
ARHR |
|
| Pillay (2014) |
Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. |
AIDS Res Ther |
|
| Pillay (2008) |
HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy. |
ARHR |
|
| Pillay (2008) |
Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng province, South Africa in 2002 and 2004. |
Antivir Ther |
|
| Pingen (2015) |
Infection with the frequently transmitted HIV-1 M41L variant has no influence on selection of tenofovir resistance. |
J Antimicrob Chemother |
|
| Pircher (2013) |
Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs. |
ARHR |
|
| Pires (2004) |
Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. |
J Clin Microbiol |
|
| Piyasirisilp (2000) |
A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. |
J Virol |
|
| Piyasujabul (2002) |
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants. |
J Clin Virol. |
|
| Planinic (2023) |
Characterization of Human Immunodeficiency Virus-1 Transmission Clusters and Transmitted Drug-Resistant Mutations in Croatia from 2019 to 2022. |
Viruses |
|
| Plantier (2009) |
A new human immunodeficiency virus derived from gorillas. |
Nat Med |
|
| Podzamczer (2002) |
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study). |
Antivir Ther |
|
| Podzamczer (2005) |
Early virological failure with a combination of tenofovir, didanosine and efavirenz. |
Antivir Ther |
|
| Pollakis (2003) |
Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. |
ARHR |
|
| Porter (2014) |
Characterization of HIV-1 drug resistance development through week 48 in antiretroviral naive subjects on rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF in the STaR study (GS-US-264-0110) |
JAIDS |
|
| Posada Cespedes (2017) |
Learning evolutionary pathways of HIV-1 subtype C under lopinavir treatment |
IAS 2017 |
|
| Pouran Yousef (2016) |
Inferring HIV-1 transmission dynamics in Germany from recently transmitted viruses. |
JAIDS |
|
| Poveda (2008) |
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues. |
AIDS |
|
| Poveda (2008) |
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes. |
AIDS |
|
| Powell (2007) |
Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G. |
ARHR |
|
| Powell (2007) |
Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. |
ARHR |
|
| Prado (2002) |
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity. |
AIDS |
|
| Praparattanapan (2011) |
Current molecular epidemiology and recombination of HIV type 1 subtypes in northern Thailand. |
ARHR |
|
| Prellwitz (2013) |
HIV behind bars: human immunodeficiency virus cluster analysis and drug resistance in a reference correctional unit from southern Brazil. |
PLoS ONE |
|
| Price (2011) |
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa |
ARHR |
|
| Puertas (2020) |
Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report. |
Lancet Microbe |
|
| Pujari (2018) |
Integrase Resistance-Associated Mutations on Raltegravir Failure in Western India: A Preliminary Analysis. |
JAIDS |
|
| Pujol-Hodge (2022) |
Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa. |
Viruses |
|
| Punzi (2005) |
HIV infection and protease genetic diversity in a rural area of the southern Central African Republic. |
J Med Virol |
|
| Puthanakit (2010) |
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy. |
HIV Med |
|
| Pyne (2013) |
Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States. |
J Clin Microbiol |
|
| Qari (2002) |
Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1. |
J Clin Microbiol. |
|
| Qi (2013) |
HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China. |
PLoS ONE |
|
| Qiu (2005) |
Characterization of five nearly full-length genomes of early HIV type 1 strains in Ruili city: Implications for the genesis of CRF07_BC and CRF08_BC circulating in China. |
ARHR |
|
| Quansah (2022) |
Transmitted Drug Resistance of Circulating HIV-1 Sub-types in ART-naive HIV Patients in Ghana |
Direct Genbank Submission |
|
| Quashie (2012) |
Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir. |
J Virol |
|
| Quashie (2015) |
Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase. |
J Virol |
|
| Queiros (2025) |
Genetic Diversity in the Capsid Protein-Coding Region of HIV-1 Circulating in Benguela, Angola: Implications for Primary Resistance to the Novel Capsid Inhibitor Lenacapavir. |
Viruses |
|
| Quinones-Mateu (1995) |
Molecular characterization of human immunodeficiency virus type 1 from Venezuela. |
ARHR |
|
| Quinones-Mateu (1998) |
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in Individuals infected with Group O strains of human immunodeficiency virus type 1. |
J Virol |
|
| Ragonnet-Cronin (2010) |
Longitudinal phylogenetic surveillance identifies distinct patterns of cluster dynamics. |
JAIDS |
|
| Ragonnet-Cronin (2012) |
Adaptive evolution of HIV at HLA epitopes is associated with ethnicity in Canada |
PLoS ONE |
|
| Ragonnet-Cronin (2012) |
Genetic diversity as a marker for timing infection in HIV-infected patients: Evaluation of a 6-month window and comparison with BED. |
J Infect Dis |
|
| Ragonnet-Cronin (2018) |
Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis. |
J Infect Dis |
|
| Ragonnet-Cronin (2016) |
A direct comparison of two densely sampled HIV epidemics: the UK and Switzerland. |
Sci Rep |
|
| Rahman (2021) |
HIV-1 drug resistance and genotypes circulating among HIV-positive key populations in Bangladesh: 2016 update. |
Int J Infect Dis |
|
| Rahman (2022) |
Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh. |
J Med Virol |
|
| Rajesh (2009) |
Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients. |
ARHR |
|
| Rakotomalala (2024) |
High HIV-1 genetic diversity and low prevalence of transmitted drug resistance among treatment-naive people living with HIV in Madagascar. |
Infect Genet Evol |
|
| Ramkissoon (2015) |
Analysis of reverse transcriptase and protease genes of HIV for antiretroviral drug resistance in treatment-exposed Jamaican pediatrics. |
AIDS Res Hum Retroviruses |
|
| Ramos (1999) |
Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. |
Emerg Infect Dis |
|
| Ramos (2003) |
New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand. |
ARHR |
|
| Rangel (2010) |
Absence of primary integrase resistance mutations in HIV type 1-infected patients in Venezuela. |
ARHR |
|
| Rashid (2024) |
Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan. |
Viruses |
|
| Rasmussen (2018) |
Tracking external introductions of HIV using phylodynamics reveals a major source of infections in rural KwaZulu-Natal, South Africa. |
Virus Evol |
|
| Rath (2012) |
Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance. |
Viruses |
|
| Raugi (2013) |
Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy. |
Antimicrob Agents Chemother |
|
| Raugi (2016) |
Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors. |
J Virol |
|
| Raugi (2019) |
Direct Submission. |
Unpublished |
|
| Raugi (2020) |
HIV-2 Drug Resistance Genotyping from Dried Blood Spots. |
J Clin Microbiol |
|
| Ravuri (2006) |
Primary drug resistance studies by genotypic analysis in HIV-1 Indian subtype C-infected individuals. |
Direct Genbank Submission |
|
| Rawizza (2013) |
Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. |
PLoS ONE |
|
| Raymond (2020) |
Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance. |
J Clin Virol |
|
| Razafindratsimandresy (2006) |
High HIV type 1 subtype diversity and few drug resistance mutations among seropositive people detected during the 2005 second generation HIV surveillance in Madagascar. |
ARHR |
|
| Razafindratsimandresy (2007) |
HIV type 1 diversity in the Seychelles. |
ARHR |
|
| Recordon-Pinson (2010) |
Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study. |
Antimicrob Agents Chemother |
|
| Recordon-Pinson (2012) |
K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data. |
PLoS ONE |
|
| Recordon-Pinson (2018) |
A New HIV-1 Circulating Recombinant Form (CRF98_cpx) Between CRF06_cpx and Subtype B Identified in Southwestern France. |
ARHR |
|
| Reddy (2024) |
K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine. |
Viruses |
|
| Reeves (1999) |
Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. |
J Virol |
|
| Reid (2005) |
Natural resistance of human immunodeficiency virus type 2 to zidovudine. |
Virology |
|
| Reigadas (2013) |
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes. |
J Antimicrob Chemother |
|
| Reinke (2001) |
Natural selection results in conservation of HIV-1 integrase activity despite sequence variability. |
AIDS |
|
| Reis (2017) |
Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions. |
PLoS ONE |
|
| Reis (2019) |
Identification of New HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 Recombinant Forms. |
Front Microbiol |
|
| Ren (2007) |
In vitro cross-resistance studies of five different classes of integrase inhibitors in recombinant HIV-1. |
Antivir Ther |
|
| Ren (2017) |
Epidemiology reveals Zhaotong City as the hub of human immunodeficiency virus type 1 transmission from the Yunnan province to other regions in China. |
J Gen Virol |
|
| Requena (2017) |
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response. |
J Antimicrob Chemother |
|
| Requena (2019) |
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain. |
J Antimicrob Chemother |
|
| Resch (2005) |
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir. |
J Virol |
|
| Reuman (2010) |
Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector. |
AAC |
|
| Revollo (2022) |
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression. |
J Antimicrob Chemother |
|
| Rey (2006) |
Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients. |
JAIDS |
|
| Rey (2009) |
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. |
AAC |
|
| Rey-Cuille (1994) |
HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis. |
Virology |
|
| Reynolds (2012) |
Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. |
ARHR |
|
| Reynolds (2012) |
Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda. |
BMC Infect Dis |
|
| Reynolds (2016) |
Low rates of transmitted drug resistance among newly identified HIV-1 seroconverters in rural Rakai,Uganda. |
ARHR |
|
| Rhee (2004) |
Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. |
AAC |
|
| Rhee (2005) |
HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. |
J Infect Dis |
|
| Rhee (2006) |
Genotypic predictors of human immunodeficiency virus type 1 drug resistance. |
PNAS |
|
| Rhee (2009) |
Predictive value of HIV-1 genotypic resistance test interpretation algorithms. |
J Infect Dis |
|
| Rhee (2010) |
HIV-1 protease mutations and protease inhibitor cross resistance. |
AAC |
|
| Rhee (2015) |
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. |
PLoS Med |
|
| Rhee (2017) |
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. |
EBioMedicine |
|
| Rhee (2018) |
Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population |
Clin Infect Dis |
|
| Rhee (2019) |
National and international dimensions of human immunodeficiency virus-1 sequence clusters in a northern California clinical cohort |
Open Forum Infect Dis |
|
| Rhee (2020) |
Virological failure and acquired genotypic resistance associated with contemporary antiretroviral treatment regimens |
Open Forum Infect Dis |
|
| Rhee (2022) |
Spectrum of atazanavir-selected protease inhibitor-resistance mutations |
Pathogens |
|
| Richard (2004) |
High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1. |
ARHR |
|
| Richman (1991) |
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. |
PNAS |
|
| Riddler (2008) |
Class-sparing regimens for initial treatment of HIV-1 infection. |
N Engl J Med |
|
| Rimsky (2012) |
Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis. |
J Acquir Immune Defic Syndr |
|
| Rios (2007) |
Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile. |
J Med Virol |
|
| Rizzardini (2020) |
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials. |
J Acquir Immune Defic Syndr |
|
| Roberts (2015) |
Structured observations reveal slow HIV-1 CTL escape. |
PLoS Genet |
|
| Rodenburg (2001) |
Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. |
ARHR |
|
| Rodes (2000) |
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. |
J Clin Microbiol |
|
| Rodes (2002) |
Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O. |
J Clin Microbiol |
|
| Rodes (2005) |
Treatment response and drug resistance in patients infected with HIV type 1 group O viruses. |
ARHR |
|
| Rodes (2006) |
Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy. |
J Antimicrob Chemother |
|
| Rodes (2006) |
Human immunodeficiency virus 2 pol protein (pol) gene, partial cds. |
Direct Genbank Submission |
|
| Rodes (2016) |
HIV-2 protease sequences from treatment naive patients attending a hospital in Coimbra, Portugal. |
Direct Genbank Submission |
|
| Rodes (2006) |
High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART. |
AIDS |
|
| Rodgers (2017) |
Sensitive next-generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo. |
J Virol |
|
| Rodgers (2017) |
Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon. |
Virology |
|
| Rodgers (2018) |
ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens. |
ARHR |
|
| Rodgers (2020) |
Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India. |
Sci Rep |
|
| Rodrigues (2005) |
Prevalence of ARV resistance mutations and impact of genotyping test in HIV patients with advance disease in Sao Paulo, Brazil. |
J Clin Virol |
|
| Rodrigues (2006) |
Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. |
Virus Res |
|
| Rodrigues (2010) |
Young pregnant women living with HIV/AIDS in Criciuma, southern Brazil, are infected almost exclusively with HIV type 1 clade C. |
ARHR |
|
| Rodriguez (2006) |
Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin. |
Virology |
|
| Roge (2003) |
K65R with and without S68: A new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine. |
Antivir Ther |
|
| Rojas Sanchez (2018) |
Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis. |
Pediatr Infect Dis J |
|
| Rokx (2015) |
Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort. |
Clin Infect Dis |
|
| Rolland (2011) |
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial |
Nat Med |
|
| Rolland (2012) |
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 |
Nature |
|
| Romano (2000) |
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. |
AIDS |
|
| Romano (2002) |
Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice. |
JAIDS |
|
| Romano (2002) |
Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118. |
J Infect Dis |
|
| Roquebert (2008) |
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro. |
J Antimicrob Chemother |
|
| Roques (2004) |
Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. |
AIDS |
|
| Rosen-Zvi (2008) |
Selecting anti-HIV therapies based on a variety of genomic and clinical factors. |
Bioinformatics |
|
| Ross (2006) |
A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine. |
AIDS |
|
| Ross (2014) |
HIV-1 transmission patterns in antiretroviral therapy-naive, HIV-infected North Americans based on phylogenetic analysis by population level and ultra-deep DNA sequencing. |
PLoS ONE |
|
| Rossi (2013) |
Sequence variability in p6 gag protein and gag/pol coevolution in human immunodeficiency type 1 subtype F genomes. |
ARHR |
|
| Rossouw (2015) |
Factors associated with the development of drug resistance mutations in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy in South Africa. |
PLoS ONE |
|
| Rottinghaus (2014) |
Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring. |
PLoS One |
|
| Roudinskii (2004) |
Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in eastern Europe: Selection of the V77I variant and its rapid spread in injecting drug user populations. |
J Virol |
|
| Rouet (2017) |
Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015. |
Clin Infect Dis |
|
| Rousseau (2006) |
Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. |
J Virol Methods |
|
| Rousseau (2008) |
HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. |
J Virol |
|
| Rousseau (2000) |
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy. |
JAIDS |
|
| Rowley (2008) |
The discovery of raltegravir, an integrase inhibitor for the treatment of HIV infection. |
Prog Med Chem |
|
| Rubio-Garrido (2021) |
High drug resistance levels could compromise the control of HIV infection in paediatric and adolescent population in Kinshasa, the Democratic Republic of Congo. |
PLoS One |
|
| Ruchansky (2009) |
Identification of a new HIV Type 1 circulating recombinant form (CRF38_BF1) in Uruguay. |
ARHR |
|
| Rudometova (2021) |
Genetic Diversity and Drug Resistance Mutations in Reverse Transcriptase and Protease Genes of HIV-1 Isolates from Southwestern Siberia. |
AIDS Res Hum Retroviruses |
|
| Rudovick (2018) |
Prevalence of pretreatment HIV drug resistance in Mwanza, Tanzania. |
J Antimicrob Chemother |
|
| Ruelle (2007) |
Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso. |
ARHR |
|
| Ruelle (2008) |
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. |
BMC Infect Dis |
|
| Ruiz (1996) |
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC. |
AIDS |
|
| Ruiz (1998) |
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients. |
JAIDS |
|
| Rumyantseva (2009) |
Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia. |
ARHR |
|
| Rungmaitree (2023) |
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014. |
J Pediatric Infect Dis Soc |
|
| Rusine (2013) |
Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda. |
PLoS ONE |
|
| Rutvisuttinunt (2012) |
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors. |
ARHR |
|
| Sa-Filho (2007) |
Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil. |
ARHR |
|
| Saad (2005) |
HIV type 1 strains common in Europe, Africa, and Asia co-circulate in Yemen. |
ARHR |
|
| Saad (2006) |
Molecular epidemiology of HIV type 1 in Ukraine: birthplace of an epidemic. |
ARHR |
|
| Saad (2006) |
Genetic forms of HIV type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. |
ARHR |
|
| Saah (2003) |
Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy. |
J Infect Dis |
|
| Sachithanandham (2016) |
Effect of HIV-1 Subtype C integrase mutations implied using molecular modeling and docking data. |
Bioinformation |
|
| Sacks-Davis (2020) |
Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia. |
PLoS One |
|
| Saeng-Aroon (2016) |
Circulation of HIV-1 multiple complexity recombinant forms among female sex workers recently infected with HIV-1 in Thailand. |
ARHR |
|
| Safina (2022) |
Molecular epidemiology of HIV-1 in Oryol Oblast, Russia. |
Virus Evol |
|
| Sagoe (2012) |
Distinct patterns of protease gene polymorphisms in human immunodeficiency virus type 1 strains found in drug naive individuals in Ghana. |
Direct Genbank Submission |
|
| Sagoe (2007) |
Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naive patients in Accra, Ghana. |
J Clin Virol |
|
| Sagoe (2016) |
Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections. |
An Acad Bras Cienc |
|
| Sahbandar (2009) |
Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia. |
ARHR |
|
| Saina (2015) |
Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children. |
PLoS One |
|
| Saini (2012) |
Resistance-associated mutations in HIV-1 among patients failing first-line antiretroviral therapy. |
J Int Assoc Physicians AIDS Care (Chic) |
|
| Saladini (2017) |
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro. |
AIDS |
|
| Saladini (2019) |
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations. |
Antimicrob Agents Chemother |
|
| Saladini (2021) |
In vitro analysis of doravirine activity on HIV-1 clones harboring multiple NNRTI resistance mutations. |
J Antimicrob Chemother |
|
| Saladini (2023) |
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry. |
Int J Antimicrob Agents |
|
| Salata (2023) |
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance. |
AIDS Res Ther |
|
| Saleeva (2020) |
Genetic characteristic of HIV-1 in patients with treatment failure in Kyrgyzstan in 2017-2018 |
EU HIV&HEP WS |
|
| Salemi (2008) |
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. |
ARHR |
|
| Salgado (2009) |
Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity. |
J Clin Virol |
|
| Salminen (1996) |
Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. |
ARHR |
|
| Salou (2016) |
High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo. |
J Int AIDS Soc |
|
| Salou (2020) |
Challenges of scale-up to dolutegravir-based regimens in sub-Saharan Africa. |
AIDS |
|
| Salvana (2014) |
The changing molecular epidemiology of HIV in the Philippines. |
Int J Infect Dis. |
|
| Salvana (2020) |
High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines. |
Int J Infect Dis |
|
| Sanabani (2006) |
Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil. |
Infect Genet Evol |
|
| Sanabani (2006) |
Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. |
ARHR |
|
| Sanabani (2009) |
Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in Sao Paulo, Brazil. |
Virology J |
|
| Sanabani (2010) |
Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil. |
Virology J |
|
| Sanabani (2011) |
Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in Sao Paulo, Brazil. |
PLoS ONE |
|
| Sanchez Onoro (2007) |
Primary antiretroviral drug resistance among patients diagnosed with HIV infection in Gran Canaria (Spain) between 2002 and 2005. |
Enferm Infecc Microbiol Clin |
|
| Sanchez (2020) |
Impact of genotypic diversity on selection of subtype-specific drug resistance profiles during raltegravir-based therapy in individuals infected with B and BF recombinant HIV-1 strains. |
J Antimicrob Chemother |
|
| Sanchez (2006) |
Molecular epidemiology of human immunodeficiency virus-infected individuals in Medellin, Colombia. |
Am J Trop Med Hyg |
|
| Sanders-Buell (2007) |
A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD. |
ARHR |
|
| Sanders-Buell (2010) |
Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan. |
ARHR |
|
| Sandstrom (2005) |
Sequences from untreated patients circa 1984. |
Unpublished |
|
| Sangeda (2021) |
Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era |
Unpublished |
|
| Santiago (2002) |
SIVcpz in wild chimpanzees. |
Science |
|
| Santiago (2003) |
Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. |
J Virol |
|
| Santoro (2020) |
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen. |
Int J Antimicrob Agents |
|
| Santos (2006) |
Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. |
AIDS |
|
| Santos (2011) |
Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naive patients from southern Brazil |
J Clin Virol |
|
| Santos (2011) |
Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil. |
J Med Virol |
|
| Saracino (2008) |
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. |
J Med Virol |
|
| Saravanan (2013) |
Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India. |
ARHR |
|
| Saravanan (2015) |
Differences in evolution of HIV-1 subtype C reverse transcriptase between children and adults likely explained by maturity of cytotoxic T-lymphocyte responses. |
ARHR |
|
| Sarker (2020) |
Migrant workers play a key role in HIV-1 strain diversity in Bangladesh |
Unpublished |
|
| Saskova (2009) |
Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. |
J Virol |
|
| Sato (2006) |
In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor. |
Antiviral Res |
|
| Sato (2009) |
S/GSK1349572 integrase inhibitor resistance profile. |
EACS2009 |
|
| Sax (2012) |
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. |
Lancet |
|
| Schader (2012) |
In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine. |
Antimicrob Agents Chemother |
|
| Schapiro (1996) |
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. |
Ann Intern Med |
|
| Scherrer (2012) |
Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M. |
JAIDS |
|
| Schmit (1996) |
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitors ritonavir (ABT-538). |
AIDS |
|
| Schneidewind (2009) |
Transmission and long-term stability of compensated CD8 escape mutations. |
J Virol |
|
| Schramm (2022) |
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study. |
Lancet HIV |
|
| Scriven (2021) |
Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study. |
Medicine (Baltimore) |
|
| Scutari (2020) |
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors. |
J Glob Antimicrob Resist |
|
| Seatla (2018) |
Preliminary virologic outcomes and prevalence of integrase strand transfer inhibitor resistance mutations among highly treatment experienced patients receiving dolutegravir in Botswana. |
IAS |
|
| Seatla (2018) |
Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana. |
AIDS |
|
| Seatla (2019) |
Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples. |
PLoS ONE |
|
| Seatla (2021) |
HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana. |
Viruses |
|
| Sebastiao (2019) |
Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola. |
PLoS ONE |
|
| Sebastiao (2024) |
HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naive adult patients in Luanda, Angola. |
Sci Rep |
|
| Segujja (2020) |
High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda. |
AIDS Res Hum Retroviruses |
|
| Seki (2015) |
Effects of raltegravir or elvitegravir resistance signature mutations on the barrier to dolutegravir resistance in vitro. |
Antimicrob Agents Chemother |
|
| Selimova (2010) |
HIV-1 pol gene subtypes isolated from drug-naive individuals in Russia. |
Direct Genbank Submission |
|
| Semengue (2021) |
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings. |
J Antimicrob Chemother |
|
| Sen (2007) |
High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India. |
ARHR |
|
| Seoighe (2007) |
A model of directional selection applied to the evolution of drug resistance in HIV-1. |
Mol Bio Evol |
|
| Serrano (2012) |
Low transmitted drug resistance and high viral genetic diversity of HIV-1 strains circulating in young pregnant women recently diagnosed with HIV-1 infection in Luada, Angola |
ASLM 2012 |
|
| Servais (2001) |
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. |
J Clin Microbiol |
|
| Servais (2001) |
Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor. |
AAC |
|
| Servais (2004) |
HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda. |
ARHR |
|
| Serwanga (2012) |
Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population. |
AIDS Res Hum Retroviruses |
|
| Seu (2015) |
Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia. |
J Med Virol |
|
| Sevigny (2004) |
Cross-resistance profile of the novel lysine-containing HIV-1 protease inhibitor PL-100. |
IHDRW 2004 |
|
| Sevigny (2006) |
Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor. |
Antiviral Res |
|
| Sevin (2000) |
Methods for investigating the relationship between drug-susceptibility phenotype and HIV-1 genotype with applications to ACTG 333. |
J Infect Dis |
|
| Seyler (2007) |
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa. |
AIDS |
|
| Shafer (1994) |
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. |
J Infect Dis |
|
| Shafer (1995) |
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1 - infected subjects to zidovudine and didanosine combination therapy. |
J Infect Dis |
|
| Shafer (1997) |
Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe. |
J Virol |
|
| Shafer (1998) |
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. |
Ann Intern Med |
|
| Shafer (1999) |
Sequence and drug susceptibility of HIV-1 type C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. |
ARHR |
|
| Shafer (2003) |
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. |
N Engl J Med |
|
| Shahid (2011) |
HIV-1 circulating recombinant form in Nepal. |
J Virol |
|
| Shahid (2019) |
Systematic determination of in vitro phenotypic resistance to HIV-1 integrase strand transfer inhibitors from clinical samples |
bioRxiv |
|
| Shahriar (2009) |
Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations. |
Antimicrob Agents Chemother |
|
| Shang (2007) |
Genotypic resistance mutation to antiretroviral drugs in treatment-naive HIV/AIDS patients in the northeast of China. |
Direct Genbank Submission |
|
| Shankaran (2024) |
Virologic Failure with Cabotegravir-Rilpivirine Injections: A Single-Site Experience |
CROI |
|
| Shao (2016) |
Molecular epidemiology is becoming complex under the dynamic HIV prevalence: The perspective from Harbin, China. |
J Med Virol |
|
| Sharma (2016) |
Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: emergence of unique recombinant forms. |
J Med Virol |
|
| Sharma (2018) |
Antiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur. |
Sci Rep |
|
| Sharma (2018) |
Comparative genetic variability in HIV-1 subtype C p24 Gene in early age groups of infants. |
Virus Genes |
|
| Shchemelev (2022) |
Detection of Patient HIV-1 Drug Resistance Mutations in Russia's Northwestern Federal District in Patients with Treatment Failure. |
Diagnostics (Basel) |
|
| Shcherbakova (2014) |
Molecular epidemiology, phylogeny, and phylodynamics of CRF63_02A1, a recently originated HIV-1 circulating recombinant form spreading in Siberia. |
ARHR |
|
| Shen (2025) |
The HIV-1 Transmitted Drug Resistance in Newly Confirmed and ART-Naive HIV-1-Infected MSM in Zhenjiang City, Jiangsu, China. |
AIDS Res Hum Retroviruses |
|
| Shi (2004) |
Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C recombinant virus. |
ARHR |
|
| Shi (2021) |
Molecular transmission networks and pre-treatment drug resistance among individuals with acute HIV-1 infection in Baoding, China. |
PLoS One |
|
| Shimura (2007) |
Broad anti-retroviral activity and resistance profile of a novel human immunodeficiency virus integrase inhibitor, Elvitegravir (JTK-303/GS-9137). |
J Virol |
|
| Shirasaka (1995) |
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. |
PNAS |
|
| Shu (2018) |
Surveillance of HIV-1 drug resistance in Xinjiang: high prevalence of K103N in treatment-naive individuals |
Arch Virol |
|
| Shulman (2000) |
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: Clinical and genotypic predictors of virologic response. |
JAIDS |
|
| Shulman (2001) |
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy. |
JAIDS |
|
| Si-Mohamed (2000) |
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. |
J Infect Dis |
|
| Sichtig (2009) |
Evolution of raltegravir resistance during therapy. |
J Antimicrob Chemother |
|
| Sierra (2004) |
The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF. |
Infect Genet Evol |
|
| Sierra (2007) |
Identification of 3 phylogenetically related HIV-1 BG intersubtype circulating recombinant forms in Cuba. |
JAIDS |
|
| Sigaloff (2011) |
Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa. |
ARHR |
|
| Sigaloff (2011) |
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. |
JAIDS |
|
| Sigaloff (2012) |
High prevalence of transmitted antiretroviral drug resistance among newly HIV type 1 diagnosed adults in Mombasa, Kenya. |
ARHR |
|
| Sigaloff (2013) |
Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy. |
ARHR |
|
| Silva (2020) |
HIV-1 prevalence, associated factors, genetic diversity and transmitted drug resistance mutations in a populations of men who have sex with men in Midwestern Brazil. |
Direct Genbank Submission |
|
| Simon (1998) |
Identification of a new human immunodeficiency type 1 group distinct from group M and group O. |
Nat Med |
|
| Simon (2002) |
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. |
AIDS |
|
| Simonetti (2014) |
Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men. |
Infect Genet Evol |
|
| Sinha (2012) |
Prevalence of HIV drug resistance mutations in HIV type 1 isolates in antiretroviral therapy naive population from northern India. |
AIDS Res Treatm |
|
| Sirivichayakul (2001) |
Survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000. |
ARHR |
|
| Sirivichayakul (2008) |
HIV drug resistance transmission threshold survey in Bangkok, Thailand. |
Antivir Ther |
|
| Sivay (2020) |
HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075. |
Clin Infect Dis |
|
| Sivay (2020) |
HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075. |
Clin Infect Dis |
|
| Skhosana (2015) |
High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa. |
PLoS ONE |
|
| Skinner (1998) |
Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors. |
JAIDS |
|
| Smith (2009) |
A public health model for the molecular surveillance of HIV transmission in San Diego, California. |
AIDS |
|
| Smith (2009) |
Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance. |
J Infect Dis |
|
| Smith (2011) |
Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance. |
AIDS |
|
| Smith (2012) |
Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens. |
PLoS ONE |
|
| Smith (2015) |
In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2. |
Retrovirology |
|
| Smith (2019) |
Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants. |
Antimicrob Agents Chemother |
|
| Smith (2022) |
Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants. |
J Infect Dis |
|
| Smith (2016) |
Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants. |
JAIDS |
|
| Smith (2018) |
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants. |
Retrovirology |
|
| Smith (2020) |
HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants. |
Antimicrob Agents Chemother |
|
| Smolen (2010) |
HIV type 1 genetic diversity in Silesia, Poland: a retrospective analysis. |
AIDS Res Hum Retroviruses |
|
| Smolen (2011) |
Retrospective analysis of the HIV-1 reverse transcriptase inhibitors' resistance in Silesia, Poland. |
Med Sci Monit |
|
| Smolen-Dzirba (2013) |
Transmission of drug-resistant HIV-1 variants among individuals with recent infection in southern Poland. |
Curr HIV Res |
|
| Smolen-Dzirba (2017) |
Prevalence of transmitted drug-resistance mutations and polymorphisms in HIV-1 reverse transcriptase, protease, and gp41 sequences among recent seroconverters in southern Poland. |
Med Sci Monit |
|
| Snoeck (2002) |
Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. |
Virus Res |
|
| Snoeck (2004) |
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. |
JAIDS |
|
| Soares (2003) |
Epidemiologic and molecular characterization of human immunodeficiency virus type 1 in southern Brazil. |
JAIDS |
|
| Soares (2010) |
Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naive Cameroonian subjects with advanced disease. |
J Clin Virol |
|
| Soares (2003) |
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. |
AIDS |
|
| Sobrino-Vegas (2011) |
The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up. |
Enferm Infecc Microbiol Clin |
|
| Soheilli (2009) |
Presence of HIV-1 CRF35_AD in Iran. |
ARHR |
|
| Soldi (2019) |
Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil. |
PLoS ONE |
|
| Somda (2012) |
Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso. |
Clin Infect Dis |
|
| Somi (2008) |
Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. |
Antivir Ther |
|
| Song (2020) |
Near Full-Length Genomic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF107_01B) Identified Among Men Who Have Sex with Men in Heilongjiang Province of China. |
AIDS Res Hum Retroviruses |
|
| Song (2016) |
Near-full-length genome sequences of a novel HIV-1 circulating recombinant form, CRF01_AE/B'/C (CRF78_cpx), in Yunnan, China. |
ARHR |
|
| Song (2020) |
Retrospective analysis of HIV-1 drug resistance mutations in Suzhou, China from 2009 to 2014. |
Virus Genes |
|
| Soria (2012) |
Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru. |
ARHR |
|
| Soria (2019) |
Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru. |
ARHR |
|
| Soto-Ramirez (1996) |
HIV-1 pol sequences from India fit distinct subtype pattern. |
JAIDS |
|
| Soulie (2015) |
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response. |
ARHR |
|
| Soundararajan (2007) |
Characterization of HIV-1 isolates from antiretroviral drug-naive children in southern India. |
ARHR |
|
| Souquiere (2000) |
Characterization of four newly derived HIV-1 Group N and two SIVcpz strains from Cameroon. |
J Med Primatol. |
|
| Souza Cavalcanti (2012) |
In-vivo selection of the mutation F121Y in a patient failing raltegravir containing salvage regimen |
Antiviral Res |
|
| Spielvogel (2023) |
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance. |
Elife |
|
| Srinivas (1998) |
Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains. |
AAC |
|
| Ssemwanga (2012) |
Low drug resistance levels among drug-naive individuals with recent HIV-1 infection in a rural clinical cohort in southwestern Uganda. |
ARHR |
|
| Ssemwanga (2012) |
Transmitted antiretroviral drug resistance among drug-naive female sex workers with recent infection in Kampala, Uganda. |
Clin Infect Dis |
|
| Ssemwanga (2012) |
HIV type 1 subtype distribution, multiple infections, sexual networks, and partnership histories in female sex workers in Kampala, Uganda. |
AIDS Res Hum Retroviruses |
|
| Ssemwanga (2020) |
Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda. |
J Antimicrob Chemother |
|
| Ssemwanga (2020) |
The Molecular Epidemiology and Transmission Dynamics of HIV Type 1 in a General Population Cohort in Uganda. |
Viruses |
|
| St Clair (1991) |
Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. |
Science |
|
| Stanojevic (2002) |
HIV-1 subtypes in Yugoslavia. |
ARHR |
|
| Stanojevic (2014) |
Ten years survey of primary HIV-1 resistance in Serbia - occurrence of multiclass resistance. |
ARHR |
|
| Steain (2005) |
HIV type 1 sequence diversity and dual infections in Kenya. |
AIDS Res Hum Retroviruses |
|
| Steegen (2009) |
Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya. |
AIDS Res Ther |
|
| Steegen (2014) |
High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen. |
PLoS ONE |
|
| Steegen (2016) |
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. |
J Antimicrob Chemother |
|
| Steegen (2016) |
Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the first South African national survey. |
PLoS ONE |
|
| Steegen (2016) |
Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa. |
J Infect Dis |
|
| Steegen (2019) |
Resistance in patients failing integrase strand transfer inhibitors: a call to replace raltegravir with dolutegravir in third-line treatment in South Africa. |
Open Forum Infect Dis |
|
| Steegen (2021) |
Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa. |
J Int AIDS Soc |
|
| Steegen (2022) |
Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment. |
Pediatr Infect Dis J |
|
| Stekler (2014) |
Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013. |
Antivir Ther |
|
| Stekler (2018) |
Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort. |
PLoS Med |
|
| Stone (2004) |
Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine. |
Antimicrob Agents Chemother |
|
| Struck (2007) |
A new HIV-1 B/F1 unique recombinant form (URF) outbreak in Luxembourg: near full-length genome characterization and phylogenetic analysis. |
Direct Genbank Submission |
|
| Struck (2015) |
Near full-length characterization and population dynamics of the human immunodeficiency virus type I circulating recombinant form 42 (CRF42_BF) in Luxembourg. |
ARHR |
|
| Su (2003) |
HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. |
AIDS |
|
| Su (2007) |
In vitro selection and characterization of viruses resistant to R1206, a novel nonnucleoside reverse transcriptase inhibitor. |
IHDRW 2007 |
|
| Su (2016) |
Identification of a Novel HIV-1 Circulating Recombinant Form (CRF85_BC) in Sichuan, China. |
ARHR |
|
| Su (2020) |
The origin and spread of CRF85_BC, driven by heterosexual transmission among older people in Sichuan, China. |
BMC Infect Dis |
|
| Su (2011) |
HIV-1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China. |
ARHR |
|
| Sucupira (2007) |
High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. |
AIDS Patient Care STDS |
|
| Sudhakar (2024) |
Molecular epidemiology of the HIV-1 epidemic in Fiji. |
Npj Viruses |
|
| Sun (2019) |
Multiple HIV-1 subtypes were found circulating in Shijingshan District of Beijing, China. |
ARHR |
|
| Sung (2001) |
Phylogenetic analysis of reverse transcriptase in antiretroviral drug-naive Korean HIV type 1 patients. |
ARHR |
|
| Sunpath (2013) |
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen. |
AIDS |
|
| Sutherland (2015) |
Gag-protease sequence evolution following protease inhibitor monotherapy treatment failure in HIV-1 viruses circulating in East Africa. |
ARHR |
|
| Sutthent (2002) |
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants. |
J Clin Virol |
|
| Svard (2017) |
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy. |
PLoS ONE |
|
| Svarovskaia (2008) |
The A62V and S68G mutations in HIV-1 reverse transcriptase partially restore the replication defect associated with the K65R mutation. |
J Acquir Immune Defic Syndr |
|
| Svicher (2006) |
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. |
J Virol |
|
| Swanson (2003) |
Full-length sequence analysis of HIV-1 isolate CM237: A CRF01_AE/B intersubtype recombinant from Thailand. |
ARHR |
|
| Swanson (2003) |
Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A-G) and group O: Sequence analysis of gag p24, pol integrase, and env gp41. |
ARHR |
|
| Sylla (2008) |
Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso. |
Antivir Ther |
|
| Tachbele (2021) |
Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia. |
Infect Drug Resist |
|
| Tadesse (2018) |
High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia. |
Viruses |
|
| Tagnouokam Ngoupo (2018) |
Short Communication: Characterization of a New HIV-1 Group N Isolate Originating from a Cameroonian Patient. |
ARHR |
|
| Taiaroa (2024) |
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study. |
Lancet Reg Health West Pac |
|
| Taiwo (2020) |
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL. |
Clin Infect Dis |
|
| Takebe (2003) |
High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: Geographical hot spot of extensive recombination. |
AIDS |
|
| Takehisa (2007) |
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. |
J Virol |
|
| Takou (2019) |
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon. |
BMC Infect Dis |
|
| Tamalet (2015) |
Emergence of clusters of CRF02_AG and B human immunodeficiency viral strains among men having sex with men exhibiting HIV primary infection in southeastern France. |
J Med Virol. |
|
| Tamalet (2018) |
Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France. |
J Med Virol |
|
| Tambuyzer (2009) |
Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors. |
Antivir Ther |
|
| Tambuyzer (2011) |
Effect of mutations at position E138 in HIV-1 reverse transcriptase on phenotypic susceptibility and virologic response to etravirine. |
J Acquir Immune Defic Syndr |
|
| Tamhane (2005) |
Characterization of a long terminal repeat region from an infectious Indian HIV type 2 isolate. |
ARHR |
|
| Tanaka (2019) |
HIV-1 Molecular Epidemiology, Transmission Clusters and Transmitted Drug Resistance Mutations in Central Brazil. |
Front Microbiol |
|
| Tanuma (2014) |
Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam. |
JAIDS |
|
| Tanuri (1999) |
Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil. |
AAC |
|
| Tao (2025) |
HIV-1 Subtype Diversity Trends in a Northern California Cohort, 2000–2019 |
AIDS |
|
| Tarasova (2021) |
RHIVDB: A Freely Accessible Database of HIV Amino Acid Sequences and Clinical Data of Infected Patients. |
Front Genet |
|
| Tatsumi (2006) |
Infectious DNA clones of subtype G and CRF02_AG HIV-1 derived from Ghananian isolates. |
Direct Genbank Submission |
|
| Taylor (2014) |
Human immunodeficiency virus type 2 infections in Austria. |
Wien Klin Wochenschr |
|
| Tchiakpe (2020) |
Moderate rate of resistance mutations transmitted to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin. |
Direct Genbank Submission |
|
| Tchiakpe (2020) |
Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin. |
BMC Res Notes |
|
| Tchiakpe (2025) |
Prevalence of pretreatment HIV-1 resistance to integrase strand transfer inhibitors in newly diagnosed and antiretroviral therapy-naive adults in Benin, West Africa. |
J Glob Antimicrob Resist |
|
| Tchouwa (2018) |
Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey. |
J Antimicrob Chemother |
|
| Tchouwa (2018) |
Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon. |
EClinicalMedicine |
|
| Tebit (2002) |
Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. |
ARHR |
|
| Tebit (2006) |
Diversity of HIV in rural Burkina Faso . |
JAIDS |
|
| Tebit (2009) |
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naive patients in Burkina Faso. |
J Med Virol |
|
| Techakriengkrai (2013) |
Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells. |
AIDS |
|
| Tee (2005) |
Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. |
AIDS |
|
| Tee (2005) |
The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. |
ARHR |
|
| Tee (2006) |
Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. |
Med Microbiol Immunol |
|
| Tee (2006) |
Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. |
JAIDS |
|
| Tee (2009) |
Estimating the date of origin of an HIV-1 circulating recombinant form. |
Virology |
|
| Tee (2017) |
Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia. |
Genome Announc |
|
| Telan (2011) |
The early phase of an HIV epidemic in a population exposed previously to HCV in the Philippines. |
J Med Virol |
|
| Telan (2013) |
Possible HIV transmission modes among at-risk groups at an early epidemic stage in the Philippines. |
J Med Virol |
|
| Telele (2018) |
Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing. |
Sci Rep |
|
| Telele (2019) |
A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort. |
BMC Infect Dis |
|
| Temereanca (2013) |
Transmitted HIV drug resistance in newly diagnosed, treatment-naive Romanian patients. |
J Med Virol |
|
| Temereanca (2017) |
HIV transmission clusters among injecting drug users in Romania. |
Rom Biotechnol Lett |
|
| Teto (2017) |
Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaounde, Cameroon. |
Sci Rep |
|
| Thao (2012) |
HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam. |
Antivir Ther |
|
| Theys (2013) |
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir. |
AAC |
|
| Theys (2013) |
Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir. |
J Antimicrob Chemother |
|
| Thiam (2013) |
HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system. |
J Clin Microbiol |
|
| Thirunavukarasu (2016) |
Patterns of HIV-1 Drug-Resistance Mutations among Patients Failing First-Line Antiretroviral Treatment in South India. |
J Int Assoc Provid AIDS Care |
|
| Thompson (2018) |
Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial. |
Clin Infect Dis |
|
| Thomson (2005) |
Full-length recombinant form CRF18_cpx; isolated in Cuba in 1999. |
Direct Genbank Submission |
|
| Thomson (2000) |
Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. |
AIDS |
|
| Thomson (2001) |
HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. |
AIDS |
|
| Thomson (2002) |
Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. |
J Gen Virol |
|
| Thomson (2004) |
Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. |
ARHR |
|
| Thomson (2005) |
Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba. |
AIDS |
|
| Thomson (2007) |
New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses. |
ARHR |
|
| Thomson (2009) |
Molecular epidemiology of HIV-1 in St Petersburg, Russia: Predominance of subtype A, former Soviet Union variant, and identification of intrasubtype subclusters. |
JAIDS |
|
| Thorat (2011) |
Surveillance of transmitted HIV type 1 drug resistance among HIV yype 1-positive women attending an antenatal clinic in Kakinada, India. |
ARHR |
|
| Tisdale (1993) |
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. |
PNAS |
|
| Tisdale (1995) |
Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors. |
AAC |
|
| Tisdale (1997) |
Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89. |
AAC |
|
| Tongo (2013) |
Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic. |
Virol J |
|
| Tongo (2015) |
Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country. |
Evol Med Public Health |
|
| Toni (2005) |
Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa. |
ARHR |
|
| Toni (2002) |
Primary HIV-1 drug resistance in Abidjan (Cote d'Ivoire) a genotypic and phenotypic study. |
AIDS |
|
| Toni (2003) |
Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire: ANRS 1257 study. |
ARHR |
|
| Toni (2005) |
Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Cote d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission. |
ARHR |
|
| Toni (2007) |
HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cote d'Ivoire: a 4-year survey, 2002-2006. |
ARHR |
|
| Topcu (2022) |
Comparative HIV-1 Phylogenies Characterized by PR/RT, Pol and Near-Full-Length Genome Sequences. |
Viruses |
|
| Topcu (2024) |
Mapping Transmission Dynamics and Drug Resistance Surveillance in the Cyprus HIV-1 Epidemic (2017-2021). |
Viruses |
|
| Torti (2005) |
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy. |
Antivir Ther |
|
| Totmenin (2013) |
Molecular epidemiology of HIV-1 in Siberia, Russia. |
Direct Genbank Submission |
|
| Totmenin (2019) |
Natural polymorphisms of HIV-1 integrase coding region in ARV-naive individuals in Tajikistan. |
Direct Genbank Submission |
|
| Totmenin (2019) |
Natural polymorphisms of HIV-1 integrase coding region in ARV-naive individuals in Novosibirsk region, Russia |
Direct Genbank Submission |
|
| Toure-Kane (2000) |
Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence. |
AIDS Res Hum Retroviruses |
|
| Tovanabutra (2001) |
First CRF01_AE/B recombinant of HIV-1 is found in Thailand. |
AIDS |
|
| Tovanabutra (2003) |
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. |
ARHR |
|
| Tovanabutra (2004) |
The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. |
ARHR |
|
| Tovanabutra (2005) |
Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel. |
ARHR |
|
| Tovanabutra (2007) |
Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. |
ARHR |
|
| Tovanabutra (2010) |
Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya. |
ARHR |
|
| Towler (2010) |
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. |
ARHR |
|
| Tramuto (2013) |
Dynamics and molecular evolution of HIV-1 strains in Sicily among antiretroviral naive patients. |
Infect Genet Evol |
|
| Tran (2024) |
Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naive patients in Northern Vietnam from 2019 to 2022. |
Glob Health Med |
|
| Tran (2012) |
No increase of drug-resistant HIV type 1 prevalence among drug-naive individuals in northern Vietnam. |
ARHR |
|
| Trebelcock (2019) |
HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru. |
J Int AIDS Soc |
|
| Treurnicht (2010) |
Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. |
Virology |
|
| Trinh (2012) |
Short communication: Drug resistance mutations in the HIV type 1 protease and reverse transcriptase genes in antiretroviral-naive Vietnamese children. |
ARHR |
|
| Triques (2000) |
Near full length genome sequencing of divergent African HIV type 1 subtype F viruses leads to identification of a new HIV type 1 designated K. |
ARHR |
|
| Tristem (1989) |
Six new isolates of human immunodeficiency virus type 2 (HIV-2) and the molecular characterization of one (HIV-2CAM2). |
J Gen Virol |
|
| Tristem (1991) |
Nucleotide sequence of a Guinea-Bissau-derived human immunodeficiency virus type 2 proviral 2clone (HIV-2CAM2). |
J Gen Virol |
|
| Truong (2006) |
Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. |
AIDS |
|
| Truong (2011) |
Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection. |
PLoS ONE |
|
| Tsai (2020) |
Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity. |
J Virol |
|
| Tscherning-Casper (2000) |
Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European network on the study of in utero transmission of HIV-1. |
ARHR |
|
| Tshabalala (2011) |
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. |
PLoS ONE |
|
| Tsiang (2016) |
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. |
Antimicrob Agents Chemother |
|
| Tsuiji (2006) |
V118 mutations in the transcriptase gene of HIV-1 from drug-naive hemophiliac patients in Japan. |
Direct Genbank Submission |
|
| Tu (2009) |
Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China. |
Transfusion |
|
| Tully (2016) |
Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus. |
PLoS Pathog |
|
| Tural (2002) |
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. |
AIDS |
|
| Turkova (2021) |
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. |
N Engl J Med |
|
| Tymchuk (2010) |
Baseline HIV resistance in Malawi. |
Direct Genbank Submission |
|
| Tzitzivacos (2009) |
Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children. |
ARHR |
|
| Tzou (2018) |
Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy. |
Sci Data |
|
| Tzou (2018) |
Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing. |
J Clin Microbiol |
|
| Tzou (2020) |
Integrase Strand Transfer Inhibitor Resistance Mutations For the Surveillance of Transmitted Drug Resistance. |
J Antimicrob Chemother |
|
| Udeze (2020) |
Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria. |
PLoS One |
|
| Ueda (2018) |
Genetic Diversity and Drug Resistance of HIV-1 Circulating in North Sulawesi, Indonesia. |
ARHR |
|
| Ugbena (2012) |
Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria. |
Clin Infect Dis |
|
| Umviligihozo (2021) |
Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts. |
Front Microbiol |
|
| Underwood (2012) |
The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults. |
JAIDS |
|
| Underwood (2022) |
Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study. |
Antimicrob Agents Chemother |
|
| Underwood (2015) |
Resistance post week 48 in ART-experienced, integrase inhibitor-naive subjects with dolutegravir (DTG) vs. raltegravir (RAL) in SAILING (ING111762). |
European HIV & Hepatitis Workshop |
|
| Vahabpour (2017) |
HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals. |
Arch Virol |
|
| Vaillancourt (1999) |
The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance. |
AIDS Res Hum Retroviruses |
|
| Vallari (2010) |
Four new HIV-1 group N isolates from Cameroon: prevalence continues to be low. |
ARHR |
|
| Vallari (2011) |
Confirmation of putative HIV-1 group P in Cameroon. |
J Virol |
|
| Valle-Bahena (2006) |
Frequency of protease and reverse transcriptase drug resistance mutations in naive HIV-infected patients. |
Arch Med Res |
|
| Vallejo (1998) |
Tropism, co-receptor use, and genetic characterization of the V3 loop and the protease gene of HIV-1 group O isolates. |
JAIDS |
|
| Van Baelen (2007) |
Low level of baseline resistance to integrase inhibitors L731,988 and L810,810 in randomly selected subtype B and non-B HIV-1 strains. |
IHDRW 2007 |
|
| Van Baelen (2009) |
A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes. |
J Virol Methods |
|
| van de Klundert (2022) |
Molecular Epidemiology of HIV-1 in Eastern Europe and Russia. |
Viruses |
|
| van der Ende (2000) |
Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy. |
JAIDS |
|
| van der Hoek (2007) |
Characterization of an HIV-1 group M variant that is distinct from the known subtypes. |
ARHR |
|
| Van Eygen (2012) |
Comparison of the Antivirogram and PhenoSense assays to determine phenotypic susceptibility to rilpivirine in patient samples from the Phase III ECHO and THRIVE trials. |
International Workshop on HIV & Hepatitis Virus |
|
| van Hal (2009) |
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure. |
Retrovirology |
|
| van Harmelen (2001) |
Characterization of full-length HIV type 1 subtype C sequences from South Africa. |
ARHR |
|
| van Kampen (2022) |
HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report. |
J Glob Antimicrob Resist |
|
| Van Laethem (2000) |
Patient HIV strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir. |
AIDS |
|
| Van Laethem (2008) |
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. |
J Virol Methods |
|
| van Oosterhout (2022) |
Dolutegravir Resistance in Malawi's National HIV Treatment Program. |
Open Forum Infect Dis |
|
| Van Tran (2016) |
A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection. |
AIDS |
|
| van Welzen (2024) |
Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis. |
Clin Infect Dis |
|
| Van Wesenbeeck (2011) |
Cross-resistance profile determination of two second-generation HIV-1 integrase inhibitors using a panel of recombinant viruses derived from raltegravir-treated clinical isolates. |
AAC |
|
| van Wyk (2020) |
Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and SWORD-2 Randomized Clinical Trials. |
J Acquir Immune Defic Syndr |
|
| van Zyl (2011) |
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the western cape, South Africa. |
J Med Virol |
|
| Van Zyl (2013) |
Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first- and second-line antiretroviral treatment regimens. |
PLoS ONE |
|
| van Zyl (2017) |
Moderate levels of pre-therapy drug resistance (PDR) in a generalised epidemic: time for better first-line ART? |
AIDS |
|
| Vanden Haesevelde (1994) |
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. |
J Virol |
|
| Vanden Haesevelde (1996) |
Sequence analysis of a highly divergent HIV-1 related lentivirus from a wild captured chimpanzee. |
Virology |
|
| Varella (2007) |
Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil. |
J Med Virol |
|
| Varghese (2010) |
HIV-1 Integrase Sequence Variability in Antiretroviral Naive Patients and in Triple-Class Experienced Patients Subsequently Treated with Raltegravir |
AIDS Res Hum Retroviruses |
|
| Varghese (2011) |
Phenotypic evidence for NRTI resistance in HIV-1 isolates with the RT mutation K64H. |
Unpublished |
|
| Varghese (2013) |
Panel of Prototypical Recombinant Multi-Protease Inhibitor Resistant Infectious Molecular Clones |
Antimicrob Agents Chemother |
|
| Varghese (2016) |
Q148N, a Novel Integrase Inhibitor Resistance Mutation Associated with Low-Level Reduction in Elvitegravir Susceptibility. |
ARHR |
|
| Vasylyeva (2018) |
Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. |
PNAS |
|
| Vaughan (2003) |
Characterization of HIV type 1 clades in the Caribbean using pol gene sequences. |
ARHR |
|
| Vavro (2013) |
Prevalent polymorphisms in wild-type HIV-1 integrase are unlikely to engender drug resistance to dolutegravir (S/GSK1349572). |
Antimicrob Agents Chemother |
|
| Vavro (2022) |
Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study. |
Antimicrob Agents Chemother |
|
| Vaz (2012) |
Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique. |
Clin Infect Dis |
|
| Vaz (2015) |
Molecular Characterization of the Human Immunodeficiency Virus Type 1 in Women and Their Vertically Infected Children. |
AIDS Res Hum Retroviruses |
|
| Vazquez de Parga (2005) |
Analysis of drug resistance-associated mutations in treatment-naive individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union. |
J Med Virol |
|
| Velasco-de-Castro (2014) |
HIV-1 diversity and drug resistance mutations among people seeking HIV diagnosis in voluntary counseling and testing sites in Rio de Janeiro, Brazil. |
PLoS ONE |
|
| Venturi (1999) |
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors. |
Eur J Clin Microbiol Infect Dis |
|
| Venturi (2000) |
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. |
J Infect Dis |
|
| Venturi (2002) |
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. |
Antivir Ther |
|
| Vercauteren (2008) |
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. |
ARHR |
|
| Vercauteren (2009) |
Transmission of drug-resistant HIV-1 is stabilizing in Europe. |
J Infect Dis |
|
| Vergani (2008) |
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir. |
J Clin Virol |
|
| Vergne (2000) |
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. |
J Clin Microbiol |
|
| Vergne (2002) |
Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries. |
JAIDS |
|
| Vergne (2003) |
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy. |
AIDS |
|
| Vergne (2003) |
Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. |
Virology |
|
| Vergne (2006) |
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. |
J Clin Virol |
|
| Vergne (2006) |
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. |
Antivir Ther |
|
| Verhofstede (2017) |
Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection. |
BMC Infect Dis |
|
| Vessiere (2006) |
HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaounde, Cameroon. |
JAIDS |
|
| Vessiere (2010) |
First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon. |
AIDS |
|
| Vetter (2014) |
Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests. |
PLoS One |
|
| Viani (2006) |
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study. |
J Infect Dis |
|
| Vicente (2001) |
Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance. |
Virus Genes |
|
| Vicenti (2007) |
Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects. |
Clin Infect Dis |
|
| Vidal (2002) |
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine. |
Antivir Ther |
|
| Vidal (2000) |
Identification of a complex env subtype E HIV type 1 virus from the Democratic Republic of Congo, recombinant with A, G, H, J, K, and unknown subtypes. |
ARHR |
|
| Vidal (2000) |
Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. |
J Virol |
|
| Vidal (2003) |
High genetic diversity of HIV-1 strains in Chad, West Central Africa. |
JAIDS |
|
| Vidal (2006) |
HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). |
ARHR |
|
| Vidal (2006) |
Identification and molecular characterization of subsubtype A4 in Central Africa. |
ARHR |
|
| Vidal (2007) |
HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi. |
ARHR |
|
| Vidal (2008) |
Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France. |
ARHR |
|
| Vidal (2009) |
Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U. |
ARHR |
|
| Vignoles (2007) |
High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children. |
Antivir Ther |
|
| Villa (2020) |
Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa. |
EClinicalMedicine |
|
| Villabona Arenas (2017) |
Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C. |
Virus Evol |
|
| Villabona-Arenas (2015) |
HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. |
Infect Genet Evol |
|
| Villena (2007) |
Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region. |
J Virol |
|
| Vingerhoets (2005) |
TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. |
J Virol |
|
| Vingerhoets (2008) |
An update of the list of NNRTI mutations associated with decreased virologic response to etravirine (ETR): Multivariate analyses on the pooled DUET-1 and DUET-2 clinical trial data. |
IHDRW 2008 |
|
| Vingerhoets (2010) |
Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies. |
AIDS |
|
| Vinogradova (2010) |
Short communication: Molecular epidemiology of HIV type 1 in the Republic of Dagestan, Russian Federation: Virtually uniform circulation of subtype A, former Soviet Union variant, with predominance of the V77I(PR) subvariant. |
ARHR |
|
| Vinoles (2005) |
Seroincidence and phylogeny of human immunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay. |
Am J Trop Med Hyg |
|
| Viputtijul (2002) |
Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand. |
ARHR |
|
| Visawapoka (2006) |
Circulating and unique recombinant forms of HIV Type 1 containing subsubtype A2. |
ARHR |
|
| Visseaux (2021) |
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution. |
Virus Evol |
|
| von Braun (2018) |
HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic. |
JAIDS |
|
| von Wyl (2007) |
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. |
Arch Intern Med |
|
| von Wyl (2010) |
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy. |
Clin Infect Dis |
|
| Vrancken (2017) |
The multi-faceted dynamics of HIV-1 transmission in Northern Alberta: A combined analysis of virus genetic and public health data. |
Infect Genet Evol |
|
| Vrancken (2020) |
Comparative Circulation Dynamics of the Five Main HIV Types in China. |
J Virol |
|
| Vubil (2016) |
Genetic Diversity and Transmitted Drug Resistance of HIV-1 Subtypes in Blood Donors Candidates in Northern Mozambique. |
J AIDS Clin Res |
|
| Wagner (2020) |
HIV-1 infection among women in Israel, 2010-2018. |
BMC Infect Dis |
|
| Wagner (2022) |
HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010-2018. |
Viruses |
|
| Wainberg (1999) |
In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. |
Antivir Ther |
|
| Waleria-Aleixo (2008) |
Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns. |
AAC |
|
| Wallis (2009) |
Varied HIV drug resistance patterns among patients on failing antiretroviral therapy in the South African national roll-out programme. |
JAIDS |
|
| Wallis (2010) |
Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient. |
Virus Genes |
|
| Wallis (2014) |
Drug susceptibility and resistance mutations after first-line failure in resource limited settings. |
Clin Infect Dis |
|
| Walter (2000) |
Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy. |
Antivir Ther |
|
| Wang (2015) |
HIV prevalence and phylogenetic characteristics among entry travelers in Xishuangbanna prefecture, Yunnan province, between 2003 and 2012. |
J Med Virol |
|
| Wang (2018) |
High HIV-1 prevalence and viral diversity among entry-exit populations at frontier ports of China, 2012-2016: A cross-sectional molecular epidemiology study. |
Infect Genet Evol |
|
| Wang (2008) |
Identification of subtype B, multiple circulating recombinant forms and unique recombinants of HIV type 1 in an MSM cohort in China. |
ARHR |
|
| Wang (2015) |
Targeting HIV prevention based on molecular epidemiology among deeply sampled subnetworks of men who have sex with men. |
Clin Infect Dis |
|
| Wang (2018) |
Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015. |
PLoS ONE |
|
| Wang (2015) |
HIV-1 prevalence and subtype/recombinant distribution among travelers entering China from Vietnam at the HeKou port in the Yunnan province, China, between 2003 and 2012. |
J Med Virol |
|
| Wang (2009) |
Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. |
J Virol |
|
| Wang (2019) |
Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China. |
BMC Infect Dis |
|
| Warachit (2007) |
Aberrant life cycle of human immunodeficiency virus type 1 CRF15_01B-like clinical isolates from Thailand in human CD4+ T-cell lines. |
Microbes Infect |
|
| Wares (2014) |
The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness. |
Retrovirology |
|
| Washaya (2025) |
Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe. |
Viruses |
|
| Watanaveeradej (2003) |
Subtype C/CRF01_AE recombinant HIV-1 found in Thailand. |
AIDS |
|
| Watanaveeradej (2006) |
Molecular epidemiology of HIV type 1 in preparation for a phase III prime-boost vaccine trial in Thailand and a new approach to HIV type 1 genotyping. |
ARHR |
|
| Watera (2021) |
HIV drug resistance among adults initiating antiretroviral therapy in Uganda. |
J Antimicrob Chemother |
|
| Watkins (2003) |
Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors. |
Antimicrob Agents Chemother |
|
| Weber (2003) |
Role of baseline pol genotype in HIV-1 fitness evolution. |
JAIDS |
|
| Weber (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. |
PLoS Med |
|
| Weber (2005) |
Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation. |
J Clin Microbiol |
|
| Weber (2019) |
Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing. |
J Mol Diagn |
|
| Wei (2013) |
Near full-length genomic characterization of a novel HIV type 1 CRF07_ BC/01_AE recombinant in men who have sex with men from Sichuan, China. |
ARHR |
|
| Wei (2014) |
Genome sequence of a novel HIV-1 circulating recombinant form (CRF57_BC) identified from Yunnan, China. |
ARHR |
|
| Wei (2014) |
Identification of a novel HIV-1 circulating recombinant form (CRF62_BC) in western Yunnan of China. |
ARHR |
|
| Wei (2015) |
The sexually driven epidemic in youths in China's southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strains. |
Sci Rep |
|
| Weidle (2000) |
Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinal site for monitoring HIV genetic diversity in the United States. |
J Infect Dis |
|
| Weidle (2001) |
Resistance to antiretroviral therapy among patients in Uganda. |
JAIDS |
|
| Weng (2016) |
Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan. |
J Microbiol Immunol Infect |
|
| Whitcomb (2002) |
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: Clinical, phenotypic and genotypic correlates. |
AIDS |
|
| White (2018) |
Bictegravir Resistance Profile: Data for External Experts. |
Unpublished |
|
| Wijting (2018) |
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy. |
J Infect Dis |
|
| Wilantho (2011) |
HIV-1 integrase isolated from infected patients in Thailand. |
Direct Genbank Submission |
|
| Wilbe (2002) |
Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. |
ARHR |
|
| Wilbe (2003) |
Characterization of novel recombinant HIV-1 genomes using the branching index. |
Virology |
|
| Wilhelmson (2018) |
Prevalence of HIV-1 pretreatment drug resistance among treatment naive pregnant women in Bissau, Guinea Bissau |
PLoS ONE |
|
| Wilkinson (2015) |
Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes A, B, G and unique recombinant AC and AD viral strains identified in South Africa. |
ARHR |
|
| Willliamson (2003) |
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. |
ARHR |
|
| Winslow (1995) |
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. |
ARHR |
|
| Winslow (1996) |
Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. |
AIDS |
|
| Winters (1997) |
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years. |
AAC |
|
| Winters (1998) |
Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment. |
J Virol |
|
| Winters (1998) |
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. |
J Clin Invest |
|
| Winters (2000) |
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors. |
J Virol |
|
| Winters (2001) |
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nucleoside analogs. |
AAC |
|
| Wirden (2024) |
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir. |
J Antimicrob Chemother |
|
| Witaningrum (2016) |
Genotypic characterization of human immunodeficiency virus type 1 derived from antiretroviral therapy-naive individuals residing in Sorong, West Papua. |
ARHR |
|
| Wittkop (2009) |
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort. |
J Antimicrob Chemother |
|
| Wolf (2016) |
Phylogenetic evidence of HIV-1 transmission between adult and adolescent men who have sex with men. |
ARHR |
|
| Wong-Staal (1985) |
Complete nucleotide sequence of the AIDS virus, HTLV-III. |
Nature |
|
| Worobey (2016) |
1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America. |
Nature |
|
| Wright (2010) |
Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: Associations with HLA type and clinical parameters. |
J Virol |
|
| Wright (2011) |
Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. |
J Virol |
|
| Wu (2012) |
Identification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitro. |
PLoS One |
|
| Wu (2015) |
In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors. |
AIDS Res Hum Retroviruses |
|
| Wu (2020) |
Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Shanghai, China, 2013-2015. |
Direct Genbank Submission |
|
| Wu (2013) |
New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. |
PLoS ONE |
|
| Wu (2015) |
The predominant cluster of CRF01_AE circulating among newly diagnosed HIV-1-positive people in Anhui Province, China. |
ARHR |
|
| Wu (2019) |
Phylogenetic analysis highlights the role of older people in the transmission of HIV-1 in Fuyang, Anhui Province, China. |
BMC Infect Dis |
|
| Wu (2024) |
CRF08_BC subtype is more prone to ART failure and new-generation NNRTI-resistance under long-term first-line ART. |
Int J Antimicrob Agents |
|
| Wu (2003) |
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. |
J Virol |
|
| Wu (2017) |
MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture. |
Antimicrob Agents Chemother |
|
| Wulan (2023) |
Development of a multiassay algorithm (MAA) to identify recent HIV infection in newly diagnosed individuals in Indonesia. |
iScience |
|
| Xie (2020) |
The Genetic Diversity of HIV-1 Within Antiretroviral-Naive Outpatients in Ganzhou, China. |
AIDS Res Hum Retroviruses |
|
| Xu (2012) |
Subunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptase. |
J Virol |
|
| Xu (2012) |
Molecular mechanism of antagonism between the Y181C and E138K mutations in HIV-1 reverse transcriptase. |
J Virol |
|
| Xu (2013) |
Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors. |
AAC |
|
| Xu (2013) |
Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine. |
Antimicrob Agents Chemother |
|
| Xu (2014) |
The connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity. |
J Virol |
|
| Xu (2008) |
Genetic diversity of integrase (IN) sequences in antiretroviral treatment-naive and treatment-experienced HIV type 2 patients. |
ARHR |
|
| Xu (2009) |
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient. |
ARHR |
|
| Xu (2018) |
Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017. |
Arch Virol |
|
| Xuan (2018) |
High prevalence of HIV-1 transmitted drug resistance among therapy-naive Burmese entering travelers at Dehong ports in Yunnan, China |
BMC Infect Dis |
|
| Yabar (2012) |
New subtypes and genetic recombination in HIV type 1-infecting patients with highly active antiretroviral therapy in Peru (2008-2010). |
ARHR |
|
| Yahi (2001) |
Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. |
J Infect Dis |
|
| Yamaguchi (2002) |
Evaluation of HIV type 1 group O isolates: Identification of five phylogenetic clusters. |
ARHR |
|
| Yamaguchi (2003) |
Near full-length genomes of 15 HIV type 1 group O isolates. |
ARHR |
|
| Yamaguchi (2004) |
HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. |
ARHR |
|
| Yamaguchi (2006) |
HIV-1 group N: Evidence of ongoing transmission in Cameroon. |
ARHR |
|
| Yamaguchi (2006) |
Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission. |
ARHR |
|
| Yamaguchi (2008) |
Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates. |
ARHR |
|
| Yamaguchi (2008) |
HIV type 2 intergroup recombinant identified in Cameroon. |
ARHR |
|
| Yamaguchi (2009) |
HIV type 1 group M subtype G in Cameroon: Five genome sequences. |
ARHR |
|
| Yamaguchi (2010) |
Near full-length sequence of HIV type 1 subtype J strain 04CMU11421 from Cameroon. |
ARHR |
|
| Yamaguchi (2017) |
HIV-2 surveillance with next-generation sequencing reveals mutations in a cytotoxic lymphocyte-restricted epitope involved in long-term nonprogression. |
ARHR |
|
| Yamaguchi (2018) |
Universal Target Capture of HIV Sequences From NGS Libraries. |
Front Microbiol |
|
| Yamaguchi (2019) |
Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L. |
J Acquir Immune Defic Syndr |
|
| Yamaguchi (1995) |
Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutations. |
Biochim Biophys Acta |
|
| Yan (2015) |
Epidemiological and molecular characteristics of HIV infection among money boys and general men who have sex with men in Shanghai, China. |
Infect Genet Evol |
|
| Yan (2021) |
Acquisition and transmission of HIV-1 among migrants and Chinese in Guangzhou, China from 2008 to 2012: Phylogenetic analysis of surveillance data. |
Infect Genet Evol |
|
| Yan (2014) |
HIV-1 diversity and drug-resistant mutations in infected individuals in Changchun, China. |
PLoS ONE |
|
| Yang (2000) |
Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O. |
ARHR |
|
| Yang (2004) |
Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya. |
ARHR |
|
| Yang (2011) |
Global surveillance of transmitted HIV-1 drug resistance in PEPFAR-supported countries using a broadly sensitive genotyping assay |
CROI 2011 |
|
| Yang (2012) |
Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV-1 diagnosed patients infected with CRF01_AE and CRF07_BC virus in Guangdong Province, China |
ARHR |
|
| Yang (2020) |
Genomic Characterization of a Novel HIV-1 CRF01_AE /B Recombinant in Henan Province, China. |
Direct Genbank Submission |
|
| Yang (2002) |
On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. |
AIDS |
|
| Yang (2003) |
Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. |
J Virol |
|
| Yang (2015) |
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study. |
J Antimicrob Chemother |
|
| Yang (2021) |
Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020). |
Infection |
|
| Yant (2019) |
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. |
Nat Med |
|
| Yao (2015) |
Trends of subtype variation of human immunodeficiency virus type 1 in Zhejiang Province, China. |
Virus Genes |
|
| Yao (2015) |
Clinical and epidemiologic characteristics of 92 HIV-1 clinical isolates from antiretroviral-naive HIV-1-infected individuals in Yunnan province, China. |
Direct Genbank Submission |
|
| Yaotse (2009) |
Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients. |
Infect Genet Evol |
|
| Yaqub (2019) |
Circulation of multiple subtypes (A, G and CRFs 02_AG) of human immunodeficiency virus type 1 (HIV-1) in selected districts of Punjab province, Pakistan. |
Arch Virol |
|
| Yates (2006) |
In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385. |
AAC |
|
| Ye (2014) |
Phylogenetic and temporal dynamics of human immunodeficiency virus type 1B in China: four types of B strains circulate in China. |
ARHR |
|
| Ye (2020) |
Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study. |
AIDS |
|
| Ye (2011) |
Sequence analysis of the gag-pol gene of human immunodeficiency virus type 1 of intersubtype (B/C) recombinant strain in Beijing, China. |
ARHR |
|
| Ye (2012) |
The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China. |
ARHR |
|
| Ye (2020) |
HIV-1 Drug Resistance in ART-Naive Individuals in Myanmar. |
Infect Drug Resist |
|
| Yebra (2009) |
Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007). |
ARHR |
|
| Yebra (2010) |
HIV-1 non-B subtypes: high transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability. |
Antiviral Res |
|
| Yebra (2018) |
A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project. |
PLoS ONE |
|
| Yerly (2001) |
Nosocomial outbreak of multiple bloodborne viral infections. |
J Infect Dis |
|
| Yerly (2004) |
HIV-1 co/super-infection in intravenous drug users |
AIDS |
|
| Yin (2020) |
Molecular Epidemiology of HIV-1 in Jiangsu Province, Southeast China: Genotypes and HIV-1 Transmission Networks Among Newly Diagnosed Men Having Sex with Men in 2017. |
AIDS Res Hum Retroviruses |
|
| Yoshinaga (2015) |
Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection. |
AAC |
|
| Yoshinaga (2018) |
Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors. |
Antiviral Res |
|
| Yoshinaga (2019) |
Barrier to Resistance of Dolutegravir in Two-Drug Combinations. |
Antimicrob Agents Chemother |
|
| Young (1995) |
L-743,726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. |
AAC |
|
| Youngpairoj (2012) |
Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon. |
ARHR |
|
| Youngpairoj (2014) |
Reference panel of cloned HIV-2 plasmid DNA for nucleic acid assay development, evaluation, and quality monitoring. |
J Clin Virol |
|
| Yu (2023) |
HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020. |
Biomed Environ Sci |
|
| Yu (2022) |
Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China. |
Pharmgenomics Pers Med |
|
| Yu (2009) |
Genetic diversity and drug resistance of HIV type 1 circulating recombinant form_BC among drug users in Guangdong province. |
ARHR |
|
| Yu (2020) |
Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China. |
Curr HIV Res |
|
| Yuan (2018) |
Characteristics of HIV-1 Molecular Epidemiology in Suzhou, China, from 2009 to 2014. |
Virol Sin |
|
| Zachary (2001) |
Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo. |
Clin Infect Dis |
|
| Zagury (1988) |
Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. |
PNAS |
|
| Zain (2015) |
Drug resistance mutations among virological failure HIV-1 infected patients in Malaysia. |
Trop Biomed
|
|
| Zain (2017) |
Identifications of drug resistance mutations among antiretroviral treatment naive HIV-1 patients in Peninsular Malaysia. |
Asian Pac J Trop Med |
|
| Zaki (2020) |
Genotyping and antiretroviral drug resistance of human immunodeficiency Virus-1 in Jazan, Saudi Arabia. |
Medicine (Baltimore) |
|
| Zarandia (2006) |
HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia. |
ARHR |
|
| Zeh (2005) |
Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections. |
ARHR |
|
| Zeh (2016) |
Molecular epidemiology and transmission dynamics of recent and long-term HIV-1 infections in rural western Kenya. |
PLoS ONE |
|
| Zeng (2012) |
Emergence of a new HIV type 1 CRF01_AE variant in Guangxi, southern China. |
ARHR |
|
| Zeng (2014) |
Reconstituting the epidemic history of mono lineage of HIV-1 CRF01_AE in Guizhou province, Southern China. |
Infect Genet Evol |
|
| Zeng (2011) |
The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers. |
Transfusion |
|
| Zeng (2013) |
HIV-1 genotypic diversity and prevalence of drug resistance among treatment naive HIV-infected individuals in Chengdu of China. |
Virus Genes |
|
| Zeng (2017) |
The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. |
PLoS ONE |
|
| Zeng (2020) |
HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China. |
AIDS Res Hum Retroviruses |
|
| Zhang (2021) |
Molecular surveillance of HIV-1 newly diagnosed infections in Shenzhen, China from 2011 to 2018. |
J Infect |
|
| Zhang (2022) |
Analysis of HIV-1 molecular transmission network reveals the prevalence characteristics of three main HIV-1 subtypes in Shenzhen, China. |
J Infect |
|
| Zhang (2018) |
Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings. |
PLoS ONE |
|
| Zhang (2010) |
Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed HIV type 1-infected patients in Shandong province, China. |
ARHR |
|
| Zhang (2015) |
Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China. |
J Med Virol |
|
| Zhang (2015) |
Genetic characteristics of CRF01_AE among newly diagnosed HIV-1-infected 16- to 25-year olds in 3 geographic regions of Guangxi, China. |
Medicine (Baltimore) |
|
| Zhang (2017) |
Phylogenetic characteristics of HIV-1 among travelers entering China from Myanmar: A retrospective study. |
J Med Virol |
|
| Zhang (2017) |
Phylodynamic Analysis Revealed That Epidemic of CRF07_BC Strain in Men Who Have Sex with Men Drove Its Second Spreading Wave in China. |
AIDS Res Hum Retroviruses |
|
| Zhang (2019) |
Genome sequences of a novel HIV-1 circulating recombinant form (CRF100_0107) identified among men who have sex with men in Shaanxi, China. |
Direct Genbank Submission |
|
| Zhang (2024) |
Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021. |
Virulence |
|
| Zhang (2014) |
Identification and characterization of a novel HIV-1 circulating recombinant form (CRF59_01B) identified among men-who-have-sex-with-men in China |
PLoS ONE |
|
| Zhang (2018) |
Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors. |
J Infect Dis |
|
| Zhang (2015) |
A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs. |
J Antimicrob Chemother |
|
| Zhang (2018) |
Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068. |
JAIDS |
|
| Zhang (2020) |
Genetic Diversity, Complicated Recombination, and Deteriorating Drug Resistance Among HIV-1-Infected Individuals in Wuhan, China. |
AIDS Res Hum Retroviruses |
|
| Zhang (2022) |
Using molecular network analysis to explore the characteristics of HIV-1 transmission in a China-Myanmar border area. |
PLoS One |
|
| Zhang (1997) |
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its gag substrate cleavage sites. |
J Virol |
|
| Zhao (2010) |
Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon. |
ARHR |
|
| Zhao (2012) |
CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon. |
JAIDS |
|
| Zhao (2016) |
The dynamics of the HIV epidemic among men who have sex with men (MSM) from 2005 to 2012 in Shenzhen, China. |
Sci Rep |
|
| Zhao (2020) |
HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-naive blood donors in China. |
Sci Rep |
|
| Zhao (2021) |
Identification, Genetic Characterization and Validation of Highly Diverse HIV-1 Viruses for Reference Panel Development. |
Viruses |
|
| Zhao (2014) |
Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013. |
PLoS ONE |
|
| Zhao (2025) |
Resistance to Dolutegravir in Treatment-experienced Patients in South Africa: A Retrospective Cohort Study. |
J Acquir Immune Defic Syndr |
|
| Zheng (2013) |
Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance. |
PLoS ONE |
|
| Zhong (2003) |
Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: Further evidence of broad HIV type 1 genetic diversity. |
ARHR |
|
| Zhong (2007) |
Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. |
ARHR |
|
| Zhou (2008) |
A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, China. |
AIDS |
|
| Zhou (2014) |
Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission. |
BMC Infect Dis |
|
| Zhu (1995) |
Was HIV present in 1959? |
Nature |
|
| Zhukova (2021) |
Cuban history of CRF19 recombinant subtype of HIV-1. |
PLoS Pathog |
|
| Ziermann (2000) |
A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir. |
J Virol |
|
| Zolfo (2010) |
Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort. |
ARHR |
|
| Zolopa (2007) |
Resistance profile after viral rebound on atazanavir-containing therapy: focus on protease inhibitor naive subjects in the IMPACT study (BMS AI424-128). |
IHDRW 2007 |
|
| Zolopa (1999) |
HIV-1 genotypic resistance patterns predict response to saquinavir/ritonavir in patients in whom previous protease inhibitor therapy failed. |
Ann Intern Med |
|
| Zuckerman (2019) |
Sexual intermingling of Arab and Jewish MSM in Israel: results of a molecular epidemiology study. |
AIDS |
|
